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ILLNESS PERCEPTIONS AND SELF-MANAGEMENT IN LATE-LIFE CHRONIC 
DISORDERS 
Hyejin Kim, PhD 
University of Pittsburgh, 2019 
 
Background: As chronic disorders become increasingly prevalent among persons 50 years of age 
and older, understanding how an individual perceives an illness in the context of disease 
characteristics (physical vs. mental), and what self-management strategies are adopted in response 
to these perceptions becomes an important issue.  
Purpose: The aims of this study were 1) to examine the associations between illness perceptions, 
self-efficacy, and self-management, and 2) to identify similarities and differences among persons 
(≥ 50 years of age) with type 2 diabetes (T2DM) and those with mild cognitive impairment (MCI), 
treating the conditions as exemplars of late-life physical and mental disorders. 
Methods: This cross-sectional study used secondary analyses of existing datasets. The coherence 
and causality subscales of the Revised Illness Perception Questionnaire, Brief Illness Perception 
Questionnaire, Self-efficacy for Managing Chronic Disease, Risk Evaluation and Education for 
Alzheimer’s disease health behavior measure, and four-item Morisky Medication Adherence 
Scale, were used. In Aims 1 and 2, we performed hierarchical linear and logistic regression 
analyses while controlling for covariates to examine the associations between illness perceptions, 
self-efficacy, and self-management among persons with MCI and those with T2DM. In Aim 3, we 
conducted multivariate analysis of covariance (MANCOVA) and hierarchical linear regression to 
compare illness perceptions between the T2DM and MCI groups.  
v 
Results: Regardless of the disease characteristics (physical [T2DM] or mental [MCI]), illness 
perceptions or its interactions with covariates were associated with either self-efficacy or self-
management behaviors (p < .05) among participants with chronic disorders. Coherence was an 
important factor of self-management in both T2DM (b = .306, p = .035) and MCI (b = .051, p = 
.089) groups when the interactions terms were added to the models. With the exception of the 
consequences dimension, each dimension of illness perception was significantly different between 
the T2DM and MCI groups.  
Conclusion: Future research should incorporate illness perceptions in the context of disease 
characteristics (physical vs. mental), sociodemomegraphics, and comorbid conditions into 
development of interventions aimed at improving both self-efficacy and self-management among 
older adults with chronic disorders, which may result in one’s positive health outcomes such as 
quality of life.  
vi 
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1.0 Proposal Introduction 
The following dissertation proposal, Illness Perceptions and Self-management in Late-life 
Chronic Disorders, is prepared according to the Doctoral Manuscript Dissertation Guidelines from 
the University of Pittsburgh School of Nursing. In response to the National Institute of Nursing 
Research (NINR)’s Strategic Plan focus “Self-Management: Improving Quality of Life for 
Individuals with Chronic Illness”, I propose to examine illness perceptions and self-management 
in late-life chronic disorders using a novel approach that compares individuals experiencing 
physical health conditions to those experiencing mental health conditions to enhance our 
understanding of how people experience late-life chronic disorders. In Manuscript 1, I will 
examine how persons with mild cognitive impairment (MCI) perceive their memory problems and 
what self-management strategies are performed in association with those perceptions, treating MCI 
as an exemplar of a common late-life mental health disorder. In Manuscript 2, I will examine the 
associations between illness perceptions, self-efficacy, and medication adherence in persons with 
type 2 diabetes mellitus (T2DM), treating T2DM as an exemplar of a late-life physical health 
disorder. Manuscript 3 will use multivariate analysis of covariance (MANCOVA) to identify 
similarities and differences in illness perceptions between older adults experiencing MCI and 
T2DM. The findings from this study will provide the foundation to develop behavioral 
interventions, disease management guidelines, or protocols for increasing physical or mental 
health in the older adult population, with significant nursing and public health implications. 
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1.1 Specific Aims 
As chronic disorders become increasingly prevalent among persons 50 years of age and 
older, understanding how an individual perceives an illness and what self-management strategies 
are adopted in response to these perceptions becomes an important issue. Evidence suggests, for 
example, that not smoking, exercising regularly, avoiding alcohol consumption, maintaining a 
healthy body weight, and getting a sufficient amount of sleep are among the most common 
behavioral determinants of health for chronic disorder prevention (Liu et al., 2016). While a wide 
range of factors likely contribute to one’s preventative health behaviors, the performance of such 
behaviors may be also influenced by one’s thoughts and feelings about what health conditions they 
may be susceptible to. Among individuals who are diagnosed with specific conditions, the 
adoption of recommended secondary prevention behaviors or health behaviors for self-
management may depend on what an individual’s health condition means to them, a concept which 
is referred to as illness perceptions (Leventhal, Brissette, & Leventhal, 2003).  
Based on the characteristics of a disorder, including signs, symptoms, etiology, and 
pathophysiology, chronic disorders affecting older adults may fall into broad categories, those 
which affect physical health (e.g., type 2 diabetes mellitus [T2DM], cancers, chronic respiratory 
diseases) and those which affect mental health (e.g., mild cognitive impairment [MCI], 
Alzheimer’s disease [AD], depression). Even though clinicians, scientists, and public health 
experts increasingly recognize the complex overlay of physical and mental health disorders, it is 
plausible older adults may hold distinct views regarding what they perceive as physical versus 
mental health disorders. Persons with physical health disorders such as T2DM may have more 
expected perceptions about the treatment and prognosis; however, those with mental health 
disorders such as MCI may hold uncertain and equivocal beliefs on their conditions. Specifically, 
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while the adverse consequences of T2DM can be prevented by a widely agreed upon set of self-
management like taking medications, exercising, and maintaining healthy eating habits (American 
Diabetes Association [ADA], 2018), effective ways to arrest age-related cognitive impairment 
(e.g., MCI, AD) have not been identified. This can lead to the potential for misunderstanding, 
stigma, anxiety, and, even suicide ideation in the face of disease progression with no treatment 
(Karlawish, 2011; Milne & Karlawish, 2017). In addition, late-life physical disorders such as 
T2DM can be treated with lifestyle changes and medications (ADA, 2018), therefore, affected 
individuals may have higher self-efficacy, a strong judgement in their ability to accomplish a task 
for future health outcomes. Despite the possibility of such fundamental differences in how affected 
individuals perceive their chronic disorders, direct comparisons of illness perceptions among 
persons diagnosed with different late-life health disorders is lacking. Most research on both illness 
perceptions and self-management for late-life chronic disorders has focused on specific physical 
or mental health disorders one at a time. This proposed study will fill this significant gap by 
examining T2DM and MCI, which are two common types of late-life physical and mental 
disorders, and will make a substantial contribution to future research and clinical practice. The 
broad, long-term goals of the proposed program of research are to 1) improve and promote self-
management of late-life chronic disorders, and 2) reduce the personal and societal burden of 
chronic disorders. 
I will use quantitative methods to examine and gain insight into illness perceptions and 
self-management of chronic disorders, particularly T2DM and MCI. The primary purpose of this 
study is to examine the association between illness perceptions and self-management among 
persons with T2DM and those with MCI, and to identify similarities and differences in illness 
perceptions between those two conditions. I will conduct a quantitative, cross-sectional, and 
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descriptive study through secondary analyses of existing data from several independent studies. 
The Common Sense Model (Leventhal et al., 2003), which is the most widely used and 
empirically validated theoretical model of illness perceptions, will guide the proposed study. 
Hence, the specific aims of this study are: 
Specific Aim 1. To examine the association between illness perceptions and self-management 
among persons with MCI.  
Specific Aim 2. To examine the associations between illness perceptions, self-efficacy, and 
medication adherence among persons with T2DM.  
Specific Aim 3. To identify similarities and differences in illness perceptions of T2DM and 
MCI, as common examples of late-life physical and mental chronic disorders.  
 
Findings from the proposed study will provide the foundation for the future directions in 
developing interventions, strategies, as well as policies for the older population with chronic 
disorders. Furthermore, these findings will also have applications in other chronic disorder 
contexts, including both physical and mental health conditions.  
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1.2 Background 
Illness Perceptions in Chronic Disorders: Making Sense of Potentially Life-long Health Threats 
Receiving a new diagnosis, learning one is at particular risk for a disease, or newly 
experiencing symptoms of a yet undiagnosed illness, can lead an individual to begin forming 
thoughts and feelings about a threat to one’s physical or mental health. Leventhal’s (2003) 
Common Sense Model (CSM), an empirically validated conceptual framework, guides the 
proposed study to understand such illness perceptions and how they impact ongoing and future 
health threats (see Figure1). The CSM identified five main dimensions of illness perceptions: 1) 
identity- one’s beliefs about the symptoms they view as being part of the disease; 2) consequences- 
the expected outcomes of the illness; 3) cause- one’s beliefs about the cause of the illness; 4) 
timeline- one’s beliefs that how long the illness will last (e.g., acute, chronic, cyclic); and 5) 
cure/control- an individual’s beliefs whether they can control the illness or not. Two more 
dimensions, illness coherence- one's belief that the illness is understandable or being confused; 
and emotional representations- how the illness affects the individual emotionally (e.g., angry, 
upset), were later added to the CSM (Moss-Morris et al., 2002). 
While acute health conditions (e.g., cold, heart attack) allow us to expect symptoms and a 
short timeline, chronic health conditions, both physical (e.g., T2DM, hypertension, heart failure) 
and mental (e.g., MCI, AD, depression) disorders are sometimes completely asymptomatic and 
not easily noticeable, suggesting that persons with chronic disorders may have different illness 
perceptions as compared to those with acute disorders. There has been research on illness 
perceptions in participants with a wide range of chronic disorders, including coronary artery 
disease (CAD) (Noureddine, Massouh, & Froelicher, 2013), hypertension (Chen, Tsai, & Chou, 
2011; Stallings, 2016), T2DM (Al-Amer, Ramjan, Glew, Randall, & Salamonson, 2016; Martinez, 
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Lockhart, Davies, Lindsay, & Dempster, 2018), schizophrenia (Hussain, Imran, Hotiana, Mazhar, 
& Asif, 2017), and depression (Antoniades, Mazza, & Brijnath, 2017). Noureddine and colleagues 
(2012) found that the majority of the participants perceived CAD to be a chronic timeline with 
serious consequences. In a study by Stallings (2016), personal control, treatment control, and 
illness coherence were high within a sample of individuals with hypertension. Interestingly, in 
sharp contrast to such physical health conditions, ambiguity regarding the disease as being chronic 
and cyclic has surfaced in analyses of persons with schizophrenia (Hussain et al., 2017) and 
depression (Brown et al., 2001). 
In the CSM, illness perceptions are also described as underlying factors in the initiation or 
maintenance of one’s self-management behaviors. In a study of persons with hypertension, Chen 
et al. (2011) found that illness identity was related to adherence to therapeutic regimens, suggesting 
that the beliefs regarding illness-related symptoms (e.g., headache) are associated with one’s self-
reported self-management behaviors such as healthy diet, exercise, or medication taking. Kaptein 
and colleagues (2008) found that people who believed their asthma has an acute timeline were less 
likely to use a peak flow meter or to keep routine health care visits for asthma. Beliefs about 
treatment control were also significantly related to one’s adherence to medication in both physical 
and mental chronic disorders. Individuals who felt their treatment could effectively control their 
disease, for example, blood pressure (Ross, Walker, & MacLeod, 2004) or bipolar disorder 
(Averous, Charbonnier, Lagouanelle-Simeoni, Prosperi, & Dany, 2018) were more likely to take 
their medications as prescribed. However, existing research has focused more on adults in mid-
life, not late-life. In view of the fact that the prevalence of late-life chronic disorders is increasing 
due to the greater longevity, aging may provide an important context that could impact such 
relation of illness perceptions to one’s self-management. 
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Despite the activation of illness perceptions may result in one’s following self-management 
behaviors in both physical and mental chronic disorders, research on such association, illness 
perceptions and self-management, from the perspective of the disease characteristics is lacking. In 
addition, direct comparisons of illness perceptions in physical versus mental health disorders have 
not been conducted.  
 
Figure 1. Conceptual Framework of Illness Perceptions and Self-management in Late-life 
Chronic Disorders (Adapted from Leventhal et al. [2003]) 
 
Illness Perceptions in Late-life Physical Health Disorder: T2DM 
A number of chronic physical disorders including heart disease, cancer, stroke, and T2DM 
pose increasing risks as people age (Centers for Disease Control and Prevention [CDC], 2017a). 
Diabetes, especially T2DM, which is a common and life-long chronic physical disorder among 
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older adults, continues to contribute to death despite the fact that effective medications including 
oral medications and insulin are available. Blood glucose level in persons with T2DM can be 
appropriately controlled by performing self-management behaviors such as physical activity, 
healthy diets, or medication taking, and those behaviors reduce the risk of severe complications 
associated with T2DM (ADA, 2018). As a potential key factor to engaging in such behaviors, 
developing an understanding of individuals’ illness perceptions in late-life T2DM in this line of 
research is a critical issue.  
Recent evidence suggests that persons with T2DM hold a strong belief that their condition 
is chronic (Al-Amer et al., 2016; Hemphill, Stephens, Rook, Franks, & Salem, 2013) and T2DM 
leads to serious consequences (Al-Amer et al., 2016). In a study by Al-Amer and colleagues 
(2016), the participants typically perceive themselves to have a clear understanding and high 
personal control over the disease. Taken together, these illness perceptions might point to an 
increased tendency to perform T2DM-related self-management behaviors. Yet, reports on 
engagement in such behaviors among persons with T2DM suggest wide variability. Regarding the 
emotional component of illness perception, one study (van Esch, Nijkamp, Cornel, & Snoek, 2014) 
showed that despite the participants perceiving themselves to have a good understanding about 
their symptoms and disease, T2DM does not considerably affect them emotionally, indicating that, 
typically, persons with T2DM do not feel angry, scared, or depressed in response to their diagnosis 
or its manifestations. 
However, the above-described research on illness perceptions in T2DM has limitations. 
The studies by Al-Amer et al. (2016) and Van Esch et al. (2014) were not limited to the older 
population, included adults aged 18 and older. Hemphill and colleagues (2013) focused on late-
life T2DM, but investigated only one dimension of illness perceptions, timeline perceptions of 
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T2DM (e.g., acute or chronic). These are problematic because research involving older population 
who have diverse beliefs on their disease is important to enhance our understanding of unique 
characteristics of illness perceptions in late-life T2DM. 
 
Illness Perceptions in Late-life Mental Health Disorder: MCI 
MCI has been described as an intermediate condition between normal cognition and AD. 
Persons with MCI experience mild cognitive changes that are noticeable, but do not affect the 
ability to perform activities of daily living (Petersen et al., 1999). Since the concept of MCI was 
introduced by Petersen and colleagues (1999), it has become an increasingly important topic in the 
field of late-life mental health. While persons with amnestic MCI experience memory impairment 
predominantly, those with non-amnestic MCI are more likely to have impairment of other 
cognitive domains such as language, attention/executive function, or visuospatial skills (Petersen, 
2004). According to the recent report from the American Academy of Neurology (AAN), MCI 
prevalence increases with age and the cumulative incidence for the conversion to dementia in older 
adults with MCI followed for 2 years was 14.9% (Petersen et al., 2018). However, this impairment 
does not necessarily lead to development of AD, and in some individuals, MCI reverts to normal 
cognition or remains stable (Alzheimer’s Association [AA], 2017), indicating that persons with 
MCI may feel confused or uncertain about their memory problems and its possibility of 
progression to AD.  
Research indicates that certain dimensions of illness perceptions, such as illness coherence, 
emotional representations (e.g., angry, scared, upset), and beliefs about causality, may be 
particularly important in the population of MCI. For example, Lin, Gleason, and Heidrich (2012) 
found that one third of participants believed MCI would convert to dementia, whereas most 
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participants were not sure about the prognosis of their memory problems. Concerns about 
uncertainty have also surfaced in qualitative research. In a metasynthesis of 17 qualitative 
interviews examining the experience of living with MCI (Gomersall et al., 2015), ambiguity was 
a key theme, suggesting that persons with MCI experienced difficulties in making sense of their 
memory problems. Lingler and colleagues (2006) also found that the participants expressed 
uncertainty and unpredictability about MCI, and those feelings may be linked to one’s 
comprehensibility of the disease because individuals who feel confused about their memory issues 
would not have a clear picture of risk factors of MCI or their future plans. In stark contrast to 
physical health conditions such as T2DM, emotional representations (e.g., feelings of anger, 
anxiety, or worry) are important in the MCI population because of uncertainty regarding the 
disease. Fear (Beard & Neary, 2013) and anxiety (Samsi et al., 2014) have also emerged in 
qualitative interviews, and memory or thinking difficulties were related to higher emotional upset 
among persons with MCI (Lingler, Terhorst, Schulz, Gentry, & Lopez, 2016) 
Although there is no proven means of preventing further cognitive decline in MCI, Langa 
and Levine (2014) have laid out an evidence-based guideline for self-management of MCI 
regardless of subtype of MCI, either amnestic or non-amnestic MCI. It is, therefore, necessary to 
examine the extent to which the individual’s beliefs regarding the cause of the illness, because 
these beliefs can influence following self-management behaviors (Weiner, 1985, 1986). One study 
suggests that persons with MCI believed the disease is controllable by personal strategies or 
medical treatment (Lin, Gleason, & Heidrich, 2012). A more recent study of attribution of MCI 
etiology (Rodakowski, Schulz, Gentry, Garand, & Lingler, 2014)  revealed the participants most 
frequently attributed uncontrollable factors (e.g., heredity, normal aging) to MCI etiology. 
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However, research on such association, individuals’ illness perceptions about the cause of the 
disease and self-management in persons with MCI is lacking.   
 
Self-management & Self-efficacy in Chronic Disorders: Catalysts for One’s Health & Well-being 
Self-management is a promising strategy to manage a chronic health condition, which has 
become a public health issue of increasing significance. Basically, in the context of health care, 
self-management refers to the actions taken by individuals to promote their own health and well-
being (Starfield, Hyde, Gervas, & Heath, 2008). Examples of self-management include lifestyle 
changes and medication management. Identifying an individual’s self-management is a first step 
to reduce the burden of chronic disorders because it provides basic information in development of 
future interventions aiming at optimizing self-management behaviors. Evidence shows that 
engaging in self-management behaviors may reduce the risk of complications and death from 
chronic disorders (Aune et al., 2017; Warburton, Nicol, & Bredin, 2006). In a prospective study 
examining health behavior changes after diagnosis of chronic disorders (heart disease, diabetes, 
cancer, stroke, and lung disease), Newsom and colleagues (2012) found that people changed their 
lifestyles such as smoking habits and alcohol consumption to reduce risk of complications and 
death. Although those self-management behaviors may be influenced by factors such as one’s 
illness perceptions (Leventhal, Leventhal, & Breland, 2011; Leventhal, Weinman, Leventhal, & 
Phillips, 2008), Newsom et al. (2012) did not investigate what factors are associated with such 
behaviors, and focused solely on physical disorders, despite the increasing importance of late-life 
mental disorders such as MCI.  
Along with lifestyle changes, medication adherence is another important self-
management behavior to reduce the risk of adverse health outcomes and health care costs (Piette, 
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Heisler, & Wagner, 2004). In recent review studies of chronic physical or mental disorders 
(Abegaz, Shehab, Gebreyohannes, Bhagavathula, & Elnour, 2017; Engelkes, Janssens, de Jongste, 
Sturkenboom, & Verhamme, 2015; Martin-Vazquez, 2016), the investigators examined the levels 
of medication adherence. Although adherence to medication may be attributable to one’s illness 
perceptions, such association was not investigated in the studies by Abegaz et al. (2017), Engelkes 
et al. (2015), and Martin-Vazquez (2016).  
Additionally, self-efficacy, an individual judgement of how well one can perform the 
behaviors required to achieve positive outcomes (Bandura, 1977), plays a critical role in one’s 
successful health outcomes. Improving one’s self-efficacy is a key goal of psychosocial 
interventions for persons with chronic disorders such as hypertension (Kim & Song, 2015), 
diabetes (Pascoe, Thompson, Castle, Jenkins, & Ski, 2017), heart failure (Rajati et al., 2014) and 
fatty liver disease (Javanmardifard, Ghodsbin, Kaviani, & Jahanbin, 2017). Evidence suggests that 
one’s illness perceptions are related to self-efficacy (Bonsaksen, Lerdal, & Fagermoen, 2012; Lau-
Walker, 2006). Schüz and colleagues (2012) found that older adults with multiple chronic health 
conditions who believed their disease to be under personal and treatment control were more likely 
to have higher self-efficacy for dealing with different demanding situations. One study showed 
that certain dimensions of illness perceptions, identity, consequences, and control were associated 
with one’s self-efficacy for managing insulin dependent diabetes (Griva, Myers, Newman, & 
Health, 2000). However, previous research has investigated young adults aged between 15 and 25 
years (Griva et al., 2000) or certain dimensions of illness perceptions (Schuz, Wurm, Warner, & 
Ziegelmann, 2012), suggesting that research on the association between more diverse aspects of 
illness perceptions and self-efficacy in late-life chronic disorders is needed as a first step to develop 
interventions at improving one’s self-efficacy for managing chronic health conditions. 
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Self-management and Self-efficacy in Late-life Physical Disorder: T2DM  
Diabetes, particularly T2DM affects people who are 50 and older, and the percentage 
increases with age, estimating 25% of people aged 65 years or older had diabetes in 2015 (CDC, 
2017). The ADA updates “Standards of Medical Care in Diabetes” and experts recommend 
lifestyle management (e.g., physical activity, eating habits), which is a fundamental aspect of 
successful diabetic management (ADA, 2018), along with an appropriate pharmacologic therapy.  
Since the first report of the treatment of diabetes was introduced in 1906 (ADA, 2014a), a 
growing body of literature has identified the importance of medication adherence throughout the 
individual’s lifetime because good glycemic control has been correlated with reduced risk of 
diabetic complications and health care resource utilization (Asche, LaFleur, & Conner, 2011). In 
a systematic review and meta-analysis of 48 studies, McGovern and colleagues (2018) analyzed 
literature identifying the types of medication which are related to better medication adherence. 
Although contributing factors such as one’s illness perceptions are associated with adherence to 
medication in chronic disorders (Bolman, Arwert, & Vollink, 2011; Tanenbaum et al., 2015), 
McGovern et al. (2018) compared medication adherence and persistence depending on medication 
classes, and did not examine such contributing factors. Previous cross-sectional or cohort studies 
have assessed medication adherence in persons with T2DM (Ashur, Shah, Bosseri, Morisky, & 
Shamsuddin, 2015; McAdam-Marx et al., 2014; Radwan, Elsous, Al-Sharif, & Abu Mustafa, 
2018); however, the investigators did not focus on the disease in late-life (Ashur et al., 2015; 
McAdam-Marx et al., 2014; Radwan et al., 2018) nor did the association between illness 
perceptions and medication adherence was not investigated (McAdam-Marx et al., 2014; Radwan 
et al., 2018).  
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Although one’s self-efficacy and its association with illness perceptions are also critical 
factors in achieving successful health outcomes (Bonsaksen et al., 2012; Lau-Walker, 2006), few 
studies investigated such factors among persons with T2DM. One study (Al-Amer et al., 2016) 
examined such association among adults with T2DM; however, they included adults who are 18 
years of age or older, suggesting that the investigators did not focus on late-life T2DM.  
 
Self-management in Late-life Mental Disorder: MCI 
As people age, the quality of mental health becomes an important concern for older adults. 
Although no medications or interventions have been established as effective at delaying or 
preventing progression from MCI to AD, nationwide efforts remain underway and experts have 
agreed that, most likely, lifestyle interventions (e.g., aerobic exercise, mental activity) will be 
required to stabilize or reverse the course of MCI (Langa & Levine, 2014). In line with this, the 
recent guideline from the AAN suggests that regular exercise and cognitive interventions may be 
beneficial in enhancing either an overall health or cognitive function (Petersen et al., 2018). This 
mounting evidence of the value of interventions for persons with MCI underscores the significance 
of one’s self-management, which have been typically linked to secondary prevention, aiming to 
detect or treat memory problems early on.  
Research on self-management in persons at risk for AD has shown mixed results. In a study 
of health behavior changes by Chao and colleagues (2008), participants were likely to initiate 
taking medications/vitamins and change their lifestyle (e.g., changes in diet or exercise). A more 
recent investigation reported that cognitive stimulation was the most frequent behavior to be 
adopted among persons with MCI (Morgan, Garand, & Lingler, 2012). Lin et al. (2012) also found 
that the participants highly engaged in dementia prevention behaviors such as mental stimulation 
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and physical exercise. Although illness perceptions may affect one’s initiation or maintenance of 
behaviors for managing health threats (Leventhal et al., 2003), as described above, such an 
association, illness perceptions and self-management behaviors, has not been investigated in the 
context of MCI. This fact highlights the compelling need for researchers to identify such 
association among persons with MCI. 
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1.3 Significance 
The significance of modifiable factors for early detection and prevention of late-life 
chronic disorders has led to increasing focus on individuals’ own beliefs on the illness and their 
self-management strategies. As demonstrated in Background section, above, despite the need for 
understanding one’s illness perceptions depending on the disease characteristics (physical vs. 
mental health), significant gaps remain as there has been no research on differences and similarities 
of illness perceptions between physical [T2DM] and mental [MCI] disorders. Building on previous 
research on chronic disorders, there is also a need to examine illness perceptions and self-
management behaviors because those behaviors may differ by the characteristics of the disorder 
and individuals’ own beliefs as threat to health. In response to the NINR’s Strategic Plan focus 
“Self-Management: Improving Quality of Life for Individuals with Chronic Illness”, I propose to 
identify the individual’s illness perceptions and its associations with self-efficacy and self-
management using secondary analyses of existing two NIH-funded datasets to establish the 
groundwork for either future research or clinical practice.  
This theory-driven proposed study is significant because of its potential to guide the 
conduct of future research, including the development of interventions aiming at promoting 
appropriate self-management behaviors for persons with chronic disorders. In addition to 
this, our findings may also inform clinical practice as health care professionals may appropriately 
incorporate individuals’ patterns of illness perceptions and self-management behaviors into 
clinical evaluation. 
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1.4 Innovation 
As the field of chronic disorder research moves toward identifying secondary prevention 
strategies, the timing of this proposed study corresponds to this movement because persons with 
T2DM and those with MCI will represent key targets for treatments to delay or stop disease 
progression. Using several novel and innovative methodological approaches, I will identify an 
individual’s illness perceptions and self-management, including self-efficacy, which are potential 
key factors in developing effective interventions. First, I will use two quantitative data from T2DM 
and MCI participants ages 50 and older, which will provide information on clinical and public 
health practices for persons from late-life physical and mental disorder groups into research. To 
my knowledge, this proposed study is the first investigation to compare illness perceptions 
of two common late-life chronic disorders. The exemplar conditions we have identified, 
T2DM and MCI, are both receiving substantial attention as prevalent and growing late-life 
physical and mental health conditions. In addition to this, an innovative way to categorize the 
attributions of MCI etiology (See Methods section in Aim 1) will allow us to group individuals’ 
beliefs into two categories, potentially uncontrollable or controllable factors. The novelty of the 
proposed study is the plan to apply findings from this approach to help comprehensive 
understanding of illness perceptions and how these perceptions are associated with self-efficacy 
and self-management, which may be useful for designing educational and intervention programs.  
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1.5 Preliminary Studies 
My first exposure to research on late-life chronic disorder was as a student in the Masters 
of Science in Nursing and certificate for gerontological nurse practitioner programs in Korea. 
During that time, I served as a research assistant and began to understand older adults’ chronic 
health conditions, with a particular emphasis on mental health issues such as MCI and AD. I 
published my thesis project titled, “A study of cognitive impairment, knowledge, and attitudes 
about Alzheimer’s disease among community-dwelling older adults in Korea.”   
Kim, H. & Jung, D. (2015). A study of cognitive impairment, knowledge and attitudes 
about Alzheimer’s disease among community-dwelling older adults in Korea. The 
Korean Gerontological Society, 35(3), 731-743. 
As a preliminary work, this study examined over 200 community-dwelling older adults and 
described basic knowledge and perceptions about AD in older adults who have not been diagnosed 
with cognitive impairment. Through my mentor’s funded grants, I remained actively involved in 
various research projects on the older population and recently co-authored a publication in 
Geriatric Nursing.  
Jung, D., Byun, J., Lee, M., & Kim, H. (2017). Psychometric testing of Korean versions 
of self-efficacy and outcome expectations for restorative care activities scales. 
Geriatric Nursing, 38(3), 207-212. 
Building on those research experiences, I have actively participated in research projects as 
a graduate student researcher (GSR) at the University of Pittsburgh Health Policy Institute and 
School of Nursing since 2016. Under the grant from the Stern Center for Evidence-based Policy 
(PI: James), Health Policy Related to Informal Caregiving, with a focus on translation from 
research to practice to policy, I performed literature reviews using a systematic review software 
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DistillerSR, and actively worked with other groups, including collaborations with database 
analysis and policy modeling groups to examine the effect of integrating informal caregivers into 
discharge planning on resource use in older adults. This experience brought interdisciplinary 
researchers together in pursuit of common goals and have provided valuable research training 
opportunities outside the School of Nursing. Working as a GSR for Dr. Jennifer Lingler’s grant 
from the National Institutes of Health (NIH) National Institute on Aging (NIA) (R01-AG046906), 
Return of Amyloid Imaging Research Results in MCI, not only supports by own personal interest 
in illness perceptions and self-management, but provides me with conceptual and methodological 
skills that will be applied in the proposed study. Working as a GSR with the MCI population fits 
into my own research. Our work was recently presented at an international conference in San 
Francisco, California. 
Lingler, J. H., Hu, L., Kim, H., Mattos, M., & Morris, J. (2017, July). How do Patients 
with Mild Cognitive Impairment and Their Care Partners Perceive the Potential 
Utility of PET Amyloid Imaging? Poster presentation at the 21st International 
Association of Gerontology and Geriatrics World Congress, San Francisco, CA. 
The manuscript of this qualitative work examining motivations for, and perceived drawbacks of, 
amyloid imaging among 30 MCI care dyads (persons with MCI + their care partners) is currently 
under review. 
Lingler, J. H., Roberts, J. S., Kim, H., Morris, J., Lu, H., Mattos, M., McDade, E., & Lopez, 
O. L. (2018 under review). Decisions regarding amyloid imaging among scan 
candidates with mild cognitive impairment.  
As an assignment in my doctoral-level course, Research Instrumentation, I tested the 
psychometric properties of the Health Behavior Assessment for persons with MCI using Dr. 
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Lingler’s dataset (R01-AG046906) and my results were presented as Correlates of Health 
Behaviors among Persons with Mild Cognitive Impairment at the 28th Greater Pittsburgh Nursing 
Research Conference.  
Kim, H. & Lingler, J. H. (2016, October). Correlates of Health Behaviors among Persons 
with Mild Cognitive Impairment. Oral presentation at the 28th Greater Pittsburgh 
Nursing Research Conference, Pittsburgh, PA. 
To extend this line of work, I received internal research funding from the University of Pittsburgh 
School of Nursing, Judith A. Erlen Nursing PhD Student Research Award, to support my planned 
dissertation study on illness perceptions and self-management behaviors among persons with MCI.  
To obtain the data for Aims 2 and 3 of the proposed study, I contacted Dr. Catherine 
Bender, a co-principal investigator (PI) of the Habit Study, and she provided the requested data 
(P01 NR010949). I have already screened these data through Dr. Susan Sereika’s PhD-level 
advanced statistics course, Advanced Quantitative Methods for Health Science Research, gained a 
better understanding of the essential body of knowledge on T2DM, and established the feasibility 
of the proposed study. This work is recently accepted for presentation at a regional conference in 
Newark, New Jersey.  
Kim, H., Sereika, S. M., & Bender, C. M. (2018, April). Illness Perceptions for Persons 
with Type 2 Diabetes: Associations with Health Outcomes. Poster presentation at the 
30th Annual Scientific Sessions of the Eastern Nursing Research Society, Newark, NJ. 
Taken together, my research experiences and training have provided me with the core 
competencies and knowledge, and allowed me to solidify the groundwork to conduct the proposed 
study. This proposed study expands my research efforts, in particular, my recently funded research 
on illness perceptions and self-management behaviors among persons with MCI.  
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1.6 Research Design and Methods 
I will conduct secondary analyses to examine illness perceptions and self-management in 
late-life chronic disorders, specifically MCI and T2DM, as these conditions represent common 
examples of largely mental (MCI) and physical (T2DM) disorders affecting older adults. Cross-
sectional data from a cohort of individuals with MCI (P50-AG005133), and baseline data from 
two NIH-supported clinical trials, the Result Study (R01-AG046906) and the Habit Study (P01-
NR010949), will be used.  
1.6.1  Manuscript 1 
Common Late-life Mental Disorder: MCI 
Aim 1: To examine the association between illness perceptions and self-management among 
persons with MCI. 
Design. A quantitative, cross-sectional, and descriptive study of illness perceptions and self-
management in MCI will be conducted (see Figure 2). I will combine two datasets to form a cohort 
of at least 130 persons with MCI. One set of data was collected as part of a study examining how 
persons with MCI and their care partners make sense of their memory problems and diagnosis. 
The other set of data (R01-AG046906) was collected as part of NIH-funded clinical trial, the Result 
Study, which was designed to determine the effect of receiving brain amyloid imaging research 
results on the understanding of MCI as a potential precursor to dementia. For the Result Study, 
only baseline data will be used for the proposed study. 
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Figure 2. Conceptual Framework (Aim 1) Adapted from Levental et al. (2003) 
 
Sample and Setting. For the first dataset, a total of 63 persons with MCI were referred to the 
parent study by staff from the University of Pittsburgh Alzheimer’s Disease Research Center 
(ADRC; P50-AG005133). Of those, 3 (4.8%) individuals declined, and the remaining 60 (95.2%) 
MCI participants provided written informed consent to this parent study. The second sample will 
be used from the Result Study dataset (R01-AG046906) and was also recruited from the ADRC 
and included written informed consent. The data collection of the Result Study is ongoing; 
however, I will include at least the 70 participants who are currently enrolled. In both studies, 
persons with MCI were included if they a) are ≥ 50 years of age; b) had an ADRC consensus 
diagnosis of MCI; c) reside within 50 miles of the University of Pittsburgh; d) have a care partner 
(family member or kin-like friend); and e) provided written informed consent to participate. 
Exclusion criteria for both studies were a) being medically unstable individuals and b) having 
evidence of active, untreated primary psychiatric disorders (e.g., depression, anxiety disorder). 
While those parent studies also included care partners of the MCI participants (e.g., family 
members, kin-like friends), I will include only persons with MCI in the proposed analysis.  
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Measures. Data describing the sample characteristics will be abstracted from each consenting 
person’s ADRC record. These data included basic sociodemographic (e.g., age, sex, race, level of 
education) and clinical (e.g., MCI subtype, duration of diagnosis) information, each participant’s 
cognitive function, and depressive symptomatology. Aim 1 key variables are described below with 
citations providing psychometric property evidence. See Appendix A for the copies of each 
measure which I will use for this proposed study.  
Key Variables. 
Illness Perceptions. The illness coherence component of illness perceptions will be measured using 
the illness coherence subscale of the Revised Illness Perception Questionnaire (IPQ-R) (Moss-
Morris et al., 2002). In both parent studies, this subscale was adapted for administration to persons 
with MCI and assessed perceived ambiguity concerning the meaning of MCI, contains 5 items, 
each rated on a 5-point Likert scale (strongly disagree [1] to strongly agree [5]) and summed to 
provide an overall rating. As recommended by Moss-Morris et al. (2002), the general IPQ-R 
phrasing, “my illness” was replaced with condition-specific terminology, “my memory or thinking 
difficulties” in the parent studies. Cronbach’s alpha for the coherence construct was .821 within 
this sample of persons with MCI (Lingler et al., 2016).  
In terms of the causality component of illness perceptions, participants were asked to list 
in rank order the three most important factors that they believe caused their memory or thinking 
difficulties. Of those three ranked factors, I will use the first ranked factor to examine the 
association between causality component and self-management behaviors. The categorization 
approach developed by Anderson, McCaul, and Langley (2011) will be adapted to describe 
attributions of MCI etiology either as potentially controllable or uncontrollable factors. While a 
study by Anderson and colleagues (2011) grouped the responses into 10 categories (e.g., lifestyle, 
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heredity/genetics, mental inactivity, aging, brain dysfunction, other medical problems, 
environment, stress), I will use two broader categories, either as potentially controllable or 
uncontrollable factors. Potentially controllable factors will be included such as stress, diet habits, 
overwork, alcohol, and smoking. Uncontrollable factors will be included such as aging, heredity, 
and personality. 
MCI-related Self-management Behaviors. In the first parent study, self-management behavior data 
were collected in two ways: chart review at the ADRC (to identify clinical recommendations made 
at the time of diagnosis) and by asking participants to self-report self-management behaviors that 
were initiated following the MCI diagnosis. In the proposed study, both of these data sources will 
be used and self-management behavior data will be manually recoded by the PI and undergraduate 
student research assistants to address the items assessed by the Risk Evaluation and Education for 
Alzheimer’s disease (REVEAL) Health Behavior measure (Chao et al., 2008), which was the self-
management behavior measure in the second parent study, the Result Study. The original 
REVEAL Health Behavior measure consists of eight items, which are “Yes (1)” or “No (0)” 
choices related to changes made specifically for the purpose of AD prevention (e.g., diet, physical 
activity, medications). First, of those eight items, I will use the nominal-scaled (Yes [1] or No [0]) 
five self-management behaviors - physical activity, medications, vitamins, herbal supplements, 
and mental activities. Of those five, vitamins and herbal supplements will be treated as one 
category. Therefore, the final MCI-related self-management behavior items in this proposed study 
will focus on: 1) physical activity, 2) medications, 3) vitamins/herbal supplements, and 4) mental 
activities (e.g., crossword puzzles, luminosity) with “Yes (1)” or “No (0)” choices for each item. 
Next, the ratio-scaled self-management behaviors will be also used to count the total number of 
performing MCI-related health behaviors using none (0) to all (4) scaling.  
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Sociodemographic Factors. Sociodemographic information, including age (in years), gender 
(male or female), race (white or non-white), education (less than 12 years or 12 or more years of 
education), and marital status (married or not married) will be extracted from the ADRC records. 
Clinical Factors. Duration of MCI symptoms and diagnosis (in months), MCI type (amnestic or 
non-amnestic), and the number of comorbid conditions will be abstracted from the participants’ 
ADRC record. To characterize each participant’s global cognitive status and level of depressive 
symptomatology, the total score of the Mini-Mental State Examination (MMSE) (Folstein, 
Folstein, & McHugh, 1975) and the Hamilton Rating Scale for Depression (HAM-D or HRSD) 
(Hamilton, 1960) will be also retrieved from the participants’ last annual ADRC visit records 
(corresponding most closely to the date of illness perception and self-management behavior data 
collection). The MMSE is a 30-point measure that assesses five areas of cognitive function. A 
score of greater than or equal to 24 points indicates a normal cognition. Cronbach’s alpha for the 
MMSE ranges from 0.62 to 0.81 in samples of older adults (Kabátová, Puteková, Martinková, & 
Súkenníková, 2016; Tombaugh, McDowell, Kristjansson, & Hubley, 1996) and demonstrated 
good concurrent and construct validity (McPherson, Berry, & Pentland, 1997; Razani et al., 2009). 
The HRSD consists of 21 items, but the scoring is based upon the first 17. Eight items are scored 
on a 5-point Likert scale, ranging from 0 to 4 and nine items are scored on a 3-point scale from 0 
to 2. Cronbach’s alpha for the 17-item HAM-D has reported at 0.83 in a sample of persons with 
chronic major depression (Rush et al., 2003) and validity ranges from 0.65 to 0.90 with global 
measures of depression severity (Pincus, Rush, First, & McQueen, 2000). 
Procedure. In both parent studies, trained research assistants conducted face-to-face interviews, 
rather than self-administered report, in a private location (participants’ home or private room at 
the ADRC). For this proposed study, inter-rater reliability of the causality component of illness 
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perceptions will be accomplished. The causality component will be categorized into two domains, 
potentially controllable or uncontrollable factors. Two trained researchers will code and enter the 
data separately, and then, inter-rater reliability of the coded data, representing the extent to which 
the level of agreement between raters, will be assessed. To confirm whether the raters yield a high 
agreement of the each of the causality items, Cohen’s kappa coefficient (κ), a statistical measure 
of inter-rater reliability for qualitative (categorical) items, will be used. Values for kappa over 0.75 
will be considered as excellent agreement between two raters (Fleiss, Cohen, & Everitt, 1969). 
Similarly, as described above, self-management behavior data from the parent studies will be 
coded in two ways, 1) coded as each of self-management behaviors, and 2) a total number of self-
management behaviors, depending on our analytic purpose. Data will be stored in locked filing 
cabinets at the University of Pittsburgh School of Nursing and access will be limited to users whose 
rights have been designated by the PI. 
Data Analysis Plan for Aim 1. Prior to analysis, all data will be screened using descriptive and 
exploratory data analysis methods. The ranges for each of the variables will be checked to identify 
whether the values are within the possible range of responses. Based on the variable’s level of 
measurement and observed data distribution, appropriate descriptive statistics will be computed to 
characterize the total sample. Nominal variables, including gender, race, level of education, marital 
status, and MCI type, will be summarized using modes, frequency counts (n), and percentages (%). 
For highly ordinal and approximate interval scaled variables, mean and standard deviation (SD) 
will be calculated. These variables include the participants’ total scores for the MMSE, HRSD, 
and illness coherence subscale of the IPQ-R. In addition to those descriptive statistics, mean, SD, 
range, and minimum/maximum values will be computed for ratio-scaled variables such as age and 
the number of comorbid conditions. If the interval and ratio-scaled variables are non-normally 
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distributed, median and semi-quartile range (SQR) (or inter-quartile range [IQR]) will be also 
computed as an alternative to mean and SD. The amount and pattern of missing data will be 
explored and an appropriate imputation strategy (e.g., stochastic regression, multiple imputation) 
will be performed. Cases with standardized scores (𝑧𝑧-scores) exceeding the absolute value of 3.29 
(p < .001, two-tailed test) will be considered as potential univariate outliers. In addition to 
inspection of 𝑧𝑧-scores, histograms, box plots, and normal probability plots will be used to identify 
univariate outliers. To reduce the influence of outliers, identified univariate outliers from 
continuous type interval/ratio scaled variables will be transformed to the next highest/lowest (non-
outlier) values plus one-unit increment higher/lower. For outliers from categorical variables, I will 
collapse the sparse categories meaningfully to maintain as much information as possible. Both 
graphical (box plots) and statistical (Mahalanobis distance) procedures will be used to detect 
multivariate outliers. Any case with a Mahalanobis distance great than 22.46, which is the critical 
chi-square (χ2) value for 6 degrees of freedom (𝑑𝑑𝑑𝑑) at a critical value of .001 (𝑑𝑑𝑑𝑑 is based on the 
number of variables), will be identified as a multivariate outlier. If the outliers are properly part of 
the intended population, appropriate steps such as score alteration or variable transformation will 
be taken to reduce their impact. After applying appropriate remedial strategies, I will screen the 
data again to determine if the amended data are free of outliers. To assess multicollinearity for the 
independent variables (IVs), the correlation coefficient (r) and the variance inflation factor (VIF) 
will be estimated. The r will be calculated for each pair of the IVs and if any of the r values is 
greater than .08, there is a possibility to have multicollinearity between the IVs. I will also check 
the VIF, which is a more rigorous approach than correlation coefficient. If the VIF goes beyond 
10, I will consider data transformation (e.g., centering the variables) to reduce the impact of 
multicollinearity. Since both logistic and linear regression analyses will be conducted to examine 
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the association between illness perceptions and self-management behaviors, underlying 
assumptions will be also checked. The normality of sampling distributions will be assessed by 
either statistical (skewness and kurtosis) or graphical (frequency histograms, normal probability 
plots) methods. Box-Tidwell approach (Hosmer & Lemeshow, 1989) will be used to check 
linearity in the logit for a linear relationship between continuous IVs and the logit transform of the 
dependent variable (DVs), 1) physical activity, 2) medications, 3) vitamins/herbal supplements, 
and 4) mental activities when using logistic regression. For linear regression, linearity will be 
checked through bivariate scatter plots between IVs and the total number of self-management 
behaviors. If the assumption of linearity is violated (e.g., curvilinear relationship), appropriate data 
transformation, for example, square of the variables or recoding the variables into dummy 
variables, will be performed.  
To examine the association between two dimensions of illness perceptions (illness 
coherence and causality) and self-management behaviors, I will perform both logistic and linear 
regression analyses. First, binary logistic regression will be used to examine the association 
between the primary IVs (illness coherence and causality) and the DVs, each of the self-
management behaviors (physical activity, medications, vitamins/herbal supplements, and mental 
activities). Based on previous research (Chao et al., 2008) sociodemographic data (age, gender, 
and education) and the number of comorbid conditions will be included as potential covariates in 
the analysis. Next, I will perform linear regression to test the association between each primary IV 
(illness coherence and causality) and DV (a total number of performing self-management 
behaviors). Potential covariates, sociodemographic information (age, gender, and education) and 
the number of comorbid conditions, will be also included in this analysis. In addition, since 
amnestic and non-amnestic MCI have distinct characteristics, using chi-square test of 
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independence (χ2) or Fisher’s exact test (cells with expected count less than 5), I will compare a 
total number of performing self-management behaviors between amnestic and non-amnestic MCI 
groups to identify differences in the magnitude of self-management behaviors as an exploratory 
purpose. I will also compare a total number of performing self-management behaviors based on 
illness coherence (high or low groups; the level of illness coherence will be determined based on 
datasets), and causality (controllable or uncontrollable factors). All analyses will be performed 
using IBM® SPSS® Statistics (Version 25.0, IBM Corp., Armonk, New York) and hypothesis 
testing will be two-sided at a significance level of .05. 
Sample Size Justification for Aim 1. Precautions are needed to ensure that we have achieved a 
representative sample of the MCI population, however, the number of participants in this proposed 
study is fixed since I will use two parent studies. Nevertheless, the fixed sample size of at least 
130 participants with MCI will have adequate statistical power to detect meaningful effects. The 
subject-to-variable ratio should be 10:1 (Nnadi-Okolo, 1990), indicating that the sample size of 
130 would allow for as many as 13 predictors in each model. Also, according to Green (1991), at 
least 110 participants (N 104 + k [the number of IVs]) are needed for a medium effect (𝑅𝑅 2= .07; 
β= .20), suggesting that I have enough sample for Aim 1.   
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1.6.2  Manuscript 2 
Common Late-life Physical Disorder: T2DM 
Aim 2: To determine the associations between illness perceptions and a) self-efficacy, and b) 
medication adherence among persons with T2DM. 
Design. Using a secondary data analysis, a quantitative, cross-sectional, and descriptive study of 
illness perceptions, self-efficacy, and medication adherence among persons with T2DM will be 
conducted (see Figure 3). I will use baseline data from the Habit Study, which was one of the 
NINR-funded P01 projects (P01-NR010949) examining a habit-training (routinization) 
intervention to improve medication adherence in adults with T2DM. The long-term goal of this 
parent study was to develop a simple and cost-effective intervention that promotes both medication 
adherence and health outcomes (e.g., health-related quality of life), and effectively translates to 
clinical practice.  
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Figure 3. Conceptual Framework (Aim 2) Adapted from Leventhal et al. (2003) 
 
Sample and Setting. The Habit Study comprised a sample of 167 adults aged 40 years and older 
who are in treatment for T2DM with hypertension and/or hypercholesterolemia from outpatient 
clinical practice sites within the University of Pittsburgh Medical Center (UPMC) Health System. 
The following criteria were used to determine subject eligibility for the parent study. 1) being at 
least 40 years of age; 2) taking one or more medications prescribed by a physician; 3) self-
managing their medications; 4) being an English speaker, and 5) having access to a telephone. 
Exclusion criteria for the parent study were 1) having medications managed by others; 2) being 
unable or unwilling to use a medication diary or electronic event monitor; and 3) participating in 
other intervention research. Since I will focus on “late-life” chronic disorders, participants who 
are younger than 50 years of age (n = 20) will be excluded from this proposed study. Except 
for this age restriction, there are no additional inclusion and exclusion criteria for Aim 2.  
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Measures. The self-reported battery of questionnaires was comprised of the parent study 
measures. Sociodemographic information (e.g., age, sex, marital status), clinical characteristics 
(e.g., number and type of comorbid conditions), and primary independent (each domain of illness 
perceptions) and dependent (self-efficacy and medication adherence) variables will be included in 
this proposed study. Key measures for Aim 2 are described below, along with citations providing 
evidence of their psychometric properties. Copies of each standardized instrument are included in 
Appendix A. 
Key Variables. 
Illness Perceptions. The Brief Illness Perception Questionnaire (Brief IPQ) (Broadbent, Petrie, 
Main, Weinman, 2006) the modified version of the Illness Perception Questionnaire (IPQ) 
(Weinman, Petrie, Moss-Morris, & Horne, 1996) and the Illness Perception Questionnaire-Revised 
(IPQ-R) (Moss-Morris et al., 2002) is comprised of nine items about an individual’s perceptions 
of illness. All items, consequences, timeline, personal control, treatment control, identity, illness 
concern, illness coherence, and emotional representations, except the causal representation item, 
were rated using 0 (not at all) to 10 (extremely) Likert scaling. The last item, causal representation 
item, asks the individuals to list the three most relevant causal factors in their illness, which will 
be only used for the descriptive purposes in this proposed study for Aim 2 because the item is an 
open-ended question adapted from the IPQ-R (Moss-Morris et al., 2002). The Brief IPQ, a nine-
item questionnaire, is more useful in some situations, for example, when assessing very ill or frail 
populations, or limited time is allowed for assessment because the Brief IPQ is simple and less 
time is required so that the individuals can complete the questionnaire more quickly. The Brief 
IPQ is widely used to investigate in a wider range of chronic disorders such as hypertension (Perez, 
2015; Saarti et al., 2016), T2DM (Al-Amer et al., 2016; Martinez et al., 2018), and depression 
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(Brown et al., 2011). For the Habit Study, the general Brief IPQ phrasing, ‘illness’, was replaced 
with ‘diabetes’ and higher scores in items indicate increases in the dimension measured. The 
original Brief IPQ has been used to examine the individual’s illness perceptions across a number 
of illnesses and has demonstrated good test-retest reliability and validity (Broadbent et al., 2006). 
Self-efficacy. The Self-Efficacy for Managing Chronic Disease (SEMCD) (Lorig, Sobel, Ritter, 
Laurent, & Hobbs, 2001). I will be used to assess the participants’ confidence level in completing 
tasks or activities for managing T2DM. This scale consists of six items and each of items are rated 
on a 10-point scale ranging from 1 (not at all confident) to 10 (totally confident), with higher scores 
reflecting higher levels of self-efficacy. The term, ‘your illness’ was replaced with ‘your diabetes’ 
in the parent study to capture the participants’ self-efficacy for managing their T2DM. 
Respondents are asked to rate their confidence to manage 1) their fatigue; 2) physical discomfort 
or pain; 3) emotional distress; and 4) any other symptoms or health problems, and confidence to 
do 5) tasks and activities for managing the health conditions to reduce the need to see a doctor, 
and 6) things to other than just taking medications. The summary score for the scale is the mean 
of the six items and if more than two items are missing, the summary score is considered as missing 
(Lorig et al., 2001). The SEMCD has demonstrated good internal consistency reliability, with 
Cronbach alpha ranges from 0.87 to 0.93 in samples of various chronic conditions (Freund, 
Gensichen, Goetz, Szecsenyi, & Mahler, 2013; Lorig et al., 2001; Ritter & Lorig, 2014). 
Medication Adherence. The 4-item Morisky Medication Adherence Scale (MMAS-4) (Morisky, 
Green, & Levine, 1986) is a generic self-reported, medication-taking behavior scale with all items 
having dichotomous response choices (Yes [0] or No [1]). The MMAS-4 is simple to administer 
and widely used to identify barriers to medication adherence. The MMAS-4 has been validated in 
a broad range of chronic disorders (Elm et al., 2007; Morisky et al., 1986; Toll, McKee, Martin, 
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Jatlow, & O'Malley, 2007). While the original items are summed to give a range of scores from 0 
to 4 with lower scores meaning better medication adherence, I will reverse the scores of the items, 
such that higher total scores indicate better adherence to medication in this proposed study. The 
first two items, forgetfulness and carelessness, are related to the unintentional non-adherence to 
medication. The last two items, stopping medication taking when feeling better or worse, are 
assessing the intentional medication non-adherence. The internal consistency of the MMAS-4 
showed Cronbach’s alpha of 0.61 (Morisky et al., 1986). 
Sociodemographic and Clinical Factors. Self-reported baseline data on sociodemographic 
information, including age (in years), gender (male or female), marital status (married or not 
married), level of education (< 12 years or ≥ 12 years of education), employment status (working, 
retired, or not working), annual income (under $20,000, $20,000 to $39,999, $40,000 to $59,999, 
$60,000 to $ 79,999, or ≥ $80,000), health insurance (yes or no), and ethnicity/racial background 
(Caucasian, African-American, or Asian), will be used for this proposed study. While information 
on the number of comorbid conditions will be used to investigate its potential moderating roles of 
illness perceptions, self-efficacy, and medication adherence, type of comorbid conditions will be 
only used for the descriptive purposes.   
Data Analysis Plan for Aim 2. Data will be analyzed using SPSS® Statistics Version 25.0 (IBM 
Corp., Armonk, New York). Prior to analysis for Aim 2, as described in the “Data Analysis Plan 
for Aim 1”, all data for Aim 2 will be screened for anomalies (e.g., outliers, missing data, violations 
of statistical assumptions) using descriptive and exploratory data analysis methods. Based on the 
variable’s level of measurement and observed data distribution, appropriate descriptive statistics 
(means with SDs for normally distributed ratio/interval variables, medians with IQRs for non-
normally distributed ratio/interval variables and ordinal variables, and modes with ranges and 
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frequencies with percentages for nominal variables) will be used to characterize the total sample. 
The amount and pattern of missing data will be explored. Depending on the mechanisms of missing 
data (e.g., missing completely at random [MCAR], missing at random [MAR], missing not at 
random or nonignorable missingness [NMAR]), appropriate strategies will be used for dealing 
with missing data. For example, missing data due to non-response, stochastic regression approach 
will be considered based on other variables as predictor variables. One participant (0.68%) from 
the Habit Study will be excluded from the analysis because this participant did not answer any of 
the Brief IPQ questionnaire items. Univariate and multivariate outliers will be screened. Identified 
potential outliers will also be treated as described in Aim 1. See “Data Analysis Plan for Aim 1” 
section for detailed methods of outlier detection and handling in analysis for Aim 2. Key 
assumptions of linear regression, such as linear relationships between IVs and DVs, normality, 
and homoscedasticity of the model residuals, and no serious multicollinearity, will be also checked 
using statistical and/or graphical methods. If linearity is violated, I will consider applying nonlinear 
transformations such adding higher-order terms of the regressors (e.g., IV2) or log transformations 
to either the IVs (each dimension of illness perceptions) and/or DVs (self-efficacy and medication 
adherence). The bivariate (Pearson’s r) correlations will be computed to see whether a statistically 
significant linear relationship exists between the potential covariate/confounding variables (age, 
gender, level of education, race, marital status, annual income, health insurance, and employment 
status) and the IVs (each domain of illness perceptions). As described in Data Analysis Plan for 
Aim 1, if the relationship is nonlinear, either transformations or recoding into dummy variables 
will be considered to enhance linearity. The potential moderating variable (the number of 
comorbid conditions) will be incorporated into the models both individually and collectively. 
Model assessment (residual analysis and assessment of potential influential observations in terms 
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of estimation of predicted values, regression coefficients, and standard errors for regression 
coefficients) will be performed for all fitted models. 
Using hierarchical linear regression, I will investigate the associations between illness 
perceptions, self-efficacy for managing T2DM, and medication adherence, where the level of 
statistical significance is set at .05 for two-sided hypothesis testing. More precisely, a hierarchical 
multiple linear regression analysis will be performed, while controlling for age, level of education, 
race, marital status, annual income, health insurance, and employment status, to limit possible 
confounding. The hierarchical expansion of regression models will include the main effect of the 
number of comorbid conditions and the interactions of each of the primary IVs (each dimension 
of illness perceptions) with the possible moderating variable (the number of comorbid conditions) 
because comorbidity might have interaction or modifying effects on self-management behaviors 
in late-life chronic disorders (Chao et al., 2008; Schuz, Wolff, Warner, Ziegelmann, & Wurm, 
2014). This will be conducted in such a way that four successive linear regression models are 
estimated for each of the DVs based on the literature review and the thorough screening of the 
data. In first block, a model with only covariates or confounders (age, education, race, marital 
status, annual income, health insurance, and employment status) will be estimated. In second 
block, the primary IVs (each dimension of illness perceptions) will be added, and in third block, I 
will add the possible moderating variable (the number of comorbid conditions). In the final model, 
interaction terms between primary IVs (each dimension of illness perceptions) and the possible 
moderating variable (the number of comorbid conditions) will be added to assess interaction on 
the DVs, self-efficacy for managing T2DM and medication adherence. The change in 𝑅𝑅2 will be 
produced using F-test at each block which allows to see the increase in variance accounted for 
when the next block is added. The zero-order correlation, the partial correlation, and the part 
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correlation between IVs (each domain of illness perceptions) and DV (self-efficacy and medication 
adherence) will be also estimated to see if there are any associations between each IV and the DV 
which are not explained by the other predictors in the model.  
Sample Size Justification for Aim 2. Although the number of sample size is fixed (N = 147) for 
Aim 2, this proposed study has the sufficient sample size and effect size to produce the reliable 
research results. Based on previous research (Green, 1991; Nnadi-Okolo, 1990), at least 14 IVs 
and 119 participants are needed for multiple regression model, indicating that this study will have 
enough statistical power to detect significant effects. 
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1.6.3  Manuscript 3 
Mental and Physical Disorders in Late-life: MCI and T2DM 
Aim 3: To identify similarities and differences in illness perceptions between MCI and T2DM, 
as common examples of late-life mental and physical disorders. 
Design. To identify similarities and differences of illness perceptions in persons with MCI and 
those with T2DM, a quantitative, cross-sectional, and descriptive study of illness perceptions in 
these two chronic disorder populations will be conducted (see Figure 4). I will use existing baseline 
data from two research studies, the Result Study and the Habit Study. The purpose of the first 
parent study for Aim 3, the Result Study, was to examine benefits and burdens of receiving brain 
amyloid scan among persons with MCI. The second parent study, the Habit Study, was conducted 
to test the effects of a 12-month intervention on medication adherence and health outcomes among 
persons with T2DM. Using secondary analysis of existing data may have some limitations. Chief 
among such limitations of this proposed study is that the data were not collected for all individuals 
with late-life physical and mental disorders, and for all geographic regions of interest, indicating 
that our sample may not represent a whole chronic disorder population. However, these two NIH-
funded parent studies provide the opportunity to examine illness perceptions of two common late-
life chronic disorders with standardized measurements, which were assessed by trained research 
personnel.  
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Figure 4. Conceptual Framework (Aim 3) Adapted from Leventhal et al. (2003) 
 
Sample and Setting. The first sample of this proposed study for Aim 3, will be extracted from the 
Result Study (R01-AG046906). The Result Study recruited persons with MCI and their care 
partners in collaboration with the University of Pittsburgh ADRC (P50-AG005133) and Advanced 
Center for Intervention and Services Research for Late-life Mood Disorders. See “Sample and 
Setting” section in Aim 1 for detailed inclusion and exclusion criteria for the Result Study. 
Although the first parent study also recruited the MCI participant’s care partner to examine the 
effect of receiving amyloid imaging research results at the dyadic level, I will only include 
persons with MCI, not their care partners. Except for this selection criterion, there are no 
additional inclusion and exclusion criteria for the sample of the Result Study for Aim 3.  
The data for the second sample of Aim 3 will be obtained from the Habit Study (P01-
NR010949), a randomized controlled trial designed to improve medication adherence among 
persons with T2DM. See “Sample and Setting” section in Aim 2 for detailed inclusion and 
exclusion criteria for the Habit Study. As described in the methods to address Aim 2, participants 
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who are younger than 50 years of age will be excluded from this analysis since I will focus on 
late-life (≥ 50 years of age) chronic disorders. Except for this selection criterion, there are no 
additional inclusion and exclusion criteria for the sample of the Habit Study for Aim 3. 
Measures. All data for Aim 3 of the proposed study will be obtained from two parent studies, the 
Result Study and the Habit Study. While baseline data of the Result Study were collected by 
trained research assistants using a face-to-face interview in participants’ home or the ADRC, data 
of the Habit Study were obtained using a self-administered battery of questionnaires. Only 
sociodemographic and clinical information for the first parent study (Result Study) were abstracted 
from each participant’s ADRC record to reduce participant burden. A detailed description of Aim 
3 key variables is provided below. See Appendix A for the copies of each instrument.   
Key Variables. 
Illness Perceptions. The Brief IPQ (Broadbent et al., 2006) will be used to assess illness 
perceptions of MCI and T2DM. A detailed description of the Brief IPQ measure is provided in the 
“Measures” section in Aim 2. The Brief IPQ consists of nine items, consequences, timeline, 
personal control, treatment control, identity, illness concern, illness coherence, emotional 
representations, and causal representation, each rated on an 11-point (0 to 10) Likert scale except 
the causal representation item, which is an open-ended question. Since the original version of the 
Brief IPQ can be modified to assess unique characteristics of the illness and its symptoms, the term 
‘illness’ was replaced with ‘my memory or thinking difficulties’ and ‘diabetes’ in the Result Study 
and the Habit Study, respectively. 
Sociodemographic and Clinical Factors. To characterize the first sample, I will obtain baseline 
data on sociodemographic (e.g., age, sex, marital status, level of education) and clinical (e.g., 
duration of MCI diagnosis, MCI type, family history of dementia) information of the Result Study 
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abstracted from the ADRC records. Baseline sociodemographic and clinical information of the 
Habit Study will be also used to characterize the second sample, which was obtained using 
standardized sociodemographic and comorbid questionnaires (Sereika & Engberg, 2006) including 
age, sex, marital status, level of education, employment status, annual income, racial background, 
and the number of comorbid conditions.  
Procedure. For this proposed investigation, the baseline datasets from two parent studies, the 
Result Study and the Habit Study, will be concatenated to analyze as one dataset based on 
sociodemographic and clinical factors, and each dimension of illness perceptions. Of the nine items 
measuring illness perceptions, the causal representation item will be only used for the descriptive 
purposes, as outlined above in Key Variable section (see Illness Perceptions variable), since the 
item is an open-ended question. 
Data Analysis Plan for Aim 3. Prior to analysis, as described on the “Data Analysis Plan for Aims 
1 and 2”, each of the datasets from the Result Study and the Habit Study will be screened separately 
and collectively using the merged dataset to ultimately be used for the analysis (See Data Analysis 
Plan for Aims 1 and 2” for detailed data screening methods). First, I will split the files by the 
grouping variable (MCI vs. T2DM) to conduct the data screening. The datasets of Result Study (n 
= at least 70) and the Habit Study (n = 146) will be separately screened for anomalies using 
descriptive and exploratory data analysis methods to examine persons with MCI and those with 
T2DM. Appropriate descriptive statistics will be used to characterize each sample based on the 
variable’s level of measurement and observed data distribution. Missing data will be appropriately 
handled depending on its mechanisms (e.g., MCAR, MAR, NMAR). Potential outliers will be 
treated as described in Aim 1. Data transformation (e.g., square root, logarithmic) and/or 
categorization (dichotomizing, trichotomizing) will be performed as needed. Residual plots and 
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bivariate scatterplots will be used to ensure the model assessment and display relations graphically. 
The linear relationships between potential covariates or confounders (sociodemographic variables 
including age, gender, race, level of education, and marital status, and the number of comorbid 
conditions) and eight dimensions of illness perceptions will be assessed. Potential covariates or 
confounders will be also examined for possible associations with the IV (grouping variable; See 
Data Analysis Plan for Aim 1 for multicollinearity check) and 2) the DVs (each illness perceptions) 
and if significant associations are found, will be controlled for in the analysis. After combining 
these two datasets, assumption of homogeneity of regression slopes will be checked whether the 
relationships between potential covariates or confounders and each separate illness perception is 
the same in MCI and T2DM groups. Homogeneity of group variance-covariance matrices will be 
also examined to test whether or not the variances and covariances between MCI group and T2DM 
group are equal. Group comparisons will be performed for all sociodemographic variables by 
disease characteristics, MCI and T2DM. Two-sample t-tests (for normally distributed variables) 
or Mann-Whitney U-test (for non-normally distributed variables) will be used for continuous-type 
variables, and χ2 test of independence or Fisher’s exact test will be used for categorical variables 
before analyzing DVs, each dimension of illness perceptions  
To identify similarities and differences in illness perceptions between MCI and T2DM, I 
will perform multivariate analysis of covariance (MANCOVA), which is a multivariate 
generalization of analysis of covariance (ANCOVA), where there are several DVs with potential 
covariates. Eight dimensions of illness perceptions (consequences, timeline, personal control, 
treatment control, identity, illness concern, illness coherence, and emotional representations), 
except the causal representation item, will be included as the set of primary DVs. For the causal 
representation item, the first ranked response will only be used for the descriptive purposes, since 
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the item is an open-ended question. Wilks’ lambda (λ) test will be performed to see whether illness 
perceptions are significantly associated with disease characteristics, MCI and T2DM. If there are 
significant differences are found, univariate ANCOVA will be conducted to determine how the 
individual illness perceptions differ for disease characteristics. The partial eta-squared (partial 𝜂𝜂2) 
will be also calculated to estimate the effect size for group (MCI vs. T2DM) mean differences. To 
explore the associations for the individual illness perceptions, the Bonferroni correction will be 
performed. All analyses will be performed using IBM® SPSS® Statistics (Version 25.0, IBM Corp., 
Armonk, New York) and the level of statistical significance will be set at .05 for two-sided 
hypothesis testing.  
Sample Size Justification for Aim 3. Since the sample size will be fixed (N = at least 216), we 
calculated the effect size for Aim 3 rather than estimating the sample size. Using PASS Version 
15.0, power and effect size for the two-group were computed and compared with Cohen’s 
guidelines (Cohen, 1988) (0.2: small effect, 0.5: moderate effect, 0.8: large effect). The two-
sample Hotelling's T-squared test statistic was used with a significance level of .05. Sample sizes 
of 146 in T2DM group and 70 in MCI group achieve 77% power to detect an effect size of 0.27 
which represents the difference between the group means of the 8 response variables, adjusted by 
the variance-covariance matrix. 
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1.7 Potential Limitations and Alternative Approaches 
The primary purpose of this proposed study is to examine illness perceptions and self-
management behaviors, depending on the disease characteristics, either physical (T2DM) or 
mental (MCI) health conditions. Although this study is the first theory-based, data-driven 
examination of late-life physical and mental disorders, there are potential methodological issues 
associated with study outcomes. First, due to the nature of the secondary analyses of existing data, 
the datasets, which will be used for this study, were not originally collected to test my research 
questions. This can be problematic because additional data may be needed for further testing for 
the aims or research questions. For example, although self-efficacy may play a potential mediating 
role in the relationship between illness perceptions and self-management behaviors (Bandura, 
1977), this proposed study cannot examine the role of self-efficacy because in the Habit Study, 
self-efficacy was assessed only at baseline. Measurements can be another issue because the parent 
studies used self-report approaches to measure the participants’ self-efficacy and self-management 
behaviors. Responses may be exaggerated due to social desirability bias, which may affect the 
results of this proposed study. In addition, the REVEAL Health Behavior measure (Chao et al., 
2008) and MMAS-4 (Morisky et al., 1986) are not strong instruments in terms of its psychometric 
properties, although the instruments are appropriate for capturing MCI or T2DM-related self-
management behaviors. These potential issues can be mitigated through close consultation with 
the PIs of the parent studies, Drs. Lingler and Bender, by delving into the circumstances of the 
original data generation and processing. For example, to reduce the possible response bias, I will 
consider to use objective measures such as medication diary or electronic event monitor if possible. 
Another major issue is that sample which I will use for this study (individuals ages 50 and older) 
may have more than one chronic disorders because approximately 75% of older adults has multiple 
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chronic conditions in the United States (Ward, Schiller, & Goodman, 2014). As such, it is possible 
that they may have multiple illness perceptions regarding their health conditions, but this limitation 
can be minimized because in both parent studies, the term “my illness” was replaced with 
“diabetes” or “my memory or thinking difficulties” to capture their specific perceptions on T2DM 
or MCI. As was shown above, representativeness of the target population should be also 
considered because the data were not collected for all chronic disorder population and all 
geographic regions. However, this study is significant and innovative as it can be used to guide the 
conduct of future research and clinical practice in this field.    
 
Table 1. Flow of Study Activities 
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1.9 Research Participant Risk and Protection 
The proposed study will be exempted from the U.S. Department of Health and Human 
Services (HHS) human subject regulations because I will conduct secondary analyses of existing 
datasets. Ethical approvals for all parent studies were obtained from the University of Pittsburgh 
Institutional Review Board prior to data collection. 
 
Human Participants Involvement and Characteristics. I will include at least 130 individuals for the 
first manuscript, 60 individuals from the first dataset and at least 70 from the Result Study (R01 
AG046906). All participants of the parent studies were persons with mild cognitive impairment 
and provided written informed consent before participating in the studies. The following criteria 
were used to determine subject eligibility for the parent studies. 
1) current ADRC consensus diagnosis of MCI; 2) at least 50 years of age; 3) community-dwelling; 
and 4) have a family member or kin-like friend who also agreed to participate. Individuals were 
excluded if they have active, untreated primary psychiatric disorders (e.g., major depression, 
anxiety disorder based on screening with the HAM-D).  
While the parent study of the second manuscript, the Habit Study (P01 NR010949), 
originally included 167 persons with type II diabetes mellitus aged 40 and older, I will include 
persons aged 50 or above to examine late-life chronic disorder. The following criteria were used 
to determine subject eligibility for the Habit Study. 1) at least 40 years of age; 2) take one or more 
medications prescribed by a physician; 3) must be self-managing their medications; and 4) English 
speaker and have access to a telephone. The last manuscript will combine two datasets, the Result 
Study and the Habit Study, the above inclusion and exclusion criteria will be applied.   
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Inclusion of persons with potentially impaired decisional capacity. For the parent studies involving 
persons with MCI, determinations of capacity to consent to the parent studies were based on a 
participant’s ability to express an understanding the study’s purpose, procedures, risks, and 
benefits during a one on one discussion with a member of the research team (investigator or trained 
project director).  
 
Sources of Materials. The parent studies will provide all the data necessary for this proposed study. 
The sources of materials for the parent studies involving persons with MCI are retrieved from 
REDCap, a web-based system, which provides secure data entry with real-time validation. 
Permission to extract data from existing databases was obtained from participants during the 
informed consent process. The Habit Study baseline self-reported data were stored on the secure 
centralized server and only the PI and the project coordinator of the Habit Study have access to 
subject identities.  
 
Potential Risks and Benefits of the Proposed Research. The date from the parent studies will 
remain de-identified for the proposed study so that this study has no direct risks to the participants. 
However, the findings from this study may suggest a number of avenues for future research. This 
study may provide an opportunity to persons with late-life chronic disorders to manage their health 
status more effectively in the future. This may be beneficial for planning purposes.  
 
Procedures for Protection against Risk. Data safety monitoring board was assembled for all of the 
parent studies and the PI of this proposed study will regularly meet with Drs. Lingler and Bender 
to ensure the data are properly used and analyzed for scientific inquiry. The investigators of all 
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parent studies highlighted to participants that study participation is voluntary and will not affect 
clinical care at UPMC Health System or involvement with the University of Pittsburgh. Study 
participants were given the opportunity to refuse to participate in the studies. To minimize the risk 
of breach of confidentiality, unique numeric identifiers were used to each participant of all parent 
datasets. These files were stored under lock and key and will be accessed only by the PI and the 
research member. Identities of participants will not be revealed in publications or presentations 
derived from this project. 
 
Importance of Knowledge to be Gained. Given the dearth of information about illness perceptions 
and self-management strategies in late-life chronic disorders based on the disease characteristics 
(physical vs. mental health conditions), the knowledge derived from this study will provide a new 
understanding of the self-management behaviors associated with one’s beliefs on their disease and 
symptoms. Findings from this proposed study may inform the future development of interventions 
to improve self-management of late-life chronic disorders in this population.  
 
Inclusion of Women, Minorities and Children. Since almost 50% of our sample is women, we 
expect an approximately equal representation of men and women. The majority of participants of 
parent studies were Caucasian, which does reflect the racial and ethnic distribution of older 
population in Pittsburgh and the surrounding region. No individuals were excluded from 
participation based on race, gender, or medical conditions like HIV status. This proposed study 
will exclude children under the age of 18 because the purpose of this research is to examine illness 
perceptions and self-management strategies among persons with T2DM and MCI aged 50 and 
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older, which are age-related chronic physical and mental health conditions that do not affect 
children. 
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2.0 Manuscript 1: Mild Cognitive Impairment 
2.1 Abstract 
Purpose: The purpose of this study was to investigate the association between illness perceptions 
(dimensions of coherence and causality) and self-management behaviors among older adults with 
mild cognitive impairment (MCI).  
Methods: We conducted a cross-sectional study of illness perceptions and self-management 
behaviors (physical activity, cognitive-enhancing medications, vitamin/herbal supplements, and 
mental activities) using a secondary analysis of pooled exiting datasets. The coherence and 
causality subscales of the Revised Illness Perception Questionnaire and the Risk Evaluation and 
Education for Alzheimer’s disease health behavior measure were used. Hierarchical linear and 
logistic regression analyses were performed while controlling for covariates to examine the 
associations between illness perceptions and 1) the total number of self-management behaviors, 
and 2) each self-management behavior, respectively.   
Results: Our final sample (N = 144) was on average (±SD) 71.9 ± 9.06 years of age and exhibited 
higher education attainment with a mean 16.7 ± 2.7 years of education. The majority were 
Caucasian (92.4%) and diagnosed with amnestic MCI (83.3%). While perceptions of coherence (p 
= .76) and causality (p = .96) were not significant predictors of total number of self-management 
behaviors, we observed a significant interaction of coherence and sex to total number of self-
management behaviors (b = - .089, p = .025) suggesting that higher coherence was associated with 
performing more self-management behaviors in the female group. An interaction of coherence and 
years of education was significant to physical activity (OR = .957, 95% CI = [.922, .993]), 
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indicating that higher coherence of MCI was associated with performing less physical activity and 
such association was limited to participants who had higher levels of education.   
Conclusion: Findings demonstrate that illness perceptions may be important factors for self-
management behaviors among older adults with MCI. Health care professionals should take into 
account unique illness perceptions and sociodemographic characteristics when discussing the 
symptoms or disease management of older adults with MCI. Future research should examine 
whether or not other dimensions of illness perception are associated with self-management 
behaviors. 
2.2 Introduction 
As the world’s older population continues to increase at an unprecedented rate, the 
corresponding increase in prevalence of cognitive dysfunction in older adults has become a 
pressing issue. Nearly 6 million people in the United States are living with Alzheimer’s disease 
(AD) (AA, 2019). In addition, mild cognitive impairment (MCI) has received worldwide attention 
because MCI is considered a potential precursor to AD (Petersen, 2004; Petersen et al., 1999). 
Persons with MCI experience cognitive changes that are noticeable, yet these changes generally 
do not affect the individual’s ability to perform activities of daily living (Petersen, 2004; Petersen 
et al., 1999). Considering that many clinical trials have failed to stop or delay AD (Mehta, Jackson, 
Paul, Shi, & Sabbagh, 2017), new fields of research should develop both pharmacologic and 
nonpharmacological interventions, which not only may serve as secondary prevention strategies 
for AD, but also could bring hope to persons with MCI. Fortunately, nationwide efforts are 
underway to do just this; moreover, experts agree that a combination of pharmacologic and 
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lifestyle interventions will be required to stabilize and/or reverse the course of MCI (Karssemeijer 
et al., 2017; Petersen et al., 2018).  
Research in other populations suggests that disease management for chronic disorders, 
which include self-management behaviors, may be influenced by a given individual’s perceptions 
about a given disease and its symptoms (Abubakari, Cousins, Thomas, Sharma, & Naderali, 2016; 
Hagger, Koch, Chatzisarantis, & Orbell, 2017). Given the subtle nature of MCI symptoms (e.g., 
cognitive/memory changes that may easily be mistaken for normal cognitive aging), an important 
research question is whether or not affected individuals would pursue such interventions should 
they become available. 
 
Illness Perceptions (perceived coherence and causality) in Mild Cognitive Impairment 
Receiving a diagnosis of or experiencing a set of symptoms for a particular ailment often 
leads individuals to form thoughts and feelings about their health condition. One way to 
conceptualize such thoughts is Leventhal’s (2003) Common Sense Model (CSM) of Self-
Regulation, which is an empirically validated framework that explains the processes by which 
individuals formulate perceptions of ongoing or future health threats (i.e., illness perceptions), 
create action plans, and perform self-management behaviors in accordance with their illness 
perceptions. Five dimensions of illness perceptions, identity (i.e., symptom experiences), 
consequences (e.g., work, family, and personal relationships), cause, timeline (i.e., acute vs. 
chronic), and cure/control (i.e., controllability over the disease), were proposed by Leventhal et al. 
(1984, 2003). Later, coherence (i.e., understandable vs. confusing/unclear), emotional 
representations (i.e., negative feelings such as anger, anxiety) (Moss-Morris et al., 2002), and 
concerns (Broadbent et al., 2006) dimensions were added to the illness perceptions model. 
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In the context of MCI, affected persons certainly possess their own thoughts about their 
cognitive or memory issues. Indeed, research indicates that two of the aforementioned dimensions 
of illness perceptions, perceived coherence about and causality of the disease, may be particularly 
salient in persons with cognitive changes (Lingler et al., 2016; Matchwick, Domone, Leroi, & 
Simpson, 2014). Regarding coherence, previous research using qualitative methods or small 
sample sizes, has shown that while there is variability in levels of illness coherence among those 
diagnosed with MCI, it is not uncommon for such individuals to voice uncertainty about the 
cognitive changes they are experiencing and what these changes may mean for the future (Lingler 
et al., 2006). The extent to which having more or less illness coherence impacts the performance 
of self-management behaviors in MCI is unknown. Regarding the causality of late life cognitive 
changes, previous studies have shown that older individuals attribute these changes to a wide array 
of factors, some controllable (e.g., lifestyle) and others uncontrollable (e.g., heredity) (Anderson, 
McCaul, & Langley, 2011; Rodakowski et al., 2014). Such differences in the perceived causality 
of cognitive changes may be another important dimension related to intention to perform self-
management behaviors for AD prevention (Anderson et al., 2011). Andersen et al. (2011) reported 
that cognitive healthy older adults believed lifestyle to be the most important factor causing AD 
and such beliefs were associated with their intention to adopt the behaviors leading to AD 
prevention. In contrast, individuals with MCI mostly attributed uncontrollable factors (e.g., 
heredity and normal aging) to cognitive impairment etiology (Rodakowski et al., 2014).   
 
Self-management Behaviors in Mild Cognitive Impairment 
Although self-management is a promising strategy to enhance individuals’ treatment 
regimens and quality of life (National Institutes of Health, 2010), research on the actual 
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performance of such behaviors among persons at risk for AD has shown mixed results. For 
example, in a study of individuals exhibiting no cognitive complaints but testing positive for an 
AD risk gene (Chao et al., 2008), participants were likely to either initiate taking 
medications/vitamins or change their lifestyle (e.g., changes in diet or exercise) for the purpose of 
AD prevention. In a study of a symptomatic population at risk for AD, cognitive stimulation was 
the most frequent behavior to be adopted among persons with MCI (Morgan et al., 2012). 
Similarly, Lin et al. (2012) reported that participants with MCI were readily engaged in the 
potential dementia prevention behaviors of mental stimulation and physical exercise. Given that 
the ultimate effectiveness of any such intervention depends upon its potential to reduce health risks 
in chronic disorders (Grady & Gough, 2014; Tanenbaum et al., 2015), caution is warranted in 
assuming that if an intervention to alter the course of MCI is identified, then those at risk would 
engage in the necessary health behaviors to take full advantage of potential benefits of the 
intervention.  
Although unique illness perceptions of individuals—especially perceived coherence about 
and causality of the disease—may result in following self-management behaviors as describe 
above, such an association (e.g., illness perception and self-management) has not been investigated 
in older adults with MCI. Indeed, previous investigations on MCI have explored either illness 
perceptions of individuals or their health behaviors. Therefore, little is understood about how the 
beliefs about MCI or its symptoms are associated with self-management behaviors of these 
individuals. Against this backdrop, the primary purpose of the study described herein was to 
examine the association between illness perceptions and self-management behaviors among older 
adults with MCI, while addressing not only perceptions of coherence (i.e., perceived understanding 
of MCI), but also causality (i.e., perceived cause of MCI).   
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2.3 Methods 
2.3.1  Study Design, Sample, and Setting 
Using a secondary analysis of two pooled existing, independent datasets, a quantitative, cross-
sectional, and descriptive study of illness perceptions and self-management among persons with 
MCI was conducted (see Figure 5). One set of data was collected to examine how persons with 
MCI and their care partners make sense of memory problems and diagnosis of patients (hereafter, 
referred to as MCI Perspectives Project [MCIPP]), and the other set of data was obtained from 
the Result Study, a clinical trial designed to determine the effect of receiving brain amyloid imaging 
research results on the understanding of MCI (NIH R01-AG046906). For the MCIPP, a total of 63 
persons with MCI were referred to the study by staff from the University of Pittsburgh Alzheimer’s 
Disease Research Center (ADRC) (NIH P50-AG005133). Of those, three (4.76%) individuals 
declined to participate, and the remaining 60 (95.2%) provided written informed consent. For the 
Result Study, individuals were recruited form the ADRC, and only the baseline data were used for 
this investigation, which included 90 participants. For the parent studies corresponding to both 
datasets, persons with MCI were included if they a) were 50 years of age or older, b) had an ADRC 
consensus diagnosis of MCI; c) resided within 50 miles of the University of Pittsburgh; d) had a 
care partner (e.g., family member or kin-like friend), and e) were provided written informed 
consent to participate. Exclusion criteria for both parent studies comprised a) being medically 
unstable and b) exhibiting evidence of active, untreated primary psychiatric disorders (e.g., 
depression and anxiety disorder). Although both parent studies included care partners, we excluded 
them from this analysis and focused on persons with MCI. Both parent studies and this study were 
approved by the University of Pittsburgh Institutional Review Board.  
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Figure 5. Conceptual Framework (Aim 1) Adapted from Leventhal et al. (2003) 
2.3.2  Measures 
Illness Perceptions: Coherence and Causality  
The coherence component of participant illness perception was measured using the coherence 
subscale of the Revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al., 2002). In 
both parent studies, this subscale was adapted for administration to persons with MCI. As such, 
the subscale contained five items, each rated on a 5-point Likert scale (i.e., from strongly disagree 
[1] to strongly agree [5]), that assessed perceived understanding about cognitive/memory changes, 
and the scores from these items were summed to provide an overall rating. For this analysis, the 
original scores of the first four items were reversed so that higher overall scores indicate a better 
perceived understanding about MCI. As recommended by Moss-Morris et al. (2002), the general 
term my illness was replaced with the condition-specific term my memory or thinking difficulties 
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in each parent study. The Cronbach’s alpha for the coherence construct was .82 for the MCI sample 
(Lingler et al., 2016) and .87 for our sample, respectively.  
In terms of the causality component of illness perception, participants from the parent studies 
were asked to list, in rank order, the three most important factors that they believed caused their 
memory or thinking difficulties. Of those three factors, the first ranked factor was used to examine 
the association between the causality component and self-management behaviors. Although two 
parent studies used different approaches to assess perceived cause of MCI (i.e., the MCIPP adapted 
Anderson et al. (2011)’s categorization approach and the Result Study used the original open-
ended question), we used two broad categories either as potentially controllable or uncontrollable 
factors as Rodakowski et al. (2014) categorized the attribution of MCI etiology. Among perceived 
causes of MCI in the MCIPP, stress/worry, behaviors, family problems/worries, overwork, 
alcohol, lifestyle, and poor physical/mental health fell into the potentially “controllable” factors, 
whereas “uncontrollable” factors included heredity, germ/virus, poor medical care in the past, 
normal aging, disease of old age, accident/injury, personality, other medical conditions (e.g., 
cancer treatment), and baseline learning/cognitive deficit.  
 
MCI-related Self-management Behaviors 
In the MCIPP, self-management behavior data were collected by not only the ADRC chart 
review, but also asking participants to self-management behaviors that were initiated following the 
MCI diagnosis. These self-management behavior data were independently recoded by the PI (HK) 
and a research assistant using the items assessed by the Risk Evaluation and Education for 
Alzheimer’s disease (REVEAL) health behavior measure (Chao et al., 2008) which was also the 
self-management behavior measure in the Result Study. The original REVEAL health behavior 
60 
measure consists of eight items, which yielded yes or no response related to changes made for the 
purpose of AD prevention (e.g., diet, physical activity, and medications). Of those eight items, the 
five self-management behaviors (i.e., physical activity, cognitive-enhancing medications, 
vitamins, herbal supplements, and mental activities) were used, based on the literature review, and 
vitamins and herbal supplements were treated as one category. The final four MCI-related self-
management behavior items deployed were the following: 1) physical activity; 2) cognitive-
enhancing medications (i.e., prescribed by a physician); 3) vitamins and/or herbal supplements; 
and 4) mental activities (e.g., crossword puzzles and Luminosity). Participants responded either 
yes (1) or no (0) for each item. Additionally, the ratio-scaled count of self-management behaviors 
were used yielding a 5-point scale ranging from none (0) to all (4). 
 
Sociodemographic and Clinical Information 
Sociodemographic and clinical information was extracted from ADRC records, which 
corresponded most closely to the dates of collection of illness perception and self-management 
behavior data. Sociodemographic data comprised age, sex, race, years of education, and marital 
status. Clinical information included duration of MCI diagnosis (in months), MCI type (amnestic 
or non-amnestic), and the number of comorbid conditions. To characterize the global cognitive 
status of each participant, the total scores of the Mini-Mental State Examination (MMSE) (Folstein 
et al., 1975) were retrieved from the last annual ADRC visit records for each participant. These 
MMSE total scores range from 0 to 30, where scores of 24 or greater reflect normal cognition. The 
Cronbach’s alpha for the MMSE ranges from 0.62 to 0.81 in samples of older adults (Kabátová et 
al., 2016; Tombaugh et al., 1996) and the MMSE features good concurrent and construct validity 
(McPherson et al., 1997; Razani et al., 2009).   
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2.3.3  Procedure 
In both parent studies, trained research assistants conducted face-to-face interviews in a 
private location (i.e., in the homes of participants or in a private room at the ADRC) to collect the 
data. Inter-rater reliability was accomplished for the causality subscale of illness perceptions of 
the Result Study and the self-management behavior measure of the MCIPP. 
To categorize the original open-ended responses of the causality subscale into two broad 
domains (i.e., potentially controllable and uncontrollable factors), the PI and a trained research 
assistant coded and entered the Result Study data separately. The inter-rater reliability of all coded 
data was assessed using Cohen’s kappa coefficient (κ) to confirm whether or not the raters 
achieved high agreement for the original causality responses. Indeed, κ for the causality subscale 
was 0.91, which indicates an excellent agreement between two raters (Fleiss et al., 1969).   
Similarly, self-management behavior data from the MCIPP Study were also coded in the same 
say. The PI and a trained research assistant reviewed the health behavior questionnaires from the 
MCIPP and separately recoded each item using the REVEAL health behavior measure (Chao et 
al., 2008). The κ of each coded health behavior item data ranged from 0.91 to 1, which suggests a 
strong agreement between the raters. Disagreements between the two raters were resolved via 
discussion. 
2.3.4  Data Analysis 
Prior to analysis, we identified six participants (4%) who had participated in both parent 
studies. Their data were removed from the Result Study because time of data collection of the 
MCIPP is more relevant to the aims of this study. All data were screened for anomalies (e.g., 
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outliers, missing data, and violations of statistical assumptions) using descriptive and exploratory 
analyses. The datasets from the two parent studies were then pooled to form one dataset, based on 
the key variables. Commensurate with the level of measurement and observed data distribution of 
each variable, appropriate descriptive statistics were computed to characterize the total sample 
(e.g., mean, median, modes, standard deviations [SDs], and interquartile ranges). The amount and 
pattern of missing data were evaluated, and six participants (4.17%) were identified as missing 
data for the causality item. Of those six participants, four did not answer the item, one believed 
that he/she does not have any cognitive issues, and one indicated that his/her memory issues were 
caused by both potentially controllable (i.e., high cholesterol and diet) and uncontrollable (i.e., 
previous health history) factors. For incomplete data (2.78%; n = 4), Little’s MCAR test was used 
to assess whether the missingness was completely at random (MCAR) or not. Covariates 
comprised age, sex, years of education, and the number of comorbid conditions, based on the data 
screening and our review of the literature (Chao et al., 2008).  
Hierarchical linear regression was used to examine the association between each primary 
independent variable (IV) (i.e., coherence and causality) and the dependent variable (i.e., total 
number of self-management behaviors) among older adults with MCI, while controlling for 
covariates. These hierarchical linear regression models were next expanded to include the main 
effect of the primary IVs and their interactions with each covariate. Specifically, only covariates 
were entered into the first block. Subsequently, a particular IV, coherence or causality, was added 
to the second block. In the final block, an interaction term between each IV and each covariate was 
entered to the model to assess for the possible moderating effect of the covariate on the relationship 
between a particular IV and the total number of self-management behaviors.  
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 To investigate the association between a particular dimension of illness perception (i.e., 
coherence or causality) and each self-management behavior (i.e., physical activity, cognitive-
enhancing medications, vitamins/herbal supplements, and mental activities), a particular primary 
IV was entered into hierarchical logistic regression models, while controlling for identified 
covariates. Similar to how we performed the hierarchical linear regression analyses, only 
covariates were included in the first block; subsequently, a particular IV (i.e., coherence or 
causality) was added to the second block. In the final block, interaction terms between a particular 
IV and each covariate were added to the model. In both our hierarchical linear and logistic 
regression analyses, mean centering was applied to the variables of age, years of education, and 
the number of comorbid conditions to minimize multicollinearity between these variables and their 
interaction terms with the primary IVs. For all fitted models, we conducted residual analysis and 
assessment of influence diagnostics in terms of (1) the predicted values of potential influential 
observations, (2) regression coefficients, and (3) the standard errors for regression coefficients. 
The level of statistical significance for two-tailed hypothesis testing was set at .05, and all analyses 
were performed using IBM® SPSS® Statistics Version 26.0 (Armonk, NY). 
2.4 Results 
2.4.1  Sample Characteristics  
The data of 144 older adults with MCI were analyzed in this study (see Table 2). In terms 
of the causality item, data from six of the 144 participants were excluded from our analysis because 
their answers to the questionnaire were either incomplete (n = 4) or invalid (n = 2). We did not 
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observe any significant differences in the participants who did not completely fill out the causality 
item (n = 4) and those who did (n = 138). Therefore, we chose a listwise deletion with a 4.8% 
sample drop-out rate. Little’s MCAR test (𝑥𝑥2= 3.710, df = 5, p = .592) demonstrated that the 
missingness of data was completely at random, further supporting the decision to include only 
those participants who completed the causality item. 
Our final sample was on average 71.9 (SD = 9.06) years of age and exhibited high levels 
of education attainment, with an average of 16.7 (SD = 2.73) years of education. Over half of the 
participants were male (58.3%; n = 84) and nearly half were currently married or living as married 
(47.3%; n = 68). Most were Caucasian (92.4%; n = 133) and diagnosed with amnestic MCI (83.3%; 
n = 120). 
 
 
 
 
 
 
 
 
 
 
 
 
 
65 
Table 2. Sample Characteristics 
(N = 144) 
 
Characteristic Mean ± SD (Min–Max) n (%) 
Age (years) 71.91 ± 9.06 (50–96)  
Education (years) 16.73 ± 2.73 (12–21)  
Sex   
 Female  60 (41.7) 
 Male  84 (58.3) 
Race   
 Caucasian  133 (92.4) 
 African-American  10 (6.9) 
 Native Hawaiian/Pacific Islander  1 (0.7) 
Marital Status   
 Currently married   59 (41.0) 
 Living as married   9 (6.3) 
 Never married  60 (41.7) 
 Widowed   12 (8.3) 
 Separated   1 (0.7) 
 Divorced   3 (2.1) 
Number of Comorbid Conditions (excluding MCI) 1.85 ± 1.27 (0–6)  
MMSE Total Score  27.22 ± 2.00 (20–30)  
Time Since Diagnosis (months) 15.61 ± 24.71 (0–135)  
MCI Type    
 Amnestic MCI  120 (83.3) 
 Non-amnestic MCI  24 (16.7) 
Note. SD = standard deviation; Min = minimum; Max = maximum; MCI = mild cognitive 
impairment; MMSE = Mini-Mental State Examination. 
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2.4.2  Perceptions of Coherence and Causality in Older Adults with MCI 
Table 3 describes illness perceptions of coherence and causality and self-management 
behaviors (i.e., physical activity, cognitive-enhancing medications, vitamins/herbal supplements, 
and mental activities) among participants with MCI. Our sample exhibited moderate levels of 
understanding about MCI with the coherence mean score of 16.04 (SD = 4.74), and the majority 
of participants (82%; n = 118) attributed their cognitive changes to uncontrollable factors. 
Regarding self-management behaviors, 74% (n = 106) of the participants performed at least one 
or more self-management behaviors for the purpose of preventing or delaying further cognitive 
problems. Among these self-management behaviors, mental activities (e.g., crossword puzzles) 
were the least frequently performed behaviors (60%; n = 87); in contrast, taking vitamins or herbal 
supplements was the most commonly reported behavior (74%; n = 107). 
Our hierarchical multivariate linear regression demonstrates that the association of 
perceived coherence of MCI with self-management behaviors by itself (p > .05) was not 
statistically significant, after controlling for covariates (i.e., age, sex, years of education, and the 
number of comorbid conditions). However, we observed some trends and a significant association 
when the interaction terms were added to the model (see Table 3). We observed a trend for the 
association between the interaction (i.e., coherence and age) and self-management behaviors (b = 
.004, p = .053), which indicates that participants who have higher levels of perceived coherence 
were likely to perform more self-management behaviors as compared to those with low perceived 
coherence of MCI, but this association is limited to the older age group. The interaction between 
coherence and sex was significantly associated with self-management behaviors (b = -.089, p = 
.025), which suggests that higher perceived coherence of MCI was related to more performance of 
self-management behaviors and such association was limited to the female group. As shown in 
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Table 4, no statistically significant associations were found between the perceived causality of 
MCI and self-management behaviors through hierarchical multivariate linear regression (p ≥ .05).  
The results of hierarchical multivariate logistic regression for each self-management 
behavior (i.e., physical activity, cognitive-enhancing medications, vitamin/herbal supplements, 
and mental activities) are presented in Tables 5 through 8. As indicated by the non-significant 
Hosmer-Lemeshow test (p = .480) (see Table 5), the final model of the relationship between 
coherence and physical activity showed a good fit of all included variables. Although the perceived 
coherence of the participants was not a statistically significant factor of any self-management 
behavior in block 2 (p ≥ .05), its interaction with years of education generated a statistically 
significant relationship with physical activity (p = .02, odds ratio [OR] = .957, 95% confidence 
interval [CI] = [.922, .993]) (see Table 5), which suggests that higher perceived coherence of MCI 
was related to less physical activity for preventing further cognitive changes, but this relationship 
was limited to participants who had more higher levels of education. We also observed an 
association trend between physical activity and the interaction (i.e., coherence and age) (p = .056, 
OR = 1.011, 95% CI = [1.000, 1.021]), which indicates that participants who had higher levels of 
perceived coherence of MCI were likely to perform physical activity compared to those with low 
perceived coherence, but such trend was limited to the older participants. As indicated in Table 6, 
the final model of the association between the variables of coherence and vitamins/herbal 
supplements indicated a good fit of included variables as the Hosmer-Lemeshow test did not yield 
a statistically significant result (p = .359). We observed association trends between taking 
vitamin/herbal supplements and two interactions, interaction of coherence and age (p = .083, OR 
= 1.009, 95% CI = [.999, 1.018]), and interaction of coherence and sex (p = .071, OR = .841, 95% 
CI = [.697, 1.015]) (see Table 6). Specifically, as compared to participants who had low levels of 
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coherence of MCI, those with higher levels of coherence of MCI were likely to take vitamins or 
herbal supplements and this trend was observed in the older participants. We also observed that 
male participants who had higher levels of coherence of MCI were likely to taking less vitamins 
or herbal supplements as compared to female participants.  
In terms of causality, non-significant p values resulting from Hosmer-Lemeshow tests for 
the final models of cognitive-enhancing medications (p = .189) and mental activities (p = .229) 
were indicators of good fit of all included variables (see Table 7 and Table 8). As shown in Table 
7 and Table 8, we observed no statistically significant associations between the perceived causality 
of MCI and any self-management behavior, when the causality variable was entered into each of 
the hierarchical multivariate logistic regression analyses. However, we did observe an association 
trend between cognitive-enhancing medications and the interaction (i.e., causality and the number 
of comorbid conditions) (p = .081, OR = .301, 95% CI = [.078, 1.158]) (see Table 7), which 
indicates that more numbers of comorbid conditions were associated with not taking cognitive-
enhancing medications among participants who believed that their cognitive changes were caused 
by controllable factors. Moreover, as shown in Table 8, we found an association trend between 
mental activities and the interaction (i.e., perceived causality and the number of comorbid 
conditions) (p = .054, OR = 2.085, 95% CI = [.987, 4.402]), which suggests that participants who 
had more comorbid conditions are likely to engage in mental activities as compared to those with 
less comorbid conditions, but this trend was limited to participants who believed that their 
cognitive changes were caused by controllable factors.  
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Table 3. Hierarchical Linear Regression Model of Coherence as a Predictor of Count of Self-management Behaviors 
(N = 144) 
  Count of Self-management Behaviors 
  Model 1 Model 2 Model 3 
  Unstandardized Regression Coefficients 
Block Predictor b SE p value b SE p value b SE p value 
1 (Constant) 1.757 0.848 0.040 1.822 0.877 0.040 1.502 3.230 0.643 
 Age (years) -0.011 0.010 0.292 -0.010 0.010 0.296 -0.067 0.033 0.041 
 Malea -0.063 0.183 0.730 -0.066 0.184 0.720 1.438 0.665 0.032 
 Education (years) 0.019 0.033 0.561 0.021 0.033 0.536 0.213 0.119 0.076 
 Comorbid conditionb 0.017 0.071 0.813 0.018 0.071 0.801 0.199 0.246 0.419 
2 Coherence    -0.006 0.019 0.760 0.051 0.030 0.089 
3c Coherence × age        0.004 0.002 0.053 
 Coherence × male       -0.089 0.039 0.025 
 Coherence × education       -0.012 0.007 0.103 
 Coherence × comorbid condition       -0.009 0.014 0.516 
 𝑅𝑅2 0.010 0.011 0.089 
 Adjusted 𝑅𝑅2 <0.001 <0.001 0.027 
Note. SE = standard error. 
aFemale was treated as the reference category for sex. 
bThe number of comorbid conditions was calculated with the exception of mild cognitive impairment. 
cFor interactions with age, education, and number of comorbid conditions, age, education, and number of comorbid conditions were mean 
centered due to multicollinearity. 
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Table 4. Hierarchical Linear Regression Model of Causality as a Predictor of Count of Self-management Behaviors 
(N = 144) 
  Count of Self-management Behaviors 
  Model 1 Model 2 Model 3 
  Unstandardized Regression Coefficients 
Block Predictor b SE p value b SE p value b SE p value 
1 (Constant) 1.653 0.857 0.056 1.648 0.868 0.060 1.640 0.914 0.075 
 Age (years) -0.005 0.010 0.643 -0.005 0.011 0.656 -0.007 0.011 0.547 
 Malea -0.026 0.185 0.889 -0.026 0.185 0.890 -0.053 0.203 0.793 
 Education (years) -0.001 0.034 0.974 -0.001 0.034 0.971 0.014 0.037 0.708 
 Comorbid conditionb 0.019 0.071 0.786 0.019 0.073 0.798 -0.021 0.085 0.806 
2 Causality    0.012 0.265 0.964 -0.071 0.401 0.860 
3c Causality × age        0.025 0.043 0.565 
 Causality × male       0.275 0.605 0.650 
 Causality × education       -0.101 0.107 0.350 
 Causality × comorbid condition       0.099 0.176 0.575 
 𝑅𝑅2 0.002 0.002 0.017 
 Adjusted 𝑅𝑅2 <0.001 <0.001 <0.001 
Note. SE = standard error. 
aFemale was treated as the reference category for sex. 
bThe number of comorbid conditions was calculated with the exception of mild cognitive impairment. 
cFor interactions with age, education, and number of comorbid conditions, age, education, and number of comorbid conditions were mean 
centered due to multicollinearity. 
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Table 5. Hierarchical Logistic Regression Model of Coherence as a Predictor of Physical Activity and Cognitive-enhancing Medications 
(N = 144) 
  Physical Activity  Cognitive-enhancing Medications 
  Model1 Model 2 Model 3 Model 1 Model 2 Model 3 
Block Predictor b OR [95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] 
1 (Constant) -0.801 0.449 -0.885 0.413 -3.764 0.023 1.462 0.391 1.728 5.628 0.570 1.768 
 Age (years) -0.033 0.967 [0.927, 1.008] -0.034 
0.967 
[0.927, 1.008] -0.188 
0.829* 
[0.696, 0.987] -0.002 
0.998 
[0.960, 1.038] -0.002 
0.998 
[0.960, 1.038] 0.043 
1.044 
[0.909, 1.198] 
 Malea -0.194 0.824 [0.389, 1.747] -0.192 
0.825 
[0.389, 1.749] 1.507 
4.515 
[0.180, 
113.101] 
-0.388 0.679 [0.333, 1.383] -0.402 
0.669 
[0.327, 1.367] 0.830 
2.294 
[0.153, 
34.488] 
 Education (years) 0.129 1.138
† 
[0.989, 1.309] 0.127 
1.136† 
[0.986, 1.309] 0.845 
2.328** 
[1.232, 4.401] -0.114 
0.892† 
[0.784, 1.015] -0.108 
0.897 
[0.788, 1.022] -0.255 
0.775 
[0.477, 1.260] 
 Comorbid conditionb 0.183 1.201 [0.904, 1.596] 0.181 
1.199 
[0.901, 1.594] 0.652 
1.920 
[0.659, 5.595] 0.068 
1.070 
[0.811, 1.413] 0.071 
1.074 
[0.812, 1.420] -0.164 
0.849 
[0.317, 2.270] 
2 Coherence   0.008 1.008 [0.932, 1.091] 0.092 
1.097 
[0.949, 1.267]   -0.022 
0.978 
[0.908, 1.054] 0.024 
1.024 
[0.907, 1.155] 
3c Coherence × age      0.010 1.011
† 
[1.000, 1.021]     -0.003 
0.997 
[0.988, 1.006] 
 Coherence × male     -0.093 0.911 [0.758, 1.096]     -0.081 
0.922 
[0.785,1.083] 
 Coherence × education     -0.044 0.957
* 
[0.922, 0.993]     0.010 
1.010 
[0.980, 1.041] 
 Coherence × comorbid  Condition     -0.023 
0.977 
[0.920, 1.037]     0.014 
1.015 
[0.959, 1.074] 
Model fitness 
(Hosmer-Lemeshow) 0.564 0.615 0.480 0.286 0.646 0.981 
Omnibus test 
(Chi-square (df), p) 6.684 (4), 0.154 6.728 (5), 0.242 17.390 (9), 0.043 5.097 (4), 0.278 5.434 (5), 0.365 7.585 (9), 0.576 
Model predictivity 
(Nagelkerke R2) 0.064 0.065 0.161 0.048 0.051 0.071 
Note. OR = odds ratio; CI = confidence interval. 
†p < .10; *p < .05; **p < .01 
aFemale was treated as the reference category for sex. 
bThe number of comorbid conditions was calculated with the exception of mild cognitive impairment. 
cFor interactions with age, education, and number of comorbid conditions, age, education, and number of comorbid conditions were mean centered due to multicollinearity. 
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Table 6. Hierarchical Logistic Regression Model of Coherence as a Predictor of Vitamins/Herbal Supplements and Mental Activities 
(N = 144) 
  Vitamins/Herbal Supplements Mental Activities 
  Model1 Model 2 Model 3 Model 1 Model 2 Model 3 
Block Predictor b OR [95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] 
1 (Constant) 0.584 1.794 0.797 2.218 -0.585 0.557 -1.877 0.153 -1.955 0.142 -0.776 0.460 
 Age (years) -0.029 0.971 [0.931, 1.013] -0.029 
0.972 
[0.932, 1.014] -0.147 
0.864† 
[0.743, 1.004] 0.008 
1.008 
[0.971, 1.047] 0.008 
1.008 
[0.971, 1.047] -0.082 
0.922 
[0.809, 1.050] 
 Malea 0.151 1.162 [0.531, 2.544] 0.141 
1.151 
[0.525, 2.524] 3.072 
21.577† 
[0.858, 
542.602] 
0.142 1.152 [0.573, 2.317] 0.145 
1.156 
[0.574, 2.325] 1.976 
7.215 
[0.463, 
112.456] 
 Education (years) 0.027 1.027 [0.892,1.183] 0.031 
1.032 
[0.895, 1.190] 0.413 
1.511 
[0.863, 2.646] 0.061 
1.063 
[0.937, 1.205] 0.059 
1.061 
[0.934, 1.205] 0.307 
1.359 
[0.836, 2.208] 
 Comorbid conditionb -0.056 0.946 [0.696, 1.285] -0.052 
0.949 
[0.697, 1.292] 
 
0.886 2.425 [0.798, 7.369] -0.110 
0.895 
[0.681, 1.177] 
 
-0.112 0.894 [0.680, 1.175] -0.096 
0.908 
[0.342, 2.413] 
2 Coherence   -0.020 0.980 [0.904, 1.062] 0.095 
1.099 
[0.950, 1.273]   0.007 
1.007 
[0.937, 1.082] 0.080 
1.083 
[0.956, 1.227] 
3c Coherence × age      0.009 1.009
† 
[0.999, 1.018]     0.006 
1.006 
[0.998, 1.015] 
 Coherence × male     -0.173 0.841
† 
[0.697, 1.015]     -0.108 
0.898 
[0.765, 1.054] 
 Coherence × education     -0.023 0.977 [0.945, 1.011]     -0.016 
0.984 
[0.956, 1.014] 
 Coherence × comorbid  condition     -0.055 
0.947 
[0.886, 1.012]     0.001 
1.001 
[0.947, 1.058] 
Model fitness 
(Hosmer-Lemeshow) 0.779 0.576 0.359 0.351 0.306 0.113 
Omnibus test 
(Chi-square (df), p) 2.358 (4), 0.670 2.599 (5), 0.762 11.683 (9), 0.232 2.163 (4), 0.706 2.198 (5), 0.821 7.445 (9), 0.591 
Model predictivity 
(Nagelkerke R2) 0.024 0.026 0.115 0.020 0.021 0.068 
Note. OR = odds ratio; CI = confidence interval; †p < .10 
aFemale was treated as the reference category for sex. 
bThe number of comorbid conditions was calculated with the exception of mild cognitive impairment. 
cFor interactions with age, education, and number of comorbid conditions, age, education, and number of comorbid conditions were mean centered due to multicollinearity. 
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Table 7. Hierarchical Logistic Regression Model of Causality as a Predictor of Physical Activity and Cognitive-enhancing Medications 
(N = 138) 
  Physical Activity Cognitive-enhancing Medications 
  Model1 Model 2 Model 3 Model 1 Model 2 Model 3 
Block Predictor b OR [95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] 
1 (Constant) -0.832 0.435 -0.971 0.379 -0.338 0.713 1.223 3.396 1.463 4.317 0.863 2.369 
 Age (years) -0.028 0.972 [0.931, 1.015] -0.026 
0.974 
[0.932, 1.018] -0.033 
0.968 
[0.924, 1.014] 0.009 
1.009 
[0.967, 1.052] 0.005 
1.005 
[0.963, 1.048] 0.008 
1.008 
[0.965, 1.054] 
 Malea -0.142 0.868 [0.405, 1.860] -0.139 
0.870 
[0.406, 1.867] 0.124 
1.133 
[0.487, 2.631] -0.329 
0.720 
[0.347,1.495] -0.339 
0.713 
[0.342, 1.484] -0.402 
0.669 
[0.305, 1.469] 
 Education (years) 0.105 1.111 [0.963, 1.281] 0.103 
1.108 
[0.961, 1.278] 0.086 
1.090 
[0.935, 1.272] -0.152 
0.859* 
[0.751, 0.983] -0.147 
0.863* 
[0.754, 0.988] -0.139 
0.870† 
[0.753, 1.005] 
 Comorbid conditionb 0.195 1.216 [0.912, 1.621] 0.179 
1.196 
[0.892, 1.604] 0.143 
1.153 
[0.814, 1.634] 0.081 
1.084 
[0.818, 1.438] 0.119 
1.126 
[0.840, 1.510] 0.258 
1.294 
[0.925, 1.811] 
 
2 Causality   0.294 1.341 [0.480, 3.750] 0.978 
2.660 
[0.554, 
12.773] 
  -0.643 0.526 [0.166, 1.663] -0.788 
0.455 
[0.073, 2.845] 
3c Causality × age      -0.014 0.986 [0.791, 1.228]     -0.016 
0.984 
[0.806, 1.201] 
 Causality × male     -2.062 0.127 [0.006, 2.615]     0.477 
1.612 
[0.079, 
32.936] 
 Causality × education     0.270 1.310 [0.760, 2.259]     -0.498 
0.608 
[0.276, 1.340] 
 Causality × comorbid  Condition     0.340 
1.405 
[0.614, 3.215]     -1.202 
0.301† 
[0.078, 1.158] 
Model fitness 
(Hosmer-Lemeshow) 0.488 0.801 0.024 0.869 0.442 0.189 
Omnibus test 
(Chi-square (df), p) 4.965 (4), 0.291 5.274 (5), 0.383 9.175 (9), 0.421 6.822 (4), 0.146 8.097 (5), 0.151 14.563 (9), 0.104 
Model predictivity 
(Nagelkerke R2) 0.050 0.053 0.091 0.066 0.078 0.138 
Note. OR = odds ratio; CI = confidence interval; †p < .10 
aFemale was treated as the reference category for sex. 
bThe number of comorbid conditions was calculated with the exception of mild cognitive impairment.  
cFor interactions with age, education, and number of comorbid conditions, age, education, and number of comorbid conditions were mean centered due to multicollinearity. 
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Table 8. Hierarchical Logistic Regression Model of Causality as a Predictor of Vitamins/Herbal Supplements and Mental Activities 
(N = 138) 
  Vitamins/Herbal Supplements Mental Activities 
  Model1 Model 2 Model 3 Model 1 Model 2 Model 3 
Block Predictor b OR [95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] b 
OR 
[95% CI] 
1 (Constant) 0.290 1.337 0.236 1.266 0.124 1.132 -1.873 0.154 -1.963 0.140 -1.868 0.154 
 Age (years) -0.024 0.976 [0.935, 1.019] -0.023 
0.977 
[0.935, 1.021] -0.028 
0.972 
[0.928, 1.018] 0.015 
1.016 
[0.976, 1.057] 0.017 
1.017 
[0.976, 1.060] 0.014 
1.014 
[0.971, 1.058] 
 Malea 0.178 1.195 [0.545, 2.622] 0.179 
1.196 
[0.545, 2.625] 0.073 
1.075 
[0.455, 2.542] 0.176 
1.193 
[0.585, 2.431] 0.180 
1.197 
[0.587, 2.442] 0.010 
1.010 
[0.462, 2.211] 
 Education (years) 0.027 1.028 [0.891, 1.185] 0.026 
1.026 
[0.889, 1.184] 0.070 
1.073 
[0.918, 1.254] 0.027 
1.027 
[0.902, 1.170] 0.025 
1.025 
[0.900, 1.168] 0.062 
1.064 
[0.924, 1.226] 
 Comorbid conditionb -0.068 0.934 [0.687, 1.270] -0.076 
0.927 
[0.679, 1.267] -0.174 
0.841 
[0.576, 1.227] -0.114 
0.892 
[0.676,1.177] -0.125 
0.883 
[0.666, 1.171] -0.340 
0.712† 
[0.501, 1.010] 
2 Causality   0.140 
1.150 
[0.388, 3.412] 
 
-0.264 0.768 [0.120, 4.907]   0.197 
1.218 
[0.442, 3.355] -0.617 
0.539 
[0.093, 3.137] 
3c Causality × age      0.069 1.072 [0.897, 1.280]     0.054 
1.056 
[0.881, 1.265] 
 Causality × male     1.076 
2.932 
[0.222, 
38.711] 
    1.206 
3.340 
[0.281, 
39.672] 
 Causality × education     -0.296 0.744 [0.481, 1.150]     -0.186 
0.830 
[0.545, 1.264] 
 Causality × comorbid  Condition     0.191 
1.210 
[0.569, 2.574]     0.735 
2.085† 
[0.987, 4.402] 
Model fitness 
(Hosmer-Lemeshow) 0.634 0.151 0.266 0.526 0.834 0.229 
Omnibus test 
(Chi-square (df), p) 1.820 (4), 0.769 1.883 (5), 0.865 5.011 (9), 0.833 1.844 (4), 0.764 1.988 (5), 0.851 8.738 (9), 0.462 
Model predictivity 
(Nagelkerke R2) 0.019 0.020 0.052 0.018 0.019 0.083 
Note. OR = odds ratio; CI = confidence interval; †p < .10 
aFemale was treated as the reference category for sex. 
bThe number of comorbid conditions was calculated with the exception of mild cognitive impairment. 
cFor interactions with age, education, and number of comorbid conditions, age, education, and number of comorbid conditions were mean centered due to multicollinearity. 
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2.5 Discussion 
In light of a growing number of persons affected by age-related cognitive disorders, we 
examined the association between illness perceptions—specifically the dimensions of coherence 
and causality—and self-management behaviors among older adults with MCI. Our results suggest 
that, among older adults with MCI, illness perceptions (i.e., perceived coherence of or causality of 
MCI) or its interactions with covariates (i.e., age, sex, years of education, and the number of 
comorbid conditions) may be associated with self-management behaviors for the purpose of 
preventing AD. Considering that diagnosis of and treatment for MCI still continue to evolve, some 
older adults with MCI may experience difficulty in making sense of their diagnosis or treatment 
for cognitive changes associated with MCI. Indeed, concerns over the ambiguity or uncertainty of 
these cognitive changes are found in qualitative (Gomersall et al., 2015) and quantitative (Lin et 
al., 2012) studies of persons with MCI. According to research in other populations, such 
perceptions may affect the performance of self-management behaviors (Brandes & Mullan, 2014; 
Hagger et al., 2017). 
Previous studies of the MCI population have revealed mixed findings about whether or not 
self-management behaviors (e.g., physical activity, cognitive-enhancing medications, or cognitive 
training) can either improve cognition or prevent disease progression in persons with MCI (Lam, 
Chan, Leung, Fung, & Leung, 2015; Nakatsuka et al., 2015; Suzuki et al., 2013). Nevertheless, 
clinicians and public health experts agree that these behaviors have overall health benefits, and 
may play a role in good cognitive health (Petersen et al., 2018). Previous studies have investigated 
either illness perceptions (Lin et al., 2012; Lingler et al., 2016) or the health behavior changes 
(Christensen et al., 2015; Morgan et al., 2012) among persons at increased risk of AD; therefore, 
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our finding of an association between illness perceptions and self-management behaviors certainly 
contributes to the literature. 
Our result is congruent with a meta-analysis of chronic disorders that higher perceived 
coherence was related to better treatment adherence (Brandes & Mullan, 2014). However, our 
findings were limited when interactions were added to the model, which suggests that 
sociodemographic factors or comorbid conditions of individuals should be considered when 
interpreting our results. Previous research has shown that age was related to self-management 
behaviors among those with chronic disorders. Interestingly, while in a study of Ory et al. (2014) 
reported a greater improvement in self-management behaviors among those with chronic disorders 
aged 50 to 64 years compared to those aged 65 years or older, our results suggest that a positive 
relationship between coherence and the total number of self-management behaviors actually 
increased with age among our participants with MCI. This relationship between coherence and 
self-management behaviors was limited to our female participants; yet, other sociocultural factors 
such as the levels of resource use or social support, likely play an important role in engaging in 
self-management behaviors and adhering to them (Grady & Gough, 2014; Mathew, Gucciardi, De 
Melo, & Barata, 2012).  
As such, we did examine the association between perceived coherence of MCI and each 
self-management behavior, and only the interaction between coherence and years of education 
among the participants was significantly related to physical activity. This suggests that a positive 
association between perceived coherence and physical activity increased with lower education 
levels. However, this finding must be interpreted with caution because our participants reported 
having received 16 years of education on average, rendering them more highly educated. 
Sociocultural factors of this sort should be considered in subsequent studies among this population.  
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Although we observed no association between the perceived causality of MCI and the total 
number of self-management behaviors, we did observe non-additive trends not only between 
causality and cognitive-enhancing medications, but also between causality and mental activities 
among participants with MCI. These findings suggest that participants who perceived their 
cognitive changes are being caused by controllable factors such as lifestyle or stress were less 
likely to take cognitive-enhancing medications if they presented more comorbid conditions. In 
contrast, participants who perceived their cognitive changes as being caused by controllable factors 
were more likely to engage in mental activities (e.g., doing crossword puzzles) if they presented 
more comorbid conditions. Although we targeted only perceptions of MCI, these perceptions—
and perceptions of illnesses in general—likely are affected by the other health conditions of the 
patients (Schuz et al., 2014). Indeed, multicomorbidity is common among older adults, which 
suggests that future research is needed to understand the potential role of comorbid conditions 
among older adults with MCI.  
Interestingly, although the majority of our participants perceived that their cognitive 
changes were caused by uncontrollable factors, they still performed at least one or more self-
management behaviors for preventing further cognitive decline, which is congruent with other 
findings in the literature. Namely, in a study of asymptomatic individuals at high risk for AD, Chao 
et al. (2008) found a similar pattern: those expressing a risk gene for AD were more likely than 
those who did not express the risk gene to change their heath behaviors to delay cognitive changes. 
Although aging and heredity are key factors for developing AD, a growing consensus about the 
potential benefits of maintaining a healthy lifestyle (e.g., regular exercise and cognitive training) 
may be one reason why we observed the self-management behaviors that we did among our 
participants with MCI (Petersen et al., 2018). Nevertheless, more in-depth studies will be needed 
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to expose all of the factors contributing to such self-management behaviors in older adults with 
MCI.  
We must acknowledge the limitations of this study. First, performing a secondary analysis 
of existing datasets prevented us from examining other important variables that may be related to 
our key variables. For example, although understanding the perceived coherence and causality of 
MCI among the individuals comprising the MCI population is important, other dimensions of 
illness perception also may be associated with their self-management behaviors. Second, the cross-
sectional design of the study is another limitation because it cannot provide evidence of any 
temporal relationship between illness perceptions and self-management behaviors among our 
participants with MCI; therefore, this study is unable to establish a cause and effect relationship 
between these factors. Third, results of our study cannot readily be generalized to the broader MCI 
population because the majority of our participants were Caucasian with relatively high levels of 
education. Finally, because data analyzed in this study except sociodemographic and clinical 
information were generated from participant self-reporting, potential bias certainly could taint our 
results. Although the parent studies conducted face-to-face interviews to minimize such bias, 
participants may have provided biased estimates of their self-assessed illness perceptions and self-
management behaviors, which could result in an under or over estimation of our results. Despite 
these limitations, our findings suggest clinical implications that health care professionals should 
take into account individual’s illness perceptions, sociodemographic characteristics, and comorbid 
conditions when discussing the symptom or disease management of older adults with MCI. 
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3.0 Manuscript 2: Type 2 Diabetes 
3.1 Abstract 
Background: Illness perceptions, patients’ beliefs about their health condition, may affect 
medication adherence as well as self-efficacy for managing the condition among persons with type 
2 diabetes (T2DM).  
Objectives: The aims of this study were to investigate the associations between illness 
perceptions, self-efficacy, and medication adherence among older adults with T2DM and explore 
whether the number of comorbid conditions moderates these associations.  
Methods: This secondary analysis of cross-sectional data used baseline data from persons with 
T2DM (≥50 years of age). Self-administered questionnaires, including the Brief Illness Perception 
Questionnaire, Self-efficacy for Managing Chronic Disease, and four-item Morisky Medication 
Adherence Scale, were used. Hierarchical multiple linear regression analyses were performed. 
Results: Participants (N = 146) were 57.5% (n = 84) female, 67.1% (n = 98) Caucasian, and on 
average 64.4 ± 8.65 years of age. Six dimensions of illness perceptions (i.e., consequences, 
personal control, treatment control, identity, concerns, and emotional representations) were 
associated with self-efficacy for managing T2DM. Five dimensions (i.e., timeline, personal 
control, treatment control, coherence, and emotional representations) were significant predictors 
of medication adherence. While the number of comorbid conditions (excluding T2DM) was 
significantly associated with self-efficacy for managing T2DM in all models (p < .001), the 
number of comorbid conditions was not associated with medication adherence. 
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Conclusion: This study suggests that illness perceptions may play a critical role in self-efficacy 
for managing T2DM and medication adherence among older adults with T2DM. Future research 
should incorporate an individual’s illness perceptions into development of interventions that may 
improve both self-efficacy and medication adherence. 
3.2 Introduction 
Diabetes, especially type 2 diabetes (T2DM), is one of the most common chronic illnesses 
among persons 50 years of age and older. The long-term complications of diabetes including 
cardiovascular disease, neuropathy, and kidney damage can be prevented by a widely agreed upon 
set of self-management strategies such as taking medication. However, given recent research that 
trends in glycemic control has not improved over the years (Lipska et al., 2017), medication 
adherence rates in T2DM remain low, including among older adults. Treatment nonadherence may 
result in poor therapeutic benefit from prescribed drugs. For example, physicians may adjust 
patients’ dose of frequency for better blood sugar control because they assume that drugs are being 
taken as ordered, but are not successfully controlling the blood glucose. Various factors likely 
contribute to one’s adherence to medication including a person’s thoughts and feelings about their 
disease and its symptoms, a concept which is referred to as illness perceptions (Leventhal et al., 
1984, 2003).   
Illness perceptions, one’s beliefs about an illness after receiving a diagnosis, have been 
shown to predict both coping behaviors and illness-specific outcomes across an array of conditions 
(Groarke, Curtis, Coughlan, & Gsel, 2004; Hallas, Wray, Andreou, & Banner, 2011; Velez-Velez 
& Bosch, 2016). Common Sense Model (CSM) of Self-Regulation is an empirically validated 
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conceptual framework focusing on the individual’s illness perceptions and self-management of 
health threats (Leventhal et al., 2003). Five main dimensions, identity (symptom experiences), 
consequences (serious consequences of the disease), cause (causes of the disease), timeline (acute 
vs. chronic), and cure/control (controllability over the disease), were identified (Leventhal et al., 
1984, 2003). Later, Moss-Morris et al. (2002) and Broadbent et al. (2006) added coherence 
(perceived understanding about the disease), emotional representations (negative feelings related 
to the disease such as anxiety and anger), and concern (levels of worry about the disease) items to 
the illness perception model. 
Self-efficacy refers to an individual’s confidence in the performance of behaviors required 
to achieve positive outcomes (Bandura, 1977). Applying this concept to self-management of 
T2DM suggests that self-efficacy for managing T2DM may play a critical role in one’s health 
behaviors and ultimately, health outcomes. Previous research on chronic disorders has found that 
an individual’s beliefs about the disease are associated with his or her confidence in the ability to 
perform or maintain self-management activities (Schuz et al., 2012; Zelber-Sagi et al., 2017).   
The number of comorbid conditions is another emerging issue in older adults with chronic 
disorders (Gerteis et al., 2014). The likelihood of having two or more health conditions is common 
with age, and such comorbidity may prevent older adults from having confidence in self-managing 
T2DM or adhering to medication and ultimately, this may impose another challenge to 
management of T2DM. 
The primary aims of this study were to investigate the associations between illness 
perceptions, and a) self-efficacy for managing T2DM, and b) medication adherence among older 
adults with T2DM. The secondary aims were to explore whether the number of comorbid 
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conditions (excluding T2DM) moderates the associations between each dimension of illness 
perception, and a) self-efficacy for managing T2DM, and b) medication adherence (Figure 6). 
 
 
Figure 6. Conceptual Framework (Aim 2) Adapted from Leventhal et al. (2003) 
3.3 Methods 
3.3.1  Study Design, Sample, and Setting 
For this secondary analysis, a quantitative, cross-sectional, and descriptive design was 
employed. We used baseline data from the Habit Study (NIH P01-NR010949), which is a 
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randomized controlled trial to examine a habit-training intervention designed to improve 
medication adherence among adults with T2DM.  
The Habit Study comprised a sample of 167 adults who were receiving treatment for T2DM 
from outpatient clinical practice sites within the University of Pittsburgh Medical Center Health 
System. The following were the eligibility criteria for the parent study: 1) minimum 40 years of 
age; 2) in treatment for T2DM; 3) taking one or more T2DM medications prescribed by a 
physician; 3) self-managing their medications; 4) English speaking, and 5) access to a telephone. 
Exclusion criteria were 1) having medications managed by others; 2) being unable or unwilling to 
use a medication diary or electronic event monitor; and 3) participating in another intervention 
research study. Since we focused on “late-life” T2DM, 20 participants (12%) who are younger 
than 50 years of age were excluded from this analysis. The parent study and this study were 
approved by University of Pittsburgh Institutional Review Board. 
3.3.2  Measures 
Illness Perceptions 
The self-reported Brief Illness Perception Questionnaire (Brief IPQ) (Broadbent et al., 
2006) has nine items to measure participants’ illness perceptions. All items, consequences, 
timeline, personal control, treatment control, identity, concerns, coherence, and emotional 
representations, except the causality item, were rated using an 11-point Likert scaling of 0 (not at 
all) to 10 (extremely). The open-ended causality item was excluded from our analysis. The Brief 
IPQ has been used in multiple chronic disorders such as hypertension (Perez, 2015; Saarti et al., 
2016), T2DM (Al-Amer et al., 2016; Martinez et al., 2018), and depression (Brown et al., 2011). 
The Brief IPQ has demonstrated good psychometric properties among persons with chronic 
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conditions (Broadbent et al., 2006). Internal consistency for the Brief IPQ in this sample was 0.60. 
The original term, ‘illness’ was replaced with ‘diabetes’ to capture participants’ unique perceptions 
about T2DM in this study. 
 
Self-efficacy for Managing Type 2 Diabetes  
The Self-Efficacy for Managing Chronic Disease (SEMCD) (Lorig et al., 2001) was used 
to assess the participants’ confidence level in completing tasks or activities for managing T2DM. 
This self-reported scale consists of six items with each item being rated on a 10-point Likert scale 
ranging from 1 (not at all confident) to 10 (totally confident). A mean of the six items is calculated, 
where higher scores indicate greater self-efficacy for managing the chronic condition (Lorig et al., 
2001). The SEMCD has demonstrated good internal consistency, with Cronbach’s alpha ranging 
from 0.87 to 0.93 in samples having chronic conditions (Freund et al., 2013; Lorig et al., 2001; 
Ritter & Lorig, 2014). Internal consistency of the SEMCD in this sample was 0.92.  
 
Medication Adherence  
The 4-item Morisky Medication Adherence Scale (MMAS-4) (Morisky et al., 1986) is a 
generic self-reported, medication-taking behavior scale with all items having dichotomous 
response choices (yes or no). With its usefulness in clinical settings to identify or monitor the non-
adherent patients (Tan, Patel, & Chang, 2014) the MMAS-4 has been validated in a range of health 
conditions with Cronbach’s alpha of 0.61 (Elm et al., 2007; Morisky et al., 1986; Tan et al., 2014; 
Toll et al., 2007). When scoring the MMAS-4 to yield a total score, we reversed the original scores 
of the items, such that higher total scores indicated better adherence to prescribed medications in 
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this study. The internal consistency of the MMAS-4 based on Cronbach’s alpha for this sample 
was of 0.40.  
 
Sociodemographic Characteristics and Comorbid Conditions 
Baseline sociodemographic information (i.e., age, years of education, sex, race, marital 
status, health insurance, and employment status) and the number of comorbid conditions were 
collected via self-report using the questionnaires developed by the Center for Research in Chronic 
Disorders at the University of Pittsburgh School of Nursing (Sereika & Engberg, 2006). 
3.3.3  Data Analysis 
Initially, data were screened for anomalies (e.g., outliers, missing data, and violations of 
statistical assumptions) using descriptive and exploratory data analysis methods. Based on the 
variable’s level of measurement, appropriate descriptive statistics (e.g., means, medians, modes, 
SDs, and interquartile ranges) were used to characterize the sample. The amount and pattern of 
missing data were explored and 1 participant (0.68%) was excluded from the analysis as the Brief 
IPQ was not completed by this participant. Identified univariate outliers for the variables of years 
of education and the number of comorbid conditions were winsorized to reduce influence on 
regression results. For example, high extreme values of years of education and the number of 
comorbid conditions were altered to the next highest values plus one-unit increment higher. Due 
to severe departures from normality, the timeline and coherence items of the Brief IPQ were each 
dichotomized as 0 to 9 versus 10. While data transformation was considered for the SEMCD score 
due to negative skewness, we report the results using the untransformed variable since similar 
results were obtained when using the transformed score. Pearson product-moment correlations 
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were first computed to explore associations among the potential covariate/confounding (i.e., age, 
years of education, sex, race, marital status, and employment status), and moderating (number of 
comorbid conditions) variables, the targeted predictors (each dimension of illness perception), and 
the dependent variables (self-efficacy for managing T2DM and medication adherence). Mean 
centering was used for the number of comorbid conditions to limit multicollinearity between the 
number of comorbid conditions and its interaction terms with each dimension of illness perception 
when exploring moderation.  
Hierarchical multiple linear regression was used to investigate the associations between 
each dimension of illness perception and the outcome variables of self-efficacy for managing 
T2DM and medication adherence, while controlling for covariates (i.e., age, years of education, 
sex, race, marital status, and employment status). To explore possible moderation by the number 
of comorbid conditions, hierarchical multiple linear regression models were expanded to include 
the main effect of the number of comorbid conditions and its interactions with each dimension of 
illness perception. This was conducted in such a way that four sequential linear regression models 
were estimated for the self-efficacy for managing T2DM and medication adherence based on the 
literature review and data screening. In the first block, only covariates were included in the model. 
In the second block, a particular dimension of illness perception, was added, and in the third block, 
the number of comorbid conditions was included. An interaction term between a particular illness 
perception dimension and the number of comorbid conditions was added to the final block to assess 
the number of comorbid conditions as a possible moderator of the associations between a particular 
dimension of illness perception and the dependent variables. Model assessment (i.e., residual 
analysis and assessment of potential influential observations in terms of predicted values, 
regression coefficients, and standard errors for regression coefficients) was performed for all fitted 
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models. Analyses were performed using SPSS® Statistics (Version 25.0, IBM Corp., Armonk, NY) 
and the level of statistical significance was set at .05. 
3.4 Results 
3.4.1  Sample Characteristics  
A total of 146 older adults with T2DM were included in this study. Our sample was 
predominantly Caucasian (67.1%) and had health insurance (95.2%), and on average (±SD) 64.4 
± 8.65 years of age with 14.0 ± 2.8 years of education, and six comorbid conditions (excluding 
T2DM) (Table 9). About half (51.4%) were married or living with a partner, and 41.8% were 
employed full or part-time. As reported in Table 10, the highest mean score among the illness 
perception dimensions was on the timeline (8.77 ± 2.01), while identity was the lowest dimension 
(4.10 ± 2.49). 
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Table 9. Sample Characteristics 
(N = 146) 
Characteristics Mean ± SD (Min-Max) n (%) 
Age (years) 64.38 ± 8.65 (50–94)  
Education (years) 13.97 ± 2.82 (8–25)  
Sex   
 Female  84 (57.5) 
 Male  62 (42.5) 
Race   
 Caucasian  98 (67.1) 
 African-American  46 (31.5) 
 Asian  2 (1.4) 
Marital Status   
 Currently married   70 (47.9) 
 Living with a partner  5 (3.4) 
 Never married  19 (13.0) 
 Widowed   28 (19.2) 
 Separated   5 (3.4) 
 Divorced   19 (13.0) 
Health Insurance    
 Yes   139 (95.2) 
 No   7 (4.8) 
Employment Status    
 Currently working (full-time/part-time)  61 (41.8) 
 Retired or not working  85 (58.2) 
Number of comorbid conditions  
(excluding type 2 diabetes) 
6.45 ± 3.4 (0–22)  
Notes. Min = minimum; Max = maximum; SD = standard deviation. 
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Table 10. Scores of Illness Perceptions     
(N = 146) 
Dimension of Illness Perceptions  
(possible score: 0 – 10) Mean  SD Median Range 
Consequences 4.74 2.64 5 0 – 10 
Timeline  8.77 2.01 10 1 – 10 
Personal Control 6.60 2.08 7 2 – 10 
Treatment Control 7.97 1.96 8 2 – 10  
Identity 4.10 2.49 4 0 – 10  
Concerns  4.45 2.99 5 0 – 10  
Coherence  8.16 2.36 9 0 – 10  
Emotional Representations 7.28 2.34 8 0 – 10  
Note. SD = standard deviation. 
3.4.2  Illness Perceptions and Self-efficacy for Managing Type 2 Diabetes 
Of eight illness perception dimensions, six dimensions (i.e., consequences, personal 
control, treatment control, identity, concerns, and emotional representations) were significantly 
associated (p < .05) with self-efficacy for managing T2DM, after controlling for covariates (i.e., 
age, years of education, sex, race, marital status, and employment status) in each hierarchical linear 
regression model. Participants’ perceived consequences of T2DM were the most significant 
predictor of self-efficacy for managing T2DM (b = -0.233, p< 0.001 [block 2]; b = -0.182, p = 
0.001 [block 3]; b = -0.191, p< 0.001 [block 4]) (Table 11). 
Participants’ higher perceptions about both personal control and treatment control over 
T2DM were associated with better self-efficacy for managing T2DM (personal control: b = 0.308, 
p <0.001 [block 2], b = 0.269, p <0.001 [block 3]; b = 0.272, p <0.001 [block 4]; treatment control: 
b = 0.335, p <0.001 [block 2]; b = 0.324, p <0.001 [block 3]; b = 0.323, p <0.001 [block 4]), and 
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remained significant when the number of comorbid conditions and interaction terms were added 
to the model (Tables 13 and 14). A significant association was found between perceived identity 
(i.e., symptom experiences) and self-efficacy for managing T2DM (b = -.251, p < .001 [block 2]; 
b = -.214, p < .001 [block 3]; b = -.213, p < .001 [block 4]), which suggests that lower levels of 
T2DM-related symptom experiences were associated with better self-efficacy for managing 
T2DM (Table 15). Likewise, a significant association was found between perceived concerns 
about T2DM and self-efficacy for managing T2DM (b = -.227, p < .001 [block 2]; b = -.182, p < 
.001 [block 3]; b = -.182, p < .001 [block 4]), suggesting that participants who have less concerns 
about T2DM were more likely to have higher levels of self-efficacy for managing T2DM (Table 
16). As shown Table 17, participants’ emotional representations, such as feelings of anger or being 
scared about T2DM, were the most significant predictors of self-efficacy for managing T2DM (b 
= .244, p < .001 [block 2]; b = .231, p < .001 [block 3]; b = .251, p< .001 [block 4]), indicating 
that lower levels of negative feelings caused by T2DM were related to better self-efficacy for 
managing T2DM in this sample. 
Expansion of the hierarchical linear regression models to examine the number of comorbid 
conditions (excluding T2DM) as a possible moderator revealed no significant interactions between 
each dimension of illness perception and the number of comorbid conditions on self-efficacy for 
managing T2DM. However, significant independent associations between the number of comorbid 
conditions with self-efficacy for managing T2DM were found in all models (p < .05), which 
suggests that less number of comorbid conditions were related to better self-efficacy for managing 
T2DM.   
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3.4.3  Illness Perceptions and Medication Adherence 
Five dimensions of illness perception (i.e., timeline, personal control, treatment control, 
coherence, and emotional representations) were statistically significant predictors of medication 
adherence after controlling for covariates (p < .05) in each hierarchical linear regression model 
(Tables 12, 13, 14, 17, and 18).  
As reported in Table 12, participants’ chronic timeline perception about T2DM was 
associated with better medication adherence (b = .350, p = .017 [block 2]; b = .348, p = .018 [block 
3]; b = .349, p = .018 [block 4]). Participants who believed T2DM is controllable were likely to 
have better medication adherence (personal control: b = .094, p = .005 [block 2], b = .091, p = .007 
[block 3]; b = .091, p = .007 [block 4]; treatment control: b = .111, p = .002 [block 2]; b = .110, p 
= .002 [block 3]; b = .111, p = .002 [block 4]), and remained statistically significant when the 
number of comorbid conditions and interaction terms were added to the model (Tables 13 and 14). 
Coherence (i.e., perceived understanding about T2DM) was positively associated with adherence 
to medication (b = .297, p = .040 [block 2]; b = .302, p = .037 [block 3]; b = .306, p = .035 [block 
4]) (Table 17). Table 18 shows the association between emotional representations and medication 
adherence among participants with T2DM, which indicates that participants’ negative feelings 
caused by T2DM were the most robust predictors of adherence to medication (b = .114, p < 0.001 
[block 2]; b =.113, p< .001 [block 3]; b = .118, p < .001 [block 4]).  
Further expansion of the regression models to examine the main effect of the number of 
comorbid conditions on medication adherence revealed no significant associations between the 
number of comorbid conditions and medication adherence (p ≥ .05). Also, no significant 
interactions were found between each dimension of illness perception with the number of 
comorbid conditions on medication adherence. 
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Table 11. Hierarchical Linear Regression Model of Consequences as a Predictor of Self-efficacy and Medication Adherence  
(N = 146) 
  Self-reported Self-efficacy for Managing Type 2 Diabetes Self-reported Medication Adherence 
  Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
  Unstandardized Regression Coefficients Unstandardized Regression Coefficients 
Block Predictor b p value b p value b p value b p value b p value b p value b p value b p value 
1 (Constant) 4.056 0.007 5.938 <0.001 4.954 <0.001 5.327 <0.001 2.656 <0.001 2.888 <0.001 2.791 <0.001 2.895 <0.001 
 Age (years) 0.029 0.105 0.024 0.163 0.036 0.028 0.033 0.047 0.005 0.527 0.005 0.582 0.006 0.496 0.005 0.572 
 
Education  
(years) 
0.100 0.092 0.078 0.166 0.071 0.176 0.070 0.183 -0.016 0.561 -0.019 0.498 -0.019 0.485 -0.020 0.476 
 Malea -0.478 0.136 -0.437 0.149 -0.561 0.050 -0.564 0.048 0.145 0.336 0.150 0.319 0.138 0.363 0.137 0.367 
 Whiteb -0.011 0.974 -0.132 0.696 0.169 0.601 0.081 0.804 0.160 0.340 0.145 0.387 0.175 0.310 0.150 0.390 
 
Married/living 
with a partnerc 
0.280 0.416 0.385 0.239 0.339 0.270 0.347 0.256 0.168 0.299 0.181 0.265 0.177 0.278 0.179 0.272 
 
Currently 
workingd 
0.553 0.093 0.312 0.322 0.107 0.720 0.144 0.630 -0.075 0.628 -0.104 0.505 -0.125 0.433 -0.114 0.473 
2 Consequences   -0.233 <0.001 -0.182 0.001 -0.191 <0.001   -0.029 0.291 -0.024 0.395 -0.026 0.354 
3 
# of comorbid 
conditionse 
    -0.194 <0.001 -0.053 0.594     -0.019 0.417 0.020 0.705 
4 Interactionf       -0.027 0.117       -0.008 0.413 
 Adjusted R2 0.040 0.147 0.247 0.255 0.001 0.002 <0.001 <0.001 
aFemale was treated as the reference category for sex. 
bNon-white was treated as the reference category for race. 
cThe combined category of never married, widowed, separated, or divorced was treated as the reference category for marital status. 
dParticipants who were retired or not working were treated as the reference category for employment status. 
eThe number of comorbid conditions was calculated with the exception of type 2 diabetes. 
fInteraction refers to the two-way interactions of consequences x # of comorbid conditions. 
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Table 12. Hierarchical Linear Regression Model of Timeline as a Predictor of Self-efficacy and Medication Adherence  
(N = 146) 
  Self-reported Self-efficacy for Managing Type 2 Diabetes Self-reported Medication Adherence 
  Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
  Unstandardized Regression Coefficients Unstandardized Regression Coefficients 
Block Predictor b p value b p value b p value b p value b p value b p value b p value b p value 
1 (Constant) 4.056 0.007 4.031 0.007 3.361 0.014 3.375 0.014 2.656 <0.001 2.639 <0.001 2.571 <0.001 2.573 <0.001 
 Age (years) 0.029 0.105 0.027 0.136 0.040 0.018 0.040 0.020 0.005 0.527 0.004 0.660 0.005 0.555 0.005 0.560 
 
Education  
(years) 
0.100 0.092 0.093 0.113 0.081 0.138 0.080 0.141 -0.016 0.561 -0.020 0.454 -0.022 0.426 -0.022 0.427 
 Malea -0.478 0.136 -0.449 0.160 -0.585 0.048 -0.566 0.057 0.145 0.336 0.165 0.267 0.151 0.310 0.153 0.308 
 Whiteb -0.011 0.974 -0.122 0.735 0.204 0.546 0.199 0.556 0.160 0.340 0.085 0.612 0.118 0.490 0.117 0.493 
 
Married/living 
with a partnerc 
0.280 0.416 0.314 0.360 0.286 0.366 0.302 0.341 0.168 0.299 0.192 0.231 0.189 0.238 0.190 0.237 
 
Currently 
workingd 
0.553 0.093 0.527 0.108 0.227 0.459 0.219 0.475 -0.075 0.628 -0.092 0.543 -0.123 0.428 -0.123 0.427 
2 Timelinee   0.514 0.102 0.498 0.085 0.505 0.081   0.350 0.017 0.348 0.018 0.349 0.018 
3 
# of comorbid 
conditionsf 
    -0.227 <0.001 -0.272 <0.001     -0.023 0.309 -0.027 0.480 
4 Interactiong       0.066 0.469       0.007 0.887 
 Adjusted R2 0.040 0.051 0.198 0.195 0.001 0.035 0.035 0.028 
aFemale was treated as the reference category for sex. 
bNon-white was treated as the reference category for race. 
cThe combined category of never married, widowed, separated, or divorced was treated as the reference category for marital status. 
dParticipants who were retired or not working were treated as reference category for employment status. 
eScores between 0 and 9 were treated as the reference category for the timeline variable. 
fThe number of comorbid conditions was calculated with the exception of type 2 diabetes. 
gInteraction refers to the two-way interactions of timeline x # of comorbid conditions. 
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Table 13. Hierarchical Linear Regression Model of Personal Control as a Predictor of Self-efficacy and Medication Adherence  
(N = 146) 
  Self-reported Self-Efficacy for Managing Type 2 Diabetes Self-reported Medication Adherence 
  Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
  Unstandardized Regression Coefficients Unstandardized Regression Coefficients 
Block Predictor b p value b p value b p value b p value b p value b p value b p value b p value 
1 (Constant) 4.056 0.007 2.575 0.070 2.154 0.103 2.065 0.119 2.656 <0.001 2.205 0.002 2.173 0.002 2.162 0.002 
 Age (years) 0.029 0.105 0.021 0.222 0.034 0.037 0.035 0.032 0.005 0.527 0.003 0.742 0.004 0.660 0.004 0.650 
 
Education  
(years) 
0.100 0.092 0.092 0.096 0.081 0.114 0.080 0.121 -0.016 0.561 -0.018 0.496 -0.019 0.477 -0.019 0.475 
 Malea -0.478 0.136 -0.449 0.135 -0.574 0.041 -0.563 0.045 0.145 0.336 0.154 0.295 0.144 0.329 0.145 0.327 
 Whiteb -0.011 0.974 0.010 0.975 0.298 0.344 0.283 0.370 0.160 0.340 0.166 0.308 0.189 0.258 0.187 0.265 
 
Married/living 
with a partnerc 
0.280 0.416 0.441 0.175 0.396 0.189 0.406 0.179 0.168 0.299 0.217 0.173 0.214 0.180 0.215 0.180 
 
Currently 
workingd 
0.553 0.093 0.561 0.069 0.288 0.321 0.303 0.298 -0.075 0.628 -0.072 0.631 -0.093 0.544 -0.091 0.554 
2 Personal control   0.308 <0.001 0.269 <0.001 0.272 <0.001   0.094 0.005 0.091 0.007 0.091 0.007 
3 
# of comorbid 
conditionse 
    -0.205 <0.001 -0.103 0.418     -0.016 0.485 -0.003 0.963 
4 Interactionf       -0.015 0.397       -0.002 0.843 
 Adjusted R2 0.040 0.161 0.277 0.276 0.001 0.050 0.046 0.040 
aFemale was treated as the reference category for sex. 
bNon-white was treated as the reference category for race. 
cThe combined category of never married, widowed, separated, or divorced was treated as the reference category for marital status. 
dParticipants who were retired or not working were treated as the reference category for employment status. 
eThe number of comorbid conditions was calculated with the exception of type 2 diabetes. 
fInteraction refers to the two-way interactions of personal control x # of comorbid conditions. 
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Table 14. Hierarchical Linear Regression Model of Treatment Control as a Predictor of Self-efficacy and Medication Adherence  
(N = 146) 
  Self-reported Self-efficacy for Managing Type 2 Diabetes Self-reported Medication Adherence 
  Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
  Unstandardized Regression Coefficients Unstandardized Regression Coefficients 
Block Predictor b p value b p value b p value b p value b p value b p value b p value b p value 
1 (Constant) 4.056 0.007 1.977 0.174 1.386 0.297 1.406 0.292 2.656 <0.001 1.968 0.006 1.911 0.008 1.894 0.008 
 Age (years) 0.029 0.105 0.027 0.105 0.040 0.011 0.040 0.012 0.005 0.527 0.005 0.567 0.006 0.475 0.006 0.444 
 
Education  
(years) 
0.100 0.092 0.060 0.283 0.048 0.343 0.051 0.324 -0.016 0.561 -0.029 0.282 -0.030 0.265 -0.032 0.240 
 Malea -0.478 0.136 -0.171 0.576 -0.312 0.267 -0.320 0.258 0.145 0.336 0.246 0.100 0.233 0.122 0.239 0.114 
 Whiteb -0.011 0.974 -0.119 0.721 0.199 0.521 0.198 0.525 0.160 0.340 0.124 0.445 0.155 0.350 0.156 0.348 
 
Married/living 
with a partnerc 
0.280 0.416 0.380 0.240 0.350 0.235 0.353 0.233 0.168 0.299 0.202 0.202 0.199 0.208 0.197 0.214 
 
Currently 
workingd 
0.553 0.093 0.515 0.095 0.222 0.437 0.217 0.448 -0.075 0.628 -0.087 0.560 -0.116 0.449 -0.112 0.466 
2 Treatment control   0.335 <0.001 0.324 <0.001 0.323 <0.001   0.111 0.002 0.110 0.002 0.111 0.002 
3 
# of comorbid 
conditionse 
    -0.222 <0.001 -0.304 0.104     -0.021 0.334 0.047 0.639 
4 Interactionf       0.010 0.650       -0.008 0.483 
 Adjusted R2 0.040 0.161 0.301 0.297 0.001 0.060 0.060 0.057 
aFemale was treated as the reference category for sex. 
bNon-white was treated as the reference category for race. 
cThe combined category of never married, widowed, separated, or divorced was treated as the reference category for marital status. 
dParticipants who were retired or not working were treated as the reference category for employment status. 
eThe number of comorbid conditions was calculated with the exception of type 2 diabetes. 
fInteraction refers to the two-way interactions of treatment control x # of comorbid conditions. 
 
 
 
 
96 
Table 15. Hierarchical Linear Regression Model of Identity as a Predictor of Self-efficacy and Medication Adherence 
(N = 146) 
  Self-reported self-efficacy for Managing Type 2 Diabetes Self-reported Medication Adherence 
  Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
  Unstandardized Regression Coefficients Unstandardized Regression Coefficients 
Block  Predictor b p value b p value b p value B p value b p value b p value b p value b p value 
1 (Constant) 4.056 0.007 6.029 <0.001 5.135 <0.001 5.062 <0.001 2.656 <0.001 3.036 <0.001 2.955 <0.001 2.930 <0.001 
 Age (years) 0.029 0.105 0.025 0.148 0.037 0.022 0.038 0.020 0.005 0.527 0.004 0.597 0.006 0.515 0.006 0.496 
 
Education  
(years) 
0.100 0.092 0.069 0.220 0.062 0.237 0.064 0.222 -0.016 0.561 -0.022 0.427 -0.023 0.414 -0.022 0.433 
 Malea -0.478 0.136 -0.573 0.059 -0.679 0.017 -0.694 0.015 0.145 0.336 0.127 0.398 0.117 0.437 0.112 0.459 
 Whiteb -0.011 0.974 -0.184 0.586 0.130 0.685 0.144 0.654 0.160 0.340 0.127 0.449 0.155 0.366 0.160 0.353 
 
Married/living 
with a partnerc 
0.280 0.416 0.264 0.416 0.242 0.423 0.220 0.471 0.168 0.299 0.165 0.305 0.163 0.311 0.156 0.339 
 
Currently 
workingd 
0.553 0.093 0.437 0.160 0.184 0.530 0.192 0.514 -0.075 0.628 -0.097 0.528 -0.120 0.444 -0.117 0.456 
2 Identity   -0.251 <0.001 -0.214 <0.001 -0.213 <0.001   -0.048 0.094 -0.045 0.123 -0.045 0.126 
3 
# of comorbid 
conditionse 
    -0.203 <0.001 -0.161 0.033     -0.018 0.426 -0.004 0.921 
4 Interactionf       -0.012 0.488       -0.004 0.660 
 Adjusted R2 0.040 0.149 0.263 0.261 0.001 0.014 0.012 0.006 
aFemale was treated as the reference category for sex. 
bNon-white was treated as the reference category for race. 
cThe combined category of never married, widowed, separated, or divorced was treated as the reference category for marital status. 
dParticipants who were retired or not working were treated as the reference category for employment status. 
eThe number of comorbid conditions was calculated with the exception of type 2 diabetes. 
fInteraction refers to the two-way interactions of identity x # of comorbid conditions. 
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Table 16. Hierarchical Linear Regression Model of Concerns as a Predictor of Self-efficacy and Medication Adherence  
(N = 146) 
  Self-reported Self-efficacy for Managing Type 2 Diabetes Self-reported Medication Adherence 
  Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
  Unstandardized Regression Coefficients Unstandardized Regression Coefficients 
Block  Predictor b p value b p value b p value b p value b p value b p value b p value b p value 
1 (Constant) 4.056 0.007 6.668 <0.001 5.586 <0.001 5.644 <0.001 2.656 <0.001 3.048 <0.001 2.949 <0.001 2.998 <0.001 
 Age (years) 0.029 0.105 0.012 0.498 0.026 0.117 0.026 0.124 0.005 0.527 0.003 0.755 0.004 0.650 0.004 0.679 
 
Education  
(years) 
0.100 0.092 0.084 0.131 0.076 0.146 0.075 0.153 -0.016 0.561 -0.019 0.502 -0.019 0.487 -0.020 0.469 
 Malea -0.478 0.136 -0.565 0.060 -0.661 0.020 -0.643 0.025 0.145 0.336 0.132 0.380 0.123 0.415 0.138 0.366 
 Whiteb -0.011 0.974 -0.167 0.616 0.134 0.677 0.111 0.732 0.160 0.340 0.136 0.415 0.164 0.341 0.145 0.406 
 
Married/living 
with a partnerc 
0.280 0.416 0.319 0.321 0.289 0.340 0.294 0.334 0.168 0.299 0.174 0.281 0.172 0.290 0.176 0.279 
 
Currently 
workingd 
0.553 0.093 0.275 0.379 0.077 0.795 0.081 0.786 -0.075 0.628 -0.116 0.457 -0.134 0.397 -0.131 0.410 
2 Concerns   -0.227 <0.001 -0.182 <0.001 -0.182 <0.001   -0.034 0.165 -0.030 0.234 -0.030 0.230 
3 
# of comorbid 
conditionse 
    -0.191 <0.001 -0.160 0.052     -0.017 0.459 0.009 0.837 
4 Interactionf        -0.007 0.657       -0.006 0.476 
 Adjusted R2 0.040 0.165 0.261 0.257 0.001 0.008 0.005 0.001 
aFemale was treated as the reference category for sex. 
bNon-white was treated as the reference category for race. 
cThe combined category of never married, widowed, separated, or divorced was treated as the reference category for marital status. 
dParticipants who were retired or not working were treated as the reference category for employment status. 
eThe number of comorbid conditions was calculated with the exception of type 2 diabetes. 
fInteraction refers to the two-way interactions of concerns x # of comorbid conditions. 
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Table 17. Hierarchical Linear Regression Model of  Coherence as a Predictor of Self-efficacy and Medication Adherence  
(N = 146) 
  Self-reported Self-efficacy for Managing Type 2 Diabetes Self-reported Medication Adherence 
  Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
  Unstandardized Regression Coefficients Unstandardized Regression Coefficients 
Block  Predictor b p value b p value b p value b p value b p value b p value b p value b p value 
1 (Constant) 4.056 0.007 3.845 0.011 3.136 0.024 3.309 0.018 2.656 <0.001 2.437 0.001 2.360 0.001 2.333 0.001 
 Age (years) 0.029 0.105 0.030 0.093 0.044 0.010 0.042 0.012 0.005 0.527 0.006 0.440 0.008 0.351 0.008 0.341 
 
Education  
(years) 
0.100 0.092 0.097 0.104 0.083 0.129 0.079 0.146 -0.016 0.561 -0.019 0.479 -0.021 0.447 -0.020 0.461 
 Malea -0.478 0.136 -0.397 0.232 -0.521 0.090 -0.555 0.071 0.145 0.336 0.229 0.139 0.215 0.164 0.220 0.157 
 Whiteb -0.011 0.974 0.005 0.988 0.333 0.319 0.293 0.381 0.160 0.340 0.177 0.285 0.213 0.207 0.219 0.197 
 
Married/living 
with a partnerc 
0.280 0.416 0.285 0.409 0.258 0.417 0.223 0.481 0.168 0.299 0.173 0.281 0.170 0.289 0.175 0.276 
 
Currently 
workingd 
0.553 0.093 0.572 0.084 0.270 0.381 0.367 0.246 -0.075 0.628 -0.055 0.717 -0.088 0.571 -0.103 0.519 
2 Coherencee   0.287 0.354 0.329 0.248 0.301 0.290   0.297 0.040 0.302 0.037 0.306 0.035 
3 
# of comorbid 
conditionsf 
    -0.230 <0.001 -0.006 0.973     -0.025 0.272 -0.060 0.496 
4 Interactiong        -0.027 0.187       0.004 0.679 
 Adjusted R2 0.040 0.039 0.188 0.192 0.001 0.025 0.026 0.020 
aFemale was treated as the reference category for sex. 
bNon-white was treated as the reference category for race. 
cThe combined category of never married, widowed, separated, or divorced was treated as the reference category for marital status. 
dParticipants who were retired or not working were treated as the reference category for employment status. 
eScores between 0 and 9 was treated as the reference category for the coherence variable. 
fThe number of comorbid conditions was calculated with the exception of type 2 diabetes. 
gInteraction refers to the two-way interactions of coherence x # of comorbid conditions. 
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Table 18. Hierarchical Linear Regression Model of Emotional Representations as a Predictor of Self-efficacy and Medication Adherence  
(N = 146) 
  Self-reported self-efficacy for managing type 2 diabetes Self-reported medication adherence 
  Model 1 Model 2 Model 3 Model 4 Model 1 Model 2 Model 3 Model 4 
  Unstandardized regression coefficients Unstandardized regression coefficients 
Block  Predictor b p value b p value b p value b p value b p value b p value b p value b p value 
1 (Constant) 4.056 0.007 2.306 0.117 1.713 0.205 1.559 0.250 2.656 <0.001 1.836 0.009 1.780 0.011 1.737 0.014 
 Age (years) 0.029 0.105 0.032 0.060 0.045 0.005 0.044 0.006 0.005 0.527 0.007 0.399 0.008 0.328 0.008 0.342 
 
Education  
(years) 
0.100 0.092 0.077 0.171 0.065 0.207 0.072 0.167 -0.016 0.561 -0.027 0.315 -0.028 0.296 -0.026 0.334 
 Malea -0.478 0.136 -0.313 0.309 -0.451 0.112 -0.496 0.083 0.145 0.336 0.222 0.124 0.209 0.150 0.197 0.181 
 Whiteb -0.011 0.974 -0.019 0.955 0.297 0.347 0.323 0.307 0.160 0.340 0.156 0.326 0.186 0.252 0.193 0.236 
 
Married/living 
with a partnerc 
0.280 0.416 0.392 0.235 0.361 0.232 0.347 0.250 0.168 0.299 0.221 0.155 0.218 0.160 0.214 0.169 
 
Currently 
workingd 
0.553 0.093 0.477 0.128 0.184 0.527 0.170 0.560 -0.075 0.628 -0.111 0.452 -0.138 0.357 -0.142 0.345 
2 
Emotional 
representations 
  0.244 <0.001 0.231 <0.001 0.251 <0.001   0.114 <0.001 0.113 <0.001 0.118 <0.001 
3 
# of comorbid 
conditionse 
    -0.223 <0.001 -0.104 0.356     -0.021 0.339 0.013 0.829 
4 Interactionf        -0.016 0.258       -0.005 0.536 
 Adjusted R2 0.040 0.133 0.273 0.275 0.001 0.098 0.097 0.093 
aFemale was treated as the reference category for sex 
bNon-white was treated as the reference category for race 
cThe combined category of never married, widowed, separated, or divorced was treated as the reference category for marital status 
dParticipants who were retired or not working were treated as the reference category for employment status  
eThe number of comorbid conditions was calculated with the exception of type 2 diabetes 
fInteraction refers to the two-way interactions of emotional representations x # of comorbid conditions 
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3.5 Discussion 
The rapid aging of the world population is widely recognized as a contributor to the T2DM 
epidemic (CDC, 2017b). Among older adults with T2DM, self-efficacy and medication adherence 
may be the key factors for optimal health maintenance, and are likely to be influenced by one’s 
perceptions about T2DM and its symptoms. This study examined the association of each of the 8 
dimensions of illness perception separately with self-efficacy for managing T2DM and medication 
adherence in a sample of older adults with T2DM. Our analysis demonstrated that several 
dimensions of illness perception were significantly associated with self-efficacy for managing 
T2DM (six dimensions) and/or medication adherence (Five dimensions), which highlights the 
importance of perceptions about T2DM and its symptoms among older adults with T2DM.  
 
Illness Perceptions and Self-efficacy for Managing Type 2 Diabetes 
With the exception of the timeline and coherence dimensions, each dimension of illness 
perception was a strong predictor of self-efficacy for managing T2DM in this sample. Our findings 
regarding perceived consequences of, and concerns about, one’s condition were consistent with 
previous research on chronic disorders (Al-Amer et al., 2016; Bonsaksen et al., 2012; Lau-Walker, 
2004; Zelber-Sagi et al., 2017) in that lower perception of serious consequences of, and less worry 
about, the condition predicted higher self-efficacy for managing T2DM.  
Dimensions of perceived personal control and treatment control were the most significant 
predictors of self-efficacy for managing T2DM. These findings are congruent with a previous 
study of Jordanian patients with T2DM wherein Al-Amer et al. (2016) found that higher levels of 
perceived personal control were associated with higher levels of self-efficacy for managing T2DM. 
These findings have clinical implications for nurses and other healthcare professionals who are 
101 
counselling older adults with T2DM, which suggests that nurses should assess patients’ beliefs 
about their potential to control the course of their T2DM before or upon intervening to promote 
self-efficacy for managing the condition. Fewer symptom experiences may signal better control 
over the disease. Our finding of a significant relationship between reporting lower levels of 
diabetes symptoms (e.g., thirst, fatigue, and blurred vision) and reporting higher levels of self-
efficacy for managing T2DM may reflect this. Interestingly, while in other samples of persons 
with chronic conditions (Bonsaksen et al., 2012; Timkova et al., 2018) reporting lower levels of 
illness-related emotional representations (e.g., anger or anxiety caused by the disease) have been 
associated with better self-efficacy, our findings showed that the participants with more feelings 
of anger or anxiety about T2DM tended to have higher self-efficacy for managing T2DM. Our 
sample endorsed higher scores on emotional representations compared to other T2DM samples 
(Al-Amer et al., 2016; Nie, Han, Xu, Huang, & Mao, 2018), which may be partially driving our 
findings. Nevertheless, further in-depth investigations of factors to affect the relationship between 
the dimension of emotional representations and self-efficacy for managing T2DM are needed in 
older adults. Since the number of comorbid conditions also predicted self-efficacy for managing 
T2DM, nurses and other healthcare professionals should take into account older adults’ co-
occurring health conditions when evaluating their self-efficacy for managing T2DM. 
 
Illness Perceptions and Medication Adherence  
Participants’ perceptions of timeline, personal control, treatment control, coherence, and 
emotional representations, were significantly associated with medication adherence among older 
adults with T2DM.  
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While the dimensions of timeline and coherence were not associated with self-efficacy for 
T2DM, these dimensions were significant predictors of medication adherence in our sample. Our 
participants who felt that T2DM is chronic, and that the disease is easily understandable, were 
more likely to have better medication adherence. Patients may continue to take prescribed drugs if 
T2DM makes more sense to them (Nie et al., 2018), and/or if they believe living with T2DM is a 
life-long journey. Two perceived controllability variables, personal control and treatment control, 
explained medication adherence in the same way that they were associated with self-efficacy for 
managing T2DM; higher perceived personal controllability as well as treatment controllability 
over T2DM were associated with better adherence to medication. These findings are partially 
supported by previous work comparing illness perceptions between the moderate-high medication 
adherence and low medication adherence groups. Ashur et al. (2015) examined Libyans with 
T2DM and found that perception of treatment control was significantly lower in a low medication 
adherence group as compared to moderate-high adherence group. Our findings suggest that strong 
beliefs in medical treatment and patient empowerment are essential for optimal symptom and 
disease management which has implications for future interventions to improve medication 
adherence in older adults taking T2DM medication. Interestingly, more feelings of anger or upset 
about T2DM were also related to better medication adherence as this dimension predicted self-
efficacy for managing T2DM in this sample. Additional research is needed to examine the 
influence of emotional representations on medication adherence in samples of older adults with 
chronic disorders (Lo, Chau, Woo, Thompson, & Choi, 2016; Miyazaki et al., 2018).  
This study has some limitations. The cross-sectional design poses a significant limitation, 
given that illness perceptions for chronic disorders are formed over time (Tasmoc, Hogas, & Covic, 
2013). This design also precludes determining the direction of relationships noted among the 
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variables. For example, self-efficacy and medication adherence could be influenced by diabetes-
related illness perceptions, and self-efficacy may mediate the association between illness 
perceptions and medication adherence. Although duration of a disease may be another factor of 
self-efficacy and medication adherence, we were not able to test such a relationship because the 
parent study did not collect this information. The findings based on a sample of older adults (≥ 50 
years) from the study with moderate sample size may not generalizable to the overall T2DM 
population. Limitations of the measurements should be also acknowledged. Use of self-reported 
questionnaires can be an issue due to response bias, which may affect the results of this study. 
Although MMAS-4 is easy and simple to administer, it has shown low internal consistency in this 
study which should be taken into account when interpreting the findings. Nevertheless, the value 
of our findings outweigh limitations because this study highlighted an important role of illness 
perceptions in self-efficacy for managing T2DM and medication adherence among older adults 
with T2DM. Further studies are needed to incorporate individuals’ illness perceptions into 
development of bio-behavioral interventions aimed at improving adherence to T2DM medications 
and promoting good health and quality of life of older adults with the disease. 
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4.0 Manuscript 3: Type 2 Diabetes vs. Mild Cognitive Impairment 
4.1 Abstract 
Objective: The burden of chronic disorders impacting physical and mental health in late-life 
suggests the need to understand individuals’ illness perceptions, taking into account disease 
characteristics (physical vs. mental). We identified similarities and differences in illness 
perceptions in older adults with type 2 diabetes (T2DM) and those with mild cognitive impairment 
(MCI) as exemplars of late-life physical and mental disorders.  
Methods: We conducted a secondary analysis of existing baseline data from the two clinical trials. 
The Brief Illness Perception Questionnaire was used. Multivariate analysis of covariance 
(MANCOVA) and hierarchical linear regression were performed to compare illness perceptions 
between older adults with T2DM and those with MCI. 
Results: Participants with MCI (n = 90) tended to be older and more educated than those with 
T2DM (n = 146) (ps < .001). Illness perceptions were different between the two groups when the 
dimensions of illness perception were examined multivariately (p < .001). Only the consequences 
dimension was not associated with participants’ disease characteristics (p = .962) when each 
dimension of illness perception was examined. Participants with T2DM were more likely than 
those with MCI to view their health condition as being controllable through personal strategies (p 
= .009) and medical treatment (p < .001). Participants with T2DM endorsed having a more clear 
understanding (p = .001) and negative feelings (e.g., anger) (p < .001) about their condition as 
compared to those with MCI.   
105 
Conclusion: Findings suggest that older adults may view mental disorders differently than 
physical disorders, which have implications for future patient education and interventions to 
facilitate symptom management. 
4.2 Introduction 
Despite the fact that the number of older adults who are living with chronic disorders has 
been increasing in recent decades (National Institute of Aging, 2017), research on how older adults 
perceive their chronic conditions is absent. Chronic disorders are sometimes asymptomatic and 
not easily noticed so that thoughts and beliefs about the conditions may vary from individual to 
individual. Understanding individuals’ beliefs about their health conditions is critical because 
activation of such beliefs may result in differences in self-management (e.g., treatment non-
adherence and seeking social support) (Hagger et al., 2017; Leventhal, Phillips, & Burns, 2016). 
Individuals have their own particular thoughts and feelings when experiencing physical 
symptoms or after receiving a medical diagnosis, this concept is known as illness perceptions 
(Leventhal et al., 2003). Common Sense Model (CSM) of Self-Regulation (Leventhal et al., 2003) 
is an empirically validated conceptual framework which explicates a set of individuals’ thoughts 
about the disease. Illness perceptions comprise five main dimensions including 1) identity 
(symptoms of the disease), 2) consequences (perceived outcomes of the disease), 3) cause 
(perceived causes of the disease), 4) timeline (perception of how the disease will last; acute vs. 
chronic), and 5) cure/control (beliefs on whether the disease is curable or not) (Leventhal et al., 
2003). Coherence (perceived levels of understanding about the disease), emotional representations 
(negative feelings caused by the disease such as anger and anxiety), and concerns (levels of worry) 
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were identified as additional dimensions of the CSM model (Broadbent et al., 2006; Moss-Morris 
et al., 2002).  
Chronic disorders affecting older adults may fall into two broad categories, those which 
affect physical health (e.g., type 2 diabetes mellitus [T2DM], hypertension, arthritis) and those 
which affect mental health (e.g., mild cognitive impairment [MCI], Alzheimer’s disease [AD], 
depression). Even though clinicians and public health experts increasingly recognize the complex 
overlay of physical and mental health disorders, older adults may hold distinct views regarding 
what they perceive as physical versus mental health disorders. Unlike physical health conditions, 
a relatively greater deal of stigma associated with late-life mental disorders may be one of the 
major culprits for differences in illness perceptions among older adults with physical disorder and 
those with mental disorder. Also, the ways of screening for, diagnosis of, or treatment for late-life 
mental health conditions are typically made by the consensus of experts, not made by the definite 
ways such as blood tests or X-rays, suggesting that affected older adults with mental disorders may 
have uncertain perceptions about their conditions. Such potential discrepancies in illness 
perceptions may be the key factor for performing or maintaining self-management behaviors (e.g., 
regular exercise, healthy diet, medication taking); therefore, prior to the symptom or disease 
management, understanding individuals’ illness perceptions based on their disease characteristics 
(physical vs. mental) should be taken into consideration.  
For example, since a diagnosis of mental disorder such as MCI is relatively ambiguous in 
the context of its etiology, treatment, or prognosis as compared to those of physical disorder such 
as T2DM, older adults with MCI may not be well informed of risk factors of, or management of 
the disease in comparison to those with T2DM. T2DM and MCI are receiving greater attention 
from researchers and health care professionals because they pose the greatest risks as people age 
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and are leading causes of death among U.S. older adults (CDC, 2019). Regarding MCI, as a 
potential precursor to AD, the fact that no definite ways to cure or manage the disease (Petersen et 
al., 2018) makes affected older adults may feel more anxious about their condition as compared to 
T2DM in that T2DM can be well managed by maintaining healthy lifestyle or taking medications 
(ADA, 2014b). 
Because of such fundamental discrepancies between the disorders in the context of disease 
characteristics (physical vs. mental), and the lack of such investigation, there is a need to 
understand and address similarities and differences in illness perceptions among older adults with 
physical disorders [T2DM] and mental disorders [MCI]. The primary purpose of this study was to 
identify similarities and differences in illness perceptions between older adults with T2DM and 
those with MCI, treating each condition as exemplars of late-life physical and mental disorders 
(Figure 7).  
 
Figure 7 Conceptual Framework (Aim 3) Adapted from Leventhal et al. (2003) 
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4.3 Methods 
4.3.1  Study Design, Sample, and Setting 
In this secondary analysis, a quantitative, cross-sectional, descriptive study was conducted 
using existing baseline data from two clinical trials. For the T2DM parent study (NIH P01-
NR010949), persons with T2DM (n = 167) were recruited from outpatient clinical practice sites 
within the University of Pittsburgh Medical Center (UPMC) Health System. Inclusion criteria for 
the T2DM parent study were as follows: 1) being at least 40 years of age and in treatment for 
T2DM; 2) taking one or more medications prescribed by a physician; 3) self-managing their 
medications; 4) being an English speaker; and 5) having access to a telephone. Exclusion criteria 
for the T2DM sample were as follows: 1) having medications managed by others; 2) being unable 
or unwilling to use a medication diary or electronic event monitor; and 3) participating in other 
intervention research. The MCI sample (n = 90) was recruited from the University of Pittsburgh 
Alzheimer’s Disease Research Center (ADRC; NIH P50-AG005133). Inclusion criteria for the 
MCI parent study (NIH R01-AG046906) were as follows: 1) ≥ 50 years of age; 2) a current ADRC 
consensus diagnosis of MCI; 3) residence within 50 miles of the University of Pittsburgh; 4) 
having a care partner (e.g., family member or kin-like friend); and 5) providing written informed 
consent to participate. Exclusion criteria for the MCI sample were 1) being medically unstable and 
2) having evidence of active, untreated primary psychiatric disorders (e.g., depression, anxiety 
disorder). As this investigation focused on “late-life” chronic disorders, participants with T2DM 
who were younger than 50 years of age (n = 20; 8%) were excluded from the analysis.  
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4.3.2  Measures 
The Brief Illness Perception Questionnaire (Brief IPQ) (Broadbent et al., 2006) is 
comprised of nine questions about an individual’s perceptions of illness and its symptoms. All 
items, consequences, timeline, personal control, treatment control, identity, concerns, coherence, 
and emotional representations, except the causality item, were rated using 0 (not at all) to 10 
(extremely) Likert scaling. The causality item was not included in the analysis because the item is 
an open-ended question. The Brief IPQ is widely used to investigate illness perceptions in chronic 
conditions (Al-Amer et al., 2016; Martinez et al., 2018; Perez, 2015; Saarti et al., 2016) and has 
demonstrated good test-retest reliability and validity (Elizabeth Broadbent, Petrie, Main, & 
Weinman, 2006; E. Broadbent et al., 2015). The original term ‘illness’ was replaced with ‘my 
memory or thinking difficulties’ and ‘diabetes’ in the MCI and T2DM parent studies, respectively.  
In the T2DM parent study, self-reported baseline data on sociodemographics and the 
number of comorbid conditions (in addition to T2DM) were collected using the CRCD 
questionnaires (Sereika & Engberg, 2006). For the MCI sample, sociodemographic information 
(i.e., age, sex, race, years of education, and marital status) and the number of comorbid conditions 
(in addition to MCI) were extracted from the ADRC records.  
4.3.3  Procedure 
Regulatory approval of this study was obtained from the University of Pittsburgh 
Institutional Review Board. All participants from the parent studies provided written informed 
consent prior to data collection. In the T2DM parent study, baseline sociodemographic and clinical 
information data were obtained using the standardized questionnaires (Sereika & Engberg, 2006). 
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In the MCI parent study, trained research assistants conducted face-to-face interviews to ensure 
the validity of participants’ responses. Sociodemographic and clinical information data were 
abstracted from each consenting person’s most recent ADRC record. Since two parent studies used 
the different questionnaires for the variables of number of comorbid conditions, several steps were 
taken to merge these variables into one variable. First, a master’s-prepared nurse researcher 
reviewed and identified differences and similarities among the comorbid condition questionnaires. 
And then, adapted each comorbid condition item in the MCI parent study to the T2DM parent 
study questionnaire, the Center for Research in Chronic Disorders (CRCD) Comorbidity 
Questionnaire (Sereika & Engberg, 2006), because the items in the CRCD questionnaire included 
more comorbid conditions. If there is a discrepancy between the ADRC and the CRCD forms, the 
items were dropped from the final form. For example, we dropped the “vitamin B12 deficiency” 
item because while the ADRC form included this item, the CRCD form did not. Also, if each 
questionnaire investigated similar health conditions, we used more generalized items to include all 
the related health conditions. For example, while the CRCD questionnaire has an item for overall 
heart conditions, the ADRC form used the separate items for the heart conditions such as 
myocardial infarct, congestive heart failure, atrial fibrillation, and angina. If the MCI participants 
answered they have diagnosed with any of these heart conditions, we coded this participant as 
diagnosed with “heart conditions” using the CRCD questionnaire. After the researcher coded and 
entered the comorbid condition data based on the CRCD questionnaire, a doctorally prepared 
statistician reviewed this procedure to verify the data reliability. A total of 15 comorbid conditions 
were identified for this study.  
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4.3.4  Data Analysis 
Prior to analysis, each of the datasets from the T2DM (n = 147) and MCI (n = 90) parent 
studies were screened using descriptive and exploratory methods separately and collectively for 
anomalies (e.g., outliers, missing data, violations of statistical assumptions). The baseline datasets 
from the two parent studies were concatenated for analysis as one dataset based on 
sociodemographic and clinical factors, and each dimension of illness perception. The analysis for 
this investigation was based on 236 participants because one individual (0.68%) from the T2DM 
parent study did not complete the Brief IPQ. Group comparisons were performed for all 
sociodemographic variables by participants’ disease group (MCI or T2DM) using independent t-
tests (for continuous-type variables) or chi-square tests of independence (for categorical variables) 
before analyzing each dimension of illness perception. Sociodemographic information and the 
number of comorbid conditions were examined as potential covariates for each dimension of 
illness perception.  
First, multivariate analysis of covariance (MANCOVA) was performed to compare overall 
illness perceptions between the T2DM and MCI groups treating the eight dimensions of Brief IPQ 
as a set simultaneously. Sociodemographics and the number of comorbid conditions were also 
examined for possible associations with each illness perception variable and, if significant 
associations were found, they were controlled for in the analysis. With the exceptions of timeline 
and coherence dimensions, statistical assumptions were met for each dimension of illness 
perception in the model. Since the dimensions of timeline and coherence were severely negatively 
skewed, these variables were reflected and then a square root transformation of the scales was 
applied. We used both original and transformed variables, which did not change the conclusions 
drawn; therefore, the original variables were used in our analysis.  
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Next, a hierarchical multiple linear regression analysis was conducted for each dimension 
of illness perception because the multivariate tests were statistically significant (F [80, 1800] = 
2.50, p < .001, Pillai’s trace = .380), suggesting that the T2DM and MCI groups have significantly 
different illness perceptions about their conditions. For each dimension of illness perception, three 
successive linear regression models were estimated. In block one, a model with only 
covariates/confounding variables (i.e., age, sex, years of education, marital status, the number of 
comorbid conditions) was estimated. In block two, a primary independent variable (disease group; 
T2DM or MCI) was added, and in the final block, interaction terms between the disease group 
variable (T2DM or MCI) and possible covariates (i.e., age, years of education, number of comorbid 
conditions) were added to explore the interactions on each dimension of illness perception. To 
limit the multicollinearity effects, age, years of education, and number of comorbid conditions 
were centered when creating the interaction terms. All analyses were performed using SPSS® 
Statistics Version 25.0 (IBM Corp., Armonk, NY) and the level of statistical significance for two-
sided hypothesis testing was set at .05. 
4.4 Results 
4.4.1  Sample Characteristics  
Our sample (N = 236; n = 146 [T2DM], n = 90 [MCI]) included participants who were, on 
average of 67.5 ± 9.5 years of age, had 14.9 ± 3.0 years of education, predominantly Caucasian 
(76.7%; n = 181), and with a reported mean 5 number of comorbid conditions ranging from 1 to 
11. Most participants reported living with a significant other or being married (61%; n = 144). 
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T2DM and MCI groups differed significantly across sociodemographic features, except the 
number of comorbid conditions (see Table 19). 
 
Table 19. Sample Characteristics  
(N = 236) 
Variable Total (N = 236) 
T2DM 
(n = 146) 
MCI 
(n = 90) Test Statistic p-value 
Age (years) 
mean ± SD 67.48 ± 9.54 64.38 ± 8.65 72.51 ± 8.77 t(234) = -6.98 < .001 
      
Education (years) 
mean ± SD 14.92 ± 2.98 13.97 ± 2.82 16.48 ± 2.55 t(234) = -6.89 < .001 
      
Sex, n (%) male 116 (49.2) 62 (42.5) 54 (60) 𝑥𝑥2(1) = 6.849 .009 
      
Race, n (%) white 181 (76.7) 98 (67.1) 83 (92.2) 𝑥𝑥2(1) = 19.624 < .001 
      
Marital Status, n (%) 
Married/living with a 
partner 
144 (61) 75 (51.4) 69 (76.7) 𝑥𝑥2(1) = 14.979 < .001 
      
†Number of 
Comorbid Conditions 
(Range Min. – Max.) 
4.98 ± 1.69 
(1–11) 
4.84 ± 1.58 
(1–11) 
5.22 ± 1.85 
(2–10) t(234) = -1.71 .089 
Notes. SD = standard deviation; MCI = mild cognitive impairment; T2DM = type 2 diabetes; Min. = 
minimum; Max. = maximum. 
†Number of comorbid conditions (in addition to MCI and T2DM) was calculated. 
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4.4.2  Illness Perceptions: Type 2 Diabetes vs. Mild Cognitive Impairment 
As indicated in Table 20, the highest mean score among the illness perception dimensions 
was on the timeline (8.77 ± 2.01 [T2DM]; 8.29 ± 2.41 [MCI]) in both groups. The identity (4.10 
± 2.49) and consequences (4.24 ± 2.20) dimensions were the lowest mean scores in the T2DM and 
MCI groups, respectively. Results from hierarchical linear regression models testing similarities 
and differences in each dimension of illness perception between MCI and T2DM groups are 
summarized in Tables 21, 22, 23, and 24. 
Consequences While participants with T2DM and those with MCI did not have significantly 
different perception of consequences of their health conditions, the interaction of participants’ 
disease group (T2DM or MCI) and the number of comorbid conditions was significant (b = -.432, 
p = .027) to the consequences variable (see Table 21).  
Timeline Participants’ race was the powerful predictor of timeline perception which was 
statistically significant in each block of hierarchical regression analyses (Table 21). Disease group 
(T2DM or MCI) was associated with participants’ perception of timeline (b = -.945, p = .008), and 
remained significantly when the interactions were added to the model (b = -.903, p = .013). There 
was a trend for the association between participants’ perception of timeline and the interaction of 
the disease group and age (b = -.062, p = .065).  
Personal control As seen in Table 22, participants’ disease group variable (T2DM or MCI) was 
significantly associated with perception of personal control and remained significant when the 
interaction terms were added to the regression model (b = -.943, p = .009 [block 2]; b = -.893, p = 
.016 [block 3]). However, the interactions of participants’ disease group variable and covariates 
were not significant to participants’ perception of personal control.  
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Treatment control Age was associated with participants’ perception about treatment controllability 
(b = -.035, p = .024) in block 1; however, this association disappeared when adding other predictors 
(see Table 22). Participants’ disease group variable (T2DM or MCI) was significantly associated 
with perception of treatment control in both block 2 (b = -1.619, p < .001) and block 3 (b = -1.435, 
p < .001). The interaction of the disease group variable and participants’ education attainment was 
significant (b = -.270, p = .011) to the treatment control. 
Identity As reported in Table 23, disease group of participants (i.e., T2DM or MCI) was the most 
significant predictor of the identity variable (b = .987, p = .012 [block 2]; b = .922, p = .020 [block 
3]). Interactions did not significantly predict identity variable when entered hierarchically into the 
analysis.  
Concerns Disease group of participants (i.e., T2DM or MCI) was tested in block 2 and the result 
shows that the disease group was associated with participants’ concerns about their health 
conditions (b = 3.273, p < .001), and remained significant when interaction terms were added to 
the model (b = 3.246, p < .001) (see Table 23). The interaction of the disease group variable and 
the number of comorbid conditions was statistically significant (b = -.563, p = .012) to the 
participants’ concerns about their conditions. 
Coherence As shown in Table 24, perceived coherence of participants (i.e., understanding of the 
conditions or its symptoms) was significantly associated with the disease group, T2DM or MCI (b 
= -1.265, p = .001), and this association remained significant when interactions were added to the 
model (b = -1.312, p = .001). The interaction of the disease group variable and age was significant 
(b = 0.080, p = 0.026) to the coherence variable. 
Emotional representations Disease group variable (i.e., T2DM or MCI) of participants was a 
robust predictor of disease-related emotional representations (e.g., anger, anxiety) (b = -2.186, p < 
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.001) (see Table 24). Emotional representations remained significant (b = -2.113, p < .001) when 
interactions were added to the regression model, but we did not observe any interaction effect. 
 
Table 20. Illness Perceptions in T2DM and MCI Participants  
(N = 236) 
 Mean (±SD)/Median Rating 
Dimension of Illness Perception  
(possible Score: 0–10) 
Total  
(N = 236) 
T2DM 
(n = 146) 
MCI 
(n = 90) 
Consequences 4.55 ± 2.49/4 4.74 ± 2.64/5 4.24 ± 2.20/4 
Timeline  8.59 ± 2.18/10 8.77 ± 2.01/10 8.29 ± 2.41/10 
Personal Control 6.24 ± 2.20/6 6.60 ± 2.08/7 5.66 ± 2.26/6 
Treatment Control 7.32 ± 2.17/8 7.97 ± 1.96/8 6.26 ± 2.09/7 
Identity 4.26 ± 2.35/4 4.10 ± 2.49/4 4.52 ± 2.10/4 
Concerns  5.39 ± 3.10/6 4.45 ± 2.99/5 6.93 ± 2.64/8 
Coherence  7.69 ± 2.36/8 8.16 ± 2.36/9 6.91 ± 2.17/7 
Emotional Representations 6.36 ± 2.65/7 7.28 ± 2.34/8 4.86 ± 2.43/5 
Notes. SD = standard deviation; MCI = mild cognitive impairment; T2DM = type 2 diabetes; Min. = 
minimum; Max. = maximum. 
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Table 21. Hierarchical Linear Regression Model of Disease Group (T2DM or MCI) as a Predictor of Consequences and Timeline  
(N = 236) 
  Consequences Timeline 
  Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
  Unstandardized Regression Coefficients 
Block Predictor b p value b p value b p value b p value b p value b p value 
1 (Constant) 7.460 <0.001 7.461 <0.001 6.710 0.001 8.547 <0.001 6.794 <0.001 5.464 0.003 
 Age (years) -0.027 0.129 -0.027 0.161 -0.028 0.259 -0.009 0.566 0.008 0.635 0.030 0.158 
 Malea 0.151 0.664 0.151 0.665 0.175 0.614 -0.288 0.349 -0.282 0.352 -0.278 0.358 
 Whiteb -0.366 0.400 -0.366 0.402 -0.428 0.329 1.017 0.008 1.068 0.005 1.041 0.007 
 Education (years) -0.105 0.071 -0.105 0.089 -0.114 0.135 0.027 0.600 0.075 0.163 0.062 0.355 
 
Married/ 
living with a 
partnerc 
<0.001 0.999 -0.001 0.999 -0.028 0.942 -0.173 0.595 0.012 0.970 0.024 0.942 
 
†Comorbid 
condition 0.137 0.163 0.137 0.166 0.340 0.012 -0.058 0.506 -0.037 0.668 -0.019 0.874 
2 MCId   0.001 0.999 0.020 0.962   -0.945 0.008 -0.903 0.013 
‡3 MCI × age      -0.008 0.831     -0.062 0.065 
 MCI × education     0.062 0.629     0.085 0.450 
 MCI × comorbid 
condition 
    -0.432 0.027     -0.049 0.771 
 𝑅𝑅2 0.045 0.045 0.068 0.036 0.065 0.082 
 Adjusted 𝑅𝑅2 0.020 0.015 0.026 0.011 0.036 0.041 
Notes. MCI = mild cognitive impairment; T2DM = type 2 diabetes. 
†Number of comorbid conditions (in addition to MCI and T2DM conditions) was calculated. 
‡For interactions, age, education, and number of comorbid conditions were mean centered due to multicollinearity. 
a Female was treated as the reference category for sex. 
b Non-white was treated as the reference category for race. 
c The combined category of never married, widowed, separated, or divorced was treated as reference category for marital status. 
d T2DM was treated as the reference category for disease group. 
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Table 22. Hierarchical Linear Regression Model of Disease Group (T2DM or MCI) as a Predictor of Personal Control and Treatment Control 
(N = 236) 
  Personal Control Treatment Control 
  Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
  Unstandardized Regression Coefficients 
Block Predictor b p value b p value b p value b p value b p value b p value 
1 (Constant) 7.801 <0.001 6.052 <0.001 5.107 0.006 11.633 <0.001 8.630 <0.001 6.275 <0.001 
 Age (years) 0.002 0.881 0.019 0.254 0.036 0.098 -0.035 0.024 -0.006 0.718 0.012 0.555 
 Malea -0.117 0.706 -0.111 0.716 -0.125 0.683 -0.540 0.072 -0.530 0.064 -0.578 0.042 
 Whiteb -0.205 0.596 -0.153 0.688 -0.165 0.669 0.075 0.842 0.163 0.648 0.065 0.855 
 Education (years) -0.045 0.386 0.003 0.953 0.015 0.822 -0.074 0.136 0.008 0.878 0.107 0.087 
 
Married/ 
living with a 
partnerc 
-0.452 0.170 -0.267 0.422 -0.243 0.466 -0.304 0.340 0.014 0.964 0.059 0.849 
 
†Comorbid 
condition -0.114 0.194 -0.093 0.284 -0.156 0.193 -0.096 0.256 -0.060 0.455 -0.079 0.472 
2 MCId   -0.943 0.009 -0.893 0.016   -1.619 <0.001 -1.435 <0.001 
‡3 MCI × age      -0.040 0.248     -0.027 0.389 
 MCI × education     -0.016 0.887     -0.270 0.011 
 MCI x comorbid condition 
    0.129 0.454     0.049 0.757 
 𝑅𝑅2 0.032 0.061 0.068 0.277 0.404 0.438 
 Adjusted 𝑅𝑅2 0.007 0.032 0.027 0.053 0.137 0.156 
Notes. MCI = mild cognitive impairment; T2DM = type 2 diabetes. 
†Number of comorbid conditions (in addition to MCI and T2DM conditions) was calculated. 
‡For interactions, age, education, and number of comorbid conditions were mean centered due to multicollinearity. 
a Female was treated as the reference category for sex. 
b Non-white was treated as the reference category for race. 
c The combined category of never married, widowed, separated, or divorced was treated as reference category for marital status. 
d T2DM was treated as the reference category for disease group. 
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Table 23. Hierarchical Linear Regression Model of Disease Group (T2DM or MCI) as a Predictor of Identity and Concerns  
(N = 236) 
  Identity Concerns 
  Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
  Unstandardized Regression Coefficients 
Block Predictor b p value b p value b p value b p value b p value b p value 
1 (Constant) 5.146 <0.001 6.977 <0.001 7.233 <0.001 3.260 0.063 9.332 <0.001 9.774 <0.001 
 Age (years) -0.004 0.817 -0.022 0.237 -0.023 0.319 0.002 0.916 -.056 0.011 -0.081 0.004 
 Malea -0.101 0.763 -0.107 0.746 -0.067 0.838 -0.016 0.972 -.036 0.929 -0.002 0.996 
 Whiteb -0.306 0.465 -0.360 0.385 -0.359 0.387 -0.132 0.809 -.312 0.533 -0.365 0.466 
 Education (years) -0.046 0.406 -0.096 0.100 -0.155 0.033 0.044 0.544 -.122 0.085 -0.128 0.142 
 
Married/ 
living with a 
partnerc 
-0.020 0.956 -0.213 0.553 -0.248 0.488 0.686 0.142 .044 0.920 -0.009 0.983 
 
†Comorbid 
condition 0.073 0.438 0.052 0.582 0.191 0.137 0.202 0.105 .130 0.253 0.399 0.010 
2 MCId   0.987 0.012 0.922 0.020   3.273 <0.001 3.246 <0.001 
‡3 MCI × age      -0.012 0.735     0.053 0.228 
 MCI × education     0.199 0.104     0.020 0.892 
 MCI × comorbid 
condition 
    -0.305 0.100     -0.563 0.012 
 𝑅𝑅2 0.013 0.041 0.066 0.024 0.196 0.223 
 Adjusted 𝑅𝑅2 -0.013 0.011 0.025 -0.002 0.172 0.188 
Notes. MCI = mild cognitive impairment; T2DM = type 2 diabetes. 
†Number of comorbid conditions (in addition to MCI and T2DM conditions) was calculated. 
‡For interactions, age, education, and number of comorbid conditions were mean centered due to multicollinearity. 
a Female was treated as the reference category for sex. 
b Non-white was treated as the reference category for race. 
c The combined category of never married, widowed, separated, or divorced was treated as reference category for marital status. 
d T2DM was treated as the reference category for disease group. 
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Table 24. Hierarchical Linear Regression Model of Disease Group (T2DM or MCI) as a Predictor of Coherence and Emotional Representations 
(N = 236) 
  Coherence  Emotional Representations 
  Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
  Unstandardized Regression Coefficients 
Block Predictor b p value b p value b p value b p value b p value b p value 
1 (Constant) 9.336 <0.001 6.989 <0.001 8.630 <0.001 13.156 <0.001 9.101 <0.001 7.722 <0.001 
 Age (years) -0.026 0.123 -0.003 0.855 -0.031 0.165 -0.075 <0.001 -0.036 0.050 -0.012 0.614 
 Malea -0.485 0.140 -0.478 0.138 -0.485 0.130 -0.666 0.062 -0.652 0.052 -0.673 0.045 
 Whiteb -0.510 0.215 -0.441 0.273 -0.408 0.312 0.192 0.665 0.312 0.455 0.294 0.486 
 Education (years) 0.021 0.700 0.085 0.134 0.106 0.130 -0.051 0.391 0.060 0.308 0.079 0.285 
 
Married/ 
living with a 
partnerc 
-0.423 0.226 -0.174 0.617 -0.187 0.590 -0.615 0.104 -0.186 0.609 -0.151 0.677 
 
†Comorbid 
condition 0.134 0.150 0.162 0.077 0.134 0.281 -0.084 0.401 -0.036 0.702 -0.125 0.337 
2 MCId   -1.265 0.001 -1.312 0.001   -2.186 <0.001 -2.113 <0.001 
‡3 MCI × age      0.080 0.026     -0.057 0.130 
 MCI × education     -0.121 0.307     -0.027 0.830 
 MCI × comorbid 
condition 
    0.073 0.684     0.182 0.330 
 𝑅𝑅2 0.059 0.103 0.128 0.124 0.229 0.240 
 Adjusted 𝑅𝑅2 0.034 0.076 0.089 0.101 0.206 0.206 
Notes. MCI = mild cognitive impairment; T2DM = type 2 diabetes. 
†Number of comorbid conditions (in addition to MCI and T2DM conditions) was calculated. 
‡For interactions, age, education, and number of comorbid conditions were mean centered due to multicollinearity. 
a Female was treated as the reference category for sex. 
b Non-white was treated as the reference category for race. 
c The combined category of never married, widowed, separated, or divorced was treated as reference category for marital status. 
d T2DM was treated as the reference category for disease group. 
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4.5 Discussion 
The present study is the first investigation comparing older adults’ illness perceptions in 
chronic disorders based on the disease characteristics, physical or mental conditions. As the field 
of research on chronic disorders moves toward identifying secondary prevention strategies, our 
investigation of T2DM and MCI participants will provide the clinical and public health 
significance of individuals’ unique perceptions about their health conditions. Such perceptions are 
related to subsequent self-management behaviors, and ultimately may affect individuals’ health 
outcomes such as quality of life (Dempster, Howell, & McCorry, 2015). Our analysis showed that, 
in general, illness perceptions were different between older adults with T2DM and those with MCI 
when the set of illness perception dimensions were examined multivariately. When the dimensions 
of illness perception were tested separately, with the exception of the consequences dimension, 
each dimension of illness perception was significantly associated with individuals’ disease 
characteristics, T2DM or MCI.  
Participants with T2DM were more likely than those with MCI to view their condition as 
being chronic and controllable. Similarly, participants with T2DM endorsed having a more clear 
understanding of, and more negative feelings (e.g., anger, upset) about their condition as compared 
to those with MCI. In contrast to these findings, persons with MCI were more likely to experience 
physical symptoms, and have higher levels of concerns about their condition compared to those 
with T2DM. Not surprisingly, the highest mean score was on the timeline dimension in both T2DM 
and MCI groups, suggesting that our participants tended to believe that their conditions will be 
long-lasting rather than short-term regardless of the disease characteristics.  
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Perceived controllability: physical disorder [T2DM] vs. mental disorder [MCI] 
According to the state of the science for late-life chronic conditions, physical conditions 
(e.g., T2DM, hypertension, and arthritis) have more promising ways to prevent or delay the disease 
progression (e.g., lifestyle change and medication taking) as compared to mental conditions (e.g., 
MCI, AD, and depression). Our findings of significant differences in control perceptions between 
older adults with T2DM and those with MCI support such scientific phenomenon. Specifically, 
our analyses revealed that participants with T2DM tended to believe their condition as being more 
controllable through personal strategies and/or medical treatment as compared to those with MCI. 
These findings are congruent with previous studies of persons with physical conditions that higher 
levels of perceived personal and/or treatment controls were noted in both Stalling’s (2016) study 
of 204 persons with hypertension and in Wierenga’s (2017) study of 58 persons with heart failure. 
While physical disorders such as T2DM are manageable chronic conditions so that persons living 
with T2DM can live long and healthy if they maintain healthy life styles or take medications (if 
prescribed), the facts remain that no medications or interventions for MCI make patients feel less 
control over their condition. This may be the reason that our T2DM participants had significantly 
higher perceptions of both personal and treatment controls over their condition.  
Given that control perceptions have been identified as a driver of problem-focused coping 
strategies (Hagger et al., 2017), lower disability, and positive health outcomes such as better 
functioning at work and better family relationships (Baines & Wittkowski, 2013; Broadbent et al., 
2015) regardless of the disease characteristics, our findings suggest that older adults with physical 
disorders [T2DM] may tend to seek information or assistance in managing their conditions as 
compared to those with mental disorders [MCI]. 
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Perceived Understanding in Physical Disorder [T2DM] and Mental Disorder [MCI] 
Our participants with MCI had significantly lower coherence perception as compared to 
those with T2DM, indicating that MCI participants endorsed the view that their cognitive or 
memory difficulties do not make sense to them or, are not easily understandable, so that such a 
lack of coherence may lead to poor treatment compliance. Although prior studies of individuals’ 
coherence perception have been focused on either mental (Hussain et al., 2017; Lingler et al., 
2016) or physical (Kristoffersen, Lundqvist, & Russell, 2019; Nie et al., 2018; Stallings, 2016) 
conditions, our finding does support previous research that persons with mental disorders were 
more likely than those with physical disorders to have lower levels of perceived understanding 
about their conditions. The mood and anxiety disorder groups reported the lowest scores on the 
coherence item among the dimensions of illness perceptions in a study by Subramanian et al. 
(2018), whereas persons with hypertension had a higher perceived understanding about their 
condition (Stallings, 2016). Such discrepancy may reflect differences in disease characteristics, for 
example, the diagnostic process or monitoring of disease progression of mental disorders 
differentiates it from physical health disorders with the definitive indicators (e.g., blood tests, urine 
test, and imaging tests).  
Concerns about patients’ uncertainty about their own mental disorders have also surfaced 
in research on the MCI population. The findings of a metasynthesis of 17 MCI qualitative 
interviews (Gomersall et al., 2015) were similar to our findings that persons with MCI were 
confused about their cognitive decline, indicating that the unclear course of the disease and the 
lack of secondary prevention strategies for AD may be related to less understanding about the 
disease in persons with MCI. In a study by Lin et al. (2012) also reported that, one third of 
participants believed MCI would convert to dementia, but most participants with MCI were not 
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sure the prognosis of their memory problems, which provides context for the current finding of 
lower perception of illness coherence in older adults with MCI as compared to those with T2DM. 
Our analysis of coherence perception in persons with T2DM is also consistent with previous 
research. For example, cross-sectional studies have revealed persons with T2DM to clearly 
understand their health conditions (Al-Amer et al., 2016; Nie et al., 2018), and in a qualitative 
interview (Tanenbaum et al., 2015), data revealed an understanding about the course of, and 
management of the condition among persons with T2DM. Tanenbaum et al. (2015) also 
highlighted that the level of understanding about T2DM is a key factor for subsequent self-
management behaviors. Considering that higher perception of illness coherence has been 
significantly associated with problem-focused coping strategies (e.g., asking for assistance and 
seeking out information) and well-being in persons with chronic disorders (Hagger et al., 2017), 
persons with physical disorders such as T2DM may be more likely than those with mental 
disorders such as MCI to engage in obtaining helpful information on available support systems.  
Interestingly, persons with T2DM had more negative feelings (e.g., anger and anxiety) 
about their condition as compared to those with MCI which was not expected. One potential reason 
for this finding is that persons with T2DM may be overwhelmed by negative feelings because 
T2DM needs a life-long, careful management including checking blood glucose levels, following 
the healthy meal plans, or taking medications if prescribed (Aljuaid, Almutairi, Assiri, Almalki, & 
Alswat, 2018). In contrast to T2DM, persons with MCI may remain stable or return to a cognitively 
intact state (Petersen et al., 2018), suggesting that persons with MCI may have less negative 
feelings than those with T2DM because the diagnosis does not necessarily mean an AD diagnosis. 
Other factors impact on negative feelings among older adults with chronic disorders should be 
investigated. 
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Given differences in illness perceptions between older adults with T2DM and those with 
MCI, clinicians and public health experts should not only focus on individuals’ disease 
characteristics (physical vs. mental), but also take into account individuals’ unique perceptions 
about the health conditions when discussing and planning self-management behaviors. Future 
studies are needed to investigate the association between illness perceptions and self-management 
behaviors in older adults with chronic disorders, depending on the disease characteristics, either 
physical or mental disorder.    
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5.0 Summary of Dissertation Findings 
This dissertation project is comprised of three complementary studies to address gaps in 
knowledge on illness perceptions and self-management in late-life chronic disorders. Findings are 
documented in the following three manuscripts: 
Manuscript 1. Illness Perceptions and Self-management among Older Adults with Mild 
Cognitive Impairment 
Manuscript 2. Illness Perceptions, Self-efficacy, and Medication Adherence among Older 
Adults with Type 2 Diabetes 
Manuscript 3. Illness Perceptions in Type 2 Diabetes and Mild Cognitive Impairment 
Although each manuscript described a study with a unique purpose, the findings together 
advance understanding of illness perceptions and self-management among older adults with 
chronic disorders by highlighting the influence of disease characteristics, specifically whether the 
condition represents a physical [T2DM] or mental [MCI] disorder. I adapted Leventhal’s (1984, 
2003) Common Sense Model (CSM) of Self-Regulation as a conceptual framework for this set of 
studies. The rationale for selecting this framework is that, unlike other models, the CSM 
framework places illness perceptions into the center of the process around the performance of 
health behaviors. Below is a summary of the key messages embedded within this framework. 
First, illness perceptions can independently, or through their interactions with 
sociodemographic characteristics/comorbid conditions, be associated with either self-
efficacy or self-management among older adults with chronic disorders. For example, in our 
sample of persons with MCI, a trend in the association between illness perceptions and self-
management was only observed when considering sociodemographic characteristics or the number 
of comorbid conditions (manuscript 1). Illness perceptions were associated with both self-efficacy 
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and medication adherence among older adults with T2DM, which suggests that beliefs about 
T2DM may play an important role in managing T2DM (manuscript 2). Taken together, these 
findings confirm previous research that not only illness perceptions, but sociodemographics and 
comorbid conditions may also affect self-management practices to prevent or delay disease 
progression among older adults with chronic disorders. This finding holds true regardless of one’s 
disease characteristics. A recent meta-analysis suggests that certain dimensions of illness 
perceptions, such as perceived controllability and illness coherence, are associated with either 
coping strategies or well-being among persons with chronic disorders (Hagger et al., 2017). 
Indeed, nurses and other health care professionals who are counseling older adults with chronic 
disorders should consider patients’ perceptions about their health conditions together with 
sociodemographic characteristics and comorbid conditions. 
Another core message from this dissertation project is that patients’ disease 
characteristics (physical [T2DM] or mental [MCI]) play a critical role in how older adults 
formulate perceptions about health conditions affecting them. Specifically, our tests of effect 
of disease characteristics (T2DM or MCI) revealed significant differences in illness perceptions 
between T2DM and MCI participants after controlling for covariates (manuscript 3). Although 
both T2DM and MCI participants believed that their conditions will be long-lasting, our 
participants with T2DM were more likely than those with MCI to view their condition as being 
controllable and understandable. This may reflect distinct differences in disease characteristics 
between late-life physical and mental disorders. For example, stigma associated with late-life 
cognitive changes and the fact that there is no curative treatment for MCI may contribute to lower 
levels of perceived controls over and understanding of a health condition among our participants 
with MCI. While illness perceptions may affect subsequent self-management behaviors in chronic 
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disorders (Leventhal et al., 2016), other factors such as sociodemographics and comorbid 
conditions may also serve as facilitators or barriers to self-management in chronic disorders 
(Schulman-Green, Jaser, Park, & Whittemore, 2016). Therefore, understanding patients’ unique 
illness perceptions based on their disease characteristics (physical or mental) as well as other 
factors (sociodemographics and comorbid conditions) is a first step to improve self-management 
in late-life chronic disorders.  
In sum, this dissertation advances the current state of scientific knowledge with regard to 
illness perceptions and self-management as well as self-efficacy within the context of late-life 
physical [T2DM] and mental [MCI] disorders. Knowledge obtained from this dissertation project 
suggests direction of future research including:  
1) Longitudinal investigations exploring the causal relationship between illness perceptions 
and self-management in late-life chronic disorders. 
2) Identifying a mediating role of self-efficacy in the relationship between illness 
perceptions and self-management. 
3) Testing a full CSM process in which associations between illness perceptions, self-
management, and health outcomes are considered. 
4) Validating and extending findings in samples comprised of persons experiencing other 
late-life physical and mental disorders. 
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Appendix A: Study Instruments and Assessments 
Brief Illness Perception Questionnaire (Brief IPQ)  
For the following questions, please circle the number that best corresponds to your views: 
(Note. The term “your illness” was replaced with “diabetes” or “your memory difficulties/MCI” 
in the parent studies) 
 
1.How much does your illness affect your life? 
 
 0 1 2 3 4 5 6 7 8 9 10 
no affect severely 
at all affects my life 
2.How long do you think your illness will continue? 
 
 0 1 2 3 4 5 6 7 8 9 10 
a very forever 
short time 
3.How much control do you feel you have over your illness? 
 
 0 1 2 3 4 5 6 7 8 9 10 
absolutely extreme amount 
no control of control 
4.How much do you think your treatment can help your illness? 
 
 0 1 2 3 4 5 6 7 8 9 10 
not at all extremely 
 helpful 
5.How much do you experience symptoms from your illness? 
 
 0 1 2 3 4 5 6 7 8 9 10 
no symptoms many severe 
at all symptoms 
6.How concerned are you about your illness? 
 
 0 1 2 3 4 5 6 7 8 9 10 
no at all extremely 
concerned concerned 
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7.How well do you feel you understand your illness? 
 
 0 1 2 3 4 5 6 7 8 9 10 
don’t understand understand 
at all very clearly 
8.How much does your illness affect you emotionally? (e.g., does it make you angry, 
scared, upset or depressed?) 
 
 0 1 2 3 4 5 6 7 8 9 10 
no at all extremely 
affected emotionally affected 
emotionally 
9.Please list in rank-order the three most important factors that you believe caused 
your illness.  
 
The most important causes for me: 
1.________________________ 
2.________________________ 
3.________________________ 
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Illness Perception Questionnaire-R (IPQ-R): Illness Coherence and Causality Subscales  
 
Illness Coherence Subscale  
The following are five statements about how you view your memory or thinking difficulties. 
Although these statements may seem similar, it is important I read all of them and ask you to rate 
how much you agree or disagree with each one. 
 
Please indicate how much you agree or disagree with the following statements about your illness 
by ticking the appropriate box. 
 
Views About Your Illness 
Strongly 
Disagree Disagree 
Neither 
Agree 
nor 
Disagree 
Agree Strongly Agree 
The symptoms of my memory or 
thinking difficulties are puzzling to 
me 
     
My memory or thinking difficulties 
are a mystery to me      
I don’t understand my memory or 
thinking difficulties      
My memory or thinking difficulties 
doesn’t make any sense to me      
I have a clear picture or 
understanding of my memory or 
thinking difficulties 
     
 
 
 
 
 
 
 
132 
Causality Subscale  
We are interested in what you consider may have been the cause of your memory or thinking 
difficulties. As people are very different, there is no correct answer for this question. We are most 
interested in your own views about the factors that caused your memory or thinking difficulties 
rather than what others including doctors or other family may have suggested to you. 
 
Please list in rank‐order the three most important factors that you believe caused your memory or 
thinking difficulties. 
 
The most important causes for me… 
 
Cause 1:   
 
Cause 2: 
 
Cause 3:  
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Assessment of Intention to Perform Health Behaviors  
(Notes. This questionnaire was used in the first set of MCI parent study. The data will be manually 
recoded to address the items assess by the REVEAL Health Behavior measure [Chao et al., 2008], 
which is provided on the next page.) 
 
Interview Instructions:  Introduce this assessment by informing the participant that the following 
set of questions focuses on his or her plans to perform health-related activities that may have been 
discussed at his or her last clinic visit (use Recommendation Form responses to identify action for 
insertion below). Instruct the participant to select the response that best describes his or her 
intentions.  
 
Section A:  
1. How likely are you to within the next six months?  
Very likely 
Somewhat 
likely 
Not sure 
Somewhat 
unlikely 
Very unlikely 
2. How likely are you to within the next six months?  
Very likely 
Somewhat 
likely 
Not sure 
Somewhat 
unlikely 
Very unlikely 
3. How likely are you to within the next six months?  
Very likely 
Somewhat 
likely 
Not sure 
Somewhat 
unlikely 
Very unlikely 
4. How likely are you to within the next six months?  
Very likely 
Somewhat 
likely 
Not sure 
Somewhat 
unlikely 
Very unlikely 
5. How likely are you to within the next six months?  
Very likely 
Somewhat 
likely 
Not sure 
Somewhat 
unlikely 
Very unlikely 
6. How likely are you to within the next six months?  
Very likely 
Somewhat 
likely 
Not sure 
Somewhat 
unlikely 
Very unlikely 
Section B:  
What, if any, other changes will you make as a result of being diagnosed with mild cognitive 
impairment?  
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Health Behavior Assessment  
Are you currently taking any steps to help prevent further memory problems or the onset of 
Alzheimer's disease? 
 
 
Yes                                                              No  
 
This lists some categories of health or behavior changes that apply to some people. 
As we run down this list, let me know which categories apply to the changes you have made, and 
then specifically what change was made. 
What types of preventative measure are you taking? Since your diagnosis, have you made any… 
 
Preventative Measures    
 Yes Please Specify 
1. Dietary changes  o  
2. Physical activities o  
3. Medications  o  
4. Vitamins o  
5. Herbal Supplements  o  
6. Activities to reduce stress  o  
7. Mental activities (e.g., crossword 
puzzles, luminosity)  
o  
8. Other life style changes (e.g., alcohol 
consumption, driving routine, etc.)  
o  
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Self-Efficacy for Managing Chronic Disease (SEMCD) 
We would like to know how confident you are in doing certain activities. For each of the following 
questions, please choose the number that corresponds to your confidence that you can do the tasks 
regularly at the present time. 
 
1. How confident are you that you can keep the fatigue caused by your diabetes from interfering 
with the things you want to do? 
Not at all 
confident   
Totally 
confident 
1 2 3 4 5 6 7 8 9 10 
 
2. How confident are you that you can keep the physical discomfort or pain of your diabetes 
from interfering with the things you want to do? 
Not at all 
confident   
Totally 
confident 
1 2 3 4 5 6 7 8 9 10 
 
3. How confident are you that you can keep the emotional distress caused by your diabetes from 
interfering with the things you want to do? 
Not at all 
confident   
Totally 
confident 
1 2 3 4 5 6 7 8 9 10 
 
4. How confident are you that you can keep any other symptoms or your diabetes you have 
from interfering with the things you want to do? 
Not at all 
confident   
Totally 
confident 
1 2 3 4 5 6 7 8 9 10 
 
5. How confident are you that you can do the different tasks and activities needed to manage 
your diabetes so as to reduce you need to see a doctor? 
Not at all 
confident   
Totally 
confident 
1 2 3 4 5 6 7 8 9 10 
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6. How confident are you that you can do things other than just taking medication to reduce 
how much your diabetes affects your everyday life? 
Not at all 
confident   
Totally 
confident 
1 2 3 4 5 6 7 8 9 10 
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4-item Morisky Medication Adherence Scale (MMAS- 4) 
 
1. Do you ever forget to take your medication?  
Yes                       No  
2. Are you careless at times about taking your medicine? 
Yes                        No  
3. Sometimes if you feel worse when you take the medicine, do you stop taking it? 
Yes                        No  
4. When you feel better do you sometimes stop taking your medicine?  
Yes                         No  
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